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ABSTRACT 
Humans configure themselves into "neural machines" to perform optimally on distinct 
tasks, and they excel at maintaining such configurations for brief episodes. The neural 
configuration needed for peak performance, however, is subject to perturbations on 
multiple time scales. This thesis reports new empirical analyses and computational 
modeling to advance understanding of the variations in reaction time (RT) on simple RT 
tasks that are associated with the duration of the preceding inter-stimulus interval (order 
of seconds); the time-on-task duration (order of minutes); and sleep deprivation duration 
(order ofhours to days). 
Responses from the psychomotor vigilance task (PVT), including anticipations 
(false alarms), normal RTs, and very long RTs (lapses in attention), were analyzed to 
discover the effects of: the 1 - 9 second inter-stimulus interval (lSI); the 1 0-minute task 
session; up to 50 hours of sleep deprivation (SD); and wake-promoting agents, caffeine 
vi 
and modafinil. Normal RTs and lapses in attention were negatively correlated with lSI 
length, whereas anticipations were positively correlated. Anticipations, normal RTs, and 
lapses increased as time-on-task increased, and during SD. Both caffeine and modafinil 
reduced lapses and anticipations during SD and decreased RT variability. A simple neural 
network model incorporating both a time-dependent inhibitory process and a time-
dependent excitatory process was developed. The model robustly simulated the lSI effect 
on behavior. The SD effects were reproducible with two parameter adjustments. 
Informed modeling of drug effects required greater neurobiological detail. In the 
basal ganglia (BG), adenosine accumulation during SD has two notable effects: it 
antagonizes dopamine to reduce BG responsiveness to incoming _cortical signals, and it 
reduces cholinergic transmission to parietal and prefrontal cortices, thus reducing 
attention to visual signals. A detailed computational model of interactions between BG 
and cortex during PVT was developed to simulate effects of adenosine and their 
amelioration by caffeine. The model simulates drug, lSI and SD effects on anticipations, 
RTs, and lapses. This model can be used to describe the effects of SD over a wide range 
of tasks requiring planned and reactive movements, and can predict and model effects of 
pharmacological agents acting on the adenosinergic, cholinergic and dopaminergic 
systems. 
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CHAPTER! 
INTRODUCTION 
Humans are well equipped to configure themselves into "neural machines" to perform 
optimally on a given task, and to maintain that configuration for brief episodes. Humans, 
however, are not machines: the neural configuration needed to maintain this optimal 
performance is subject to perturbations over multiple time scales. For example, on tasks 
measuring reaction time (RT) to a visual cue, moment-to-moment fluctuations (order of 
seconds) in neural activity introduce noise that results in variable RTs with a dihribution 
between 150 and 250 ms, while the probability of longer RTs and of outright errors of 
omission and commission rise as a function of time as the task episode is extended (order 
of minutes). These sub-optimal responses are further increased as the task is repeated 
during extended sleep deprivation (order of hours to days). Although the neural 
configuration needed for optimal RTs can still be achieved even after 36 hours of sleep 
deprivation (Drummond et al., 2005), it becomes nearly impossible to maintain this 
configuration for a significant portion of the task (Belenky et al., 2003; Van Dong en et 
al., 2003; Dorrian et al., 2005; Santhi et al., 2007; Cohen et al., 2010). 
These observations raise several important questions about the ability to maintain 
the neural configuration necessary for optimal performance. What neural circuits enable a 
person to reconfigure his or her information processing to optimize performance on a 
given task? What circuits are responsible for the susceptibility to normal performance 
1 
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decline related to increasing time on task? What circuits are responsible for the decreased 
ability to maintain optimal performance in the presence of sleep deprivation? 
Qualitative and quantitative models of neural circuits implicated m the 
deterioration of task performance due to inadequate sleep have focused on the roles of 
brainstem regions comprising the ascending arousal system, the thalamus, and areas of 
the cortex receiving cholinergic modulation (Saper et al., 2001; Fuller et al., 2006; 
Tamakawa et al, 2006; Behn et al., 2007; Phillips and Robinson, 2007). Emerging 
evidence, however, suggests an important role for the basal ganglia system (BGS) in the 
regulation of sleep and wake. BGS connections with cortex are organized into distinct 
circuits or loops that reciprocally interconnect diverse cortical areas to control the flow of 
information between and within each loop (Middleton and Strick, 2000); BGS 
connections with motor cortical areas, for example, are central to the control of 
movement. Lesions of different BGS nuclei produce drastic changes in the observed 
amount of sleep and wake across a 24 hour period (Qiu et al., 2010; Vetrivelan et al., 
2010). Furthermore, the endogenous somnogen adenosine, which increases in the 
extracellular space within basal forebrain and thalamus during sleep deprivation (Porkka-
Heiskanen et al., 2002; Basheer et al., 2004), has many of its effects in striatal and 
pallidal regions of the BGS (Xie et al., 2007) as a modulator of psychomotor activation. 
Acetylcholine (ACh), which is involved in both arousal (e.g. Saper et al., 2001; Jones 
2008) and sustained attention during task performance (e.g. Parikh and Sarter 2008), is 
opposed by adenosine in both cortical and sub-cortical regions (e.g. Van Dort et al., 
2009). Changes in response latencies observed across sleep deprivation may, therefore, 
-:;;·.;-_ 
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be the result of both local (BGS) and global (cortex) effects of adenosine. 
The goal of the dissertation is to present and assess evidence to further elaborate 
and refine a hypothesis regarding how the effects of adenosine in BGS and cortex may 
mediate changes in R T observed under sleep deprivation. This evidence will be presented 
in three parts: (1) the proposal of a conceptual model, based on an extensive literature 
review, of how the action of adenosine in BGS nuclei can give rise to the effects on sleep 
and wake observed in lesion studies; (2) an empirical analysis of experimental data to 
explore changes in RT over three time scales, and a simple computational model to 
describe these changes; and (3) a detailed computational model of BGS interactions with 
cortex and thalamus to describe adenosinergic, cholinergic and dopaminergic effects on 
RTs under sleep deprivation, including the effect ofthe wake-promoting agents caffeine 
and modafinil. The remainder of this introduction will review the existing literature on 
the behavioral effects of sleep deprivation on RTs, reprise results from neuroimaging 
studies that have probed the neural circuits underlying responses on simple RT tasks, and 
introduce some evidence for cholinergic and adenosinergic effects within these circuits. 
1.1 Effects of acute sleep deprivation on reaction time 
Acute sleep deprivation is defined as sleep loss over a single continuous waking episode. 
The effects of acute sleep deprivation on cognitive function have been reported for 
several tasks, including increased latencies and errors in tests of vigilant attention 
(Belenky et al., 2003; Van Dongen et al., 2003; Dorrian et al., 2005 ; Santhi et al., 2007), 
reduced working memory (Van Dongen et al., 2003; Wyatt et al., 2004; Mu et al., 2005; 
I> 
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Chee et al., 2006), and impaired decision making (Chuah et al., 2006; Venkatraman et al., 
2007). The primary focus of this dissertation is the effect of sleep loss on response 
latencies on tasks probing RT to the onset of a stimulus. 
The psychomotor vigilance task (PVT) is a simple reaction time task that has been 
used extensively as a sensitive index of changes in attentiveness associated with sleep 
loss in humans (Dinges and Powell, 1985; Belenky et al., 2003; Van Dongen et al., 2003; 
Wyatt et al., 2004; Dorrian et al., 2005; Santhi et al., 2007; Cohen et al., 2010). The PVT 
requires rapid execution of the same pre-planned action to each onset of a stimulus that 
recurs after a variable interval ranging from 1 to 9 seconds. Outcome measures from the 
PVT include mean or median reaction times (RTs) across a n-minute task (the most 
common protocol utilizes n = 10); lapses, which are often defined as RTs greater than 
500 ms; and anticipations, often defined as RTs less than 100 ms. The latter are also 
called false alarms or errors of commission, because the short (sometimes negative) RT 
is less than the physiologically-possible response time and indicates that the participant 
did not wait for cue onset before initiating response generation. 
Sleep deprivation is marked by a shift towards longer mean and median RT and 
increases in lapses in attention and anticipations. In most analyses, any response over 500 
ms is considered a lapse in attention, although this cut off does not account for inter-
individual differences in response times (Santhi et al., 2007). :A recent study found that 
not all lapses are equal: lapses just above 500 ms were likely to occur when the subject's 
eyes were open facing in the direction of the stimulus, lapses longer than 2 seconds were 
more likely to occur when the subject's eyes were closed, and intermediate-length lapses 
5 
were due to prolonged fixation on a distractor stimulus (Anderson et al., 2010). Longer 
lapses may, therefore, reflect complete disengagement from the task. Anticipations may 
reflect the opposite: a hyper-activity of the task mode resulting in reduced ability to 
inhibit a response. 
1.2 Neurobiology of reaction time 
Successful performance of a simple reaction time task requires recruitment of sensory 
processes to detect the stimulus and motor processes to execute a response with 
intermediate processes to transform the stimulus into the appropriate motor response. The 
neural circuits activated during simple reaction time tasks have been extrapolated from a 
wealth of primate studies, with recent contributions from human neuroimaging studies 
(Wu et al., 1991; Naito et al., 2000; Oguz et al., 2003; Kansaku et al., 2004). Processing 
of the stimulus requires a right frontoparietal attention system, including the right middle 
frontal gyrus (rMFG), the right inferior parietal lobes (riPL), the right anterior cingulate 
cortex (rACC) and the right thalamus (Kinomura et al., 1996; Sturm and Willmes, 2001; 
Drummond et al., 2005); some of these regions are also proposed to mediate the 
transformation of the stimulus into the appropriate motor response (Hare et al., 2011). 
The motor circuit that generates the movement for response includes primary motor and 
premotor cortices (lateral and medial) as well as "motor" thalamic nuclei and basal 
ganglia regions that include the dorsal striatum, the internal globus pallidus (GPi), and 
the sub-thalamic nucleus (STN). 
Several human flv1RI studies have differentiated the neural circuits underlying fast 
''-.~··.~<.~. .-_ .· . ~ .' .. - .·-
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as compared to slow RTs. Fast RTs are generated by a network that includes activation of 
both the motor circuit (including cortical motor areas, BGS, and thalamus) and the 
frontoparietal attention network (Sturm and Willmes, 2001; Oguz et al., 2003; 
Drummond et al., 2005). Slow RTs, including lapses in attention, were associated with 
increased activation of the ACC (Naito et al., 2000; Rushworth et al. 2007) as well as the 
medial and superior frontal gyri (Drummond et al., 2005; Weissman et al., 2006). 
Although the ACC is implicated in the frontoparietal attention network, and would 
therefore be expected to activate during fast RTs, further probing into the role of the ACC 
has suggested that increased activity in this region during sustained attention tasks serves 
to re-engage the attentional system, particularly following detected performance errors 
(Aston-Jones and Cohen, 2005; Eichele et al., 2008). Errors of commission 
(anticipations) have also been associated with increased activation of the ACC and 
middle frontal gyrus (Kiehl et al., 2000). 
Fast RT trials studied under sleep deprivation show the same fMRl activation 
pattern in the motor circuit and frontoparietal attention network as observed during rested 
conditions. The activation pattern during slow RT trials under sleep deprivation 
compared to slow RT trials under rested conditions, however, shows marked differences: 
greater activity is observed in the medial frontal, superior frontal, and ventral anterior 
cingulate gyri and reduced activity is observed in visual cortex (Chee et al., 2008) and 
thalamus (Wu et al., 1991; Chee et al., 2008; Tomasi et al., 2009) during slow RTs 
generated under sleep deprivation. These brain regions are associated with the default-
mode network, which is most active during times of quiet rest (Raichle et al., 2001); it 
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has been shovm that the functional connectivity between the default-mode network and 
the task-activated network is disrupted following sleep deprivation (Gujar et al., 201 0; 
Samann et al., 2010; De Havas et al., 2012). Slow RTs, therefore, may be due to the extra 
time required for the brain to switch from the default-mode network to the task-mode 
network. 
1.3 Cholinergic and adenosinergic modulation of the reaction time network 
1.3.1 Cholinergic modulation ofthefrontoparietal attention network 
Cortical cholinergic modulation arising from the basal forebrain plays an important role 
in regulating the activity of the frontoparietal attention network for cue detection during 
attentional tasks. Frontoparietal ACh efflux increases at the onset of a sustained attention 
task, remains elevated during the task, and declines to below pre-task levels at the end of 
the task (Sarter et al., 1996; Himmelheber et al., 2000; Passetti et al., 2000; Dalley et al., 
2001; Arnold et al., 2002). RT may be affected by ACh levels in the frontoparietal 
network: accelerated response latencies on a working memory task were observed 
following pharmacological increases in ACh in the posterior parietal cortex (Furey et al., 
2000). Cholinergic augmentation has also been demonstrated to both increase task-related 
activation in parieto-occipital areas and improve visual task performance that has been 
degraded by sleep deprivation (Chuah and Chee, 2008). 
The relationship between RT and ACh may, however, be more complex. 
Response latencies to visual cues are increased when cues are presented with distractor 
stimuli, and these response latencies are further increased by cholinergic deafferentation 
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in both posterior parietal cortex (PPC) and medial pre-frontal cortex (mPFC) without 
changing the response latency (or number of false alarms) to visual cues presented 
without distractors (Gill et al., 2000; Newman and McGaughy, 2008; Broussard et al., 
2009). These fmdings suggest an important role of cortical ACh in top-down suppression 
of task irrelevant stimuli during sustained attention tasks. For example, increases of 
lapses in attention, particularly in the presence of distractor stimuli (Anderson et al., 
201 0), may be due to changes in ACh levels in the frontoparietal network during sleep 
deprivation. 
1.3.2 Adenosinergic modulation of psychomotor response in the basal ganglia 
Whereas ACh exerts its effects on RT primarily through the right frontoparietal attention 
network, adenosine may have its primary effects on motor output through the basal 
ganglia. In the BGS, two neuronal circuits, known as the direct and indirect pathways, 
jointly determine the intensity ofthalamic excitation of motor cortex, and thereby control 
the initiation and execution of movement. As elegantly summarized in a review by Xie et 
al. (2007), both A1 and A2A subtypes of adenosine receptors are expressed in basal 
ganglia. A1Rs are expressed primarily in the direct pathway, wherein their activation has 
an inhibitory effect on locomotor output, and A2ARs are expressed primarily in the 
indirect pathway, wherein their activation has an excitatory effect on locomotor output. 
Adenosine thus acts synergistically on the direct and indirect pathways to suppress 
movement, in opposition to dopamine's synergistic effects to promote movement. 
Arousal and locomotor effects of caffeine may be mediated primarily through the 
striatal adenosine receptors (Xie et al., 2007). An increase in wakefulness following 
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caffeine administration was observed in wild-type and ArR knockout mice, but not in 
A2AR knockout mice (Huang et al, 2005); in a follow up study, the A2AR-mediated effect 
of caffeine was reported to be specific to A2ARs in the shell of the nucleus accumbens 
(Lazarus et al., 2011 ), i.e. in ventral striatum. Another study reported that performance on 
a choice RT task tested in rats was improved by caffeine and other A2AR antagonists, but 
not by ArR antagonists (Higgins et al., 2007). Other studies, however, report A1R-
mediated effects of caffeine on arousal (Maximino et al., 2011), particularly in pre-frontal 
cortex 01 an Dort et al., 2009). These results suggest that in BGS caffeine acts primarily 
through adenosine A2ARs to inhibit the indirect pathway, which disinhibits direct 
pathway promotion of locomotor activity. Recent lesion studies of striatal and pallidal 
regions of the basal ganglia further support a role for the BGS in the regulation of cortical 
activity during wake and sleep (Qiu et al., 201 0; Vetrivelan et al., 201 0). 
1.3.3 Adenosinergic effects on cholinergic transmission 
In addition to the effects of adenosine on the direct and indirect pathways of the BGS, 
adenosine has significant effects on cortical cholinergic activity. Adenosine is released by 
the basal forebrain (BF) and increases in a dose-dependent manner under prolonged 
wakefulness, but decreases back toward rested levels during sleep (Porkka-Heiskanen et 
al., 2002; Basheer et al., 2004). Most evidence points to an A1R dependence of the 
somnogenic effects of adenosine in the cholinergic BF (e.g. Strecker et al., 2000; 
Stenberg et al., 2003; Thakkar et al., 2003). Perfusions of ArR and A2AR agonists in PFC 
have opposite effects on ACh levels: A2AR agonists increased cortical ACh release in 
PFC while A1R agonists decreased cortical ACh release 01 an Dort et al., 2009). 
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Adenosine acting on cholinergic BF neurons also affects performance: adenosine 
perfusion into cholinergic BF increases response latencies on a version of the 
psychomotor vigilance test conducted in rats (Christie et al., 2008). 
1.4 Organization of the dissertation 
Chapter 2 reviews an emerging body of literature for the role of the basal ganglia in the 
regulation of sleep and wake. In this chapter, a conceptual model of the local action of 
adenosine in the BGS is proposed to explain the basal ganglia lesion studies at the heart 
of the hypothesized role of the BGS in sleep and wake. Chapter 3 presents an empirical 
analysis of behavioral data from PVT tasks performed while rested, und~r sleep 
deprivation, and during placebo or pharmaceutical interventions that acted on the 
adenosinergic (caffeine) and dopaminergic (modafinil) systems. These analyses allow 
characterization of statistically reliable effects at three time scales: moment-to-moment 
changes in anticipations, normal RTs, and lapses dependent on the inter-stimulus interval 
(lSI); performance waning in the form of unfavorable changes in these measures that 
depend on the elapsed time-on-task (TOT); and performance waning that depend on the 
amount of sleep deprivation. Chapter 3 also introduces a simple network model to 
simulate the main observed behavioral trends. It assumes a simplified BGS, and does not 
model drug effects. Chapter 4 presents a formal computational model of the BGS with 
interactions between cortex and thalamus that incorporates effects of adenosine locally 
within the BGS, effects of ACh on the frontoparietal network and interactions between 
adenosine, dopamine and ACh. This computational model successfully simulates the 
I .· 
I 
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PVT data described in Chapter 3 and generates predictions for other reaction time tasks 
not previously studied under sleep deprivation. Chapter 5 concludes the dissertation with 
a discussion of highlights of the statistical and neural models, how changes in 
performance associated with sleep deprivation arise in neural circuits, and suggestions of 
future directions for related research. 
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CHAPTER2 
BEYOND BRAINSTEM CONTROL OF SLEEP, WAKE AND 
VIGILANCE: ASSESSING THE ROLE OF THE BASAL GANGLIA 
SYSTEM 
2.1 Introduction 
Sleep is a state of conscwusness defmed behaviorally by decreased response to 
stimulation and a marked reduction in most motor activity. A notable motoric exception 
is that many species exhibit a "paradoxical" sleep characterized by rapid eye movement 
(REM). Unlike apparently similar states such as torpor, coma or anesthesia, sleep affords 
a quick transition to wake. A sleep-like state appears across species as diverse as fruit 
flies, fish, birds, and mammals. In birds and most mammals, sleep is divided into separate 
NREM (non-REM) and REM phases, although recent studies revealed that in egg-laying 
mammals (monotremes), high-voltage NREM activity in the forebrain occurs 
simultaneously with REM-associated activity patterns in the brainstem (Siegel, 2009). 
Three stages ofNREM sleep can be identified by surface electroencephalography (EEG). 
Called N1, N2 and N3, these range from light to deep sleep, and differ in the content of 
synchronized slow delta waves (1 -4Hz). Stage N3 contains the most delta waves and is 
also referred to as slow-wave sleep (SWS). REM sleep exhibits EEG theta waves ( 4-7 
Hz) and loss of skeletal muscle tone (measured by electromyography, EMG). In contrast 
to NREM and REM, wake is identified by the presence of desynchronized EEG waves 
with frequencies of 14Hz and above (beta and gamma bands). 
Most reports implicate an ascending arousal system as a distributed controller of 
endogenous transitions between sleep and wake states. Key neuroanatomical and 
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neuromodulatory components of this system have been elegantly reviewed by Saper et al. 
(2005) and Fuller et al. (2006). As depicted in Figure 2-1, the ascending arousal system 
originates from diverse cell groups in the reticular formation of the brain stem. A dorsal, 
wake- and REM -active pathway runs from the cholinergic pedunculopontine and 
laterodorsal tegmental (PPT, LDT) nuclei to both excitatory thalamic relay nuclei and the 
thalamic reticular nucleus (TRN), which inhibits the other thalamic nuclei. A ventral 
pathway is composed of monoaminergic (MA) fibers from neurons in the upper 
brainstem and caudal hypothalamus. The neuronal nuclei and the key MAs they release 
are: locus coeruleus (LC) cells that release norepinephrine (NE), dorsal raphe (DR) cells 
that release 5HT, ventral periaqueductal gray (vP AG) cells that release DA, and 
tuberomammilary nucleus (TMN) cells that release histamine (HST). Rostral projections 
from the MA cell groups terminate on further key controllers of wake-sleep states, 
including: the ventrolateral preoptic nucleus (VLPO), lateral hypothalamus (LH) cells 
that release orexin (ORX) or melanin-concentrating hormone (MCH), and basal forebrain 
(BF) cells, some of which send a diffuse cholinergic projection to the cortex and TRN 
(Hallanger et al. 1987; Szymusiak et al., 2000), whereas others send a GABAergic 
projection to cortex and thalamic nuclei (Gritti et al., 1998, 2003; Manns et al., 2003). 
The LH's ORX cells are inhibited by sleep-active cells of the VLPO, which are in turn 
inhibited by components of the MA projection. 
These functional interactions support the hypothesis that transitions between sleep 
and wake states, and their stabilization, are controlled by a mutually inhibitory "flip-flop 
switch" (Saper et al., 2005; see also Phillips and Robinson, 2007). Circadian signals from 
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Figure 2-1: Interactions of the brainstem ascending arousal system with cortical, thalamic and basal 
ganglia regions. A sleep-wake switchlng circuit in the brainstem (right side of dashed vertical) sends 
ascending arousal-promoting signals to thalamus and many forebrain regions (left side). Circadian 
signals from the SCN reach the switching circuit via the D11H, among other paths. On the basis of 
transmitter families, the brainstem switch can be divided into four major parts: (1) the GABAergic 
VLPO and MnPO; (2) the orexinergic LH and PeF; (3) the cholinergic PPT and LDT nuclei; and (4) a 
set of monoaminergic (MA) nuclei that includes: the histaminergic TMN, the noradrenergic LC, the 
serotonergic DRN, and the dopaminergic vPAG area. Cooperative and competitive interactions among 
these cell groups enable the circuit to act like a "flip-flop switch" (Saper et al., 2005; see also Phillips 
and Robinson, 2007), which enables the brain to quickly execute, and then stabilize, switches between 
sleep and wake states. Sleep-active cells in VLPO/MnPO inhibit the other three groups during sleep. 
During transitions to wake, e.g., when SCN/D11H begins to send excitation to LH/PeF and inhibition to 
VLPO, excitation from LH/PeF and LDT/PPT to the MA group enables it, and LH/PeF, to increasingly 
inhibit the VLPO. Reduced VLPO output further disinhibits MA and LH activity, to stabilize wake. 
Later, as sleep-promoting inputs progressively excite VLPO, its inhibition of all wake-promoting 
projections disinhibits the VLPO itself, to enable stable sleep. Outputs from three of the four parts of 
the switch, namely the LDT/PPT, MA, and LH/PeF groups, promote cortical arousal both directly and 
indirectly via thalamus (e.g. reticular thalamus, thalamic relay) and many zones of the BGS. The BGS 
includes striatal, pallidal and nigral zones (encompassing GPe, GPi and SNr), striatal-recipient cortico-
petal zones (including NBM), as well as the two major sources of dopaminergic innervation of the 
BGS, the SNc and VTA. See main text for details. In this and subsequent figures, excitatory links 
terminate in arrowheads, whereas inhibitory links terminate in filled circles. 
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the suprachiasmatic nucleus (SCN) of the hypothalamus reach the switching circuit via 
the dorsomedial hypothalamus (DMH), among other paths. During transitions to wake, 
e.g., when SCN/DMH begins to send excitation to LH/PeF and inhibition to VLPO, 
excitation from LH/PeF and LDT/PPT to the MA group enables it, and LH/PeF, to 
increasingly inhibit the VLPO. Reduced VLPO output further disinhibits MA and LH 
activity, to stabilize wake. Later, as sleep-promoting circadian and other somnogenic 
inputs excite VLPO, its inhibition of all wake-promoting projections disinhibits the 
VLPO itself, to enable stable sleep. Endogenous arousal from sleep to wake results from 
the waning of sleep-promoting inputs to VLPO, whereas rapid exogenous arousal from 
stable sleep is possible because of potent subcortical, and even sub-thalamic, sensory 
pathways to the brainstem arousal centers. 
2.2 The role of the basal ganglia system in wake-sleep switching: N euroanatomical 
and neurophysiological considerations 
It is now widely believed that the flip-flop switch enables ascending neuromodulatory 
projections from brainstem to cortex/thalamus to switch the thalamo-cortical system back 
and forth between sleep states, which allow only the genesis of slow-waves (low EEG 
frequencies), and wake states, which involve the genesis of much higher EEG 
frequencies. Discussions of wake-sleep switching typically do not mention any role for 
the basal ganglia system (BGS); however, a comprehensive assessment of both its 
functional connectivity and recent lesion effects on sleep and wakefulness, reveals that it 
must be considered. As shown in Figure 2-1, the MA groups of the flip-flop switch have 
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strong projections to the striatal and pallidal zones of the BGS, as well as into basal 
forebrain territories that contain significant numbers of striatal-recipient cortico-petal 
(SRCP) neurons, e.g., large GABAergic and cholinergic neurons with monosynaptic 
projections to cerebral cortex (see Section 2.5 for further details). Figure 2-2 depicts an 
integrative model of connections among cell types found in the pallidal and SRCP zones, 
and their links with various parts of the brain. The figure highlights the important point 
that SRCP zones themselves contain sleep-active GABAergic cells that inhibit SRCP 
cholinergic neurons, which promote cortical arousal. Moreover, the fibers projecting 
from striatum to the SRCP zones are also GABAergic. Thus there are strong analogies 
between accepted elements of the flip-flop circuitry and circuitry that includes the BGS, 
as will be described below. 
2.2.1 Review of the direct and indirect pathways of the dorsal BGS 
The BGS is currently regarded as composed of the dorsal striatum (including caudate and 
putamen) and the ventral striatum (including nucleus accumbens and adjacent zones), the 
(dorsal) globus pallidus with internal and external segments (GPi and GPe), the ventral 
pallidum (VP), the subthalamic nucleus (STN), and the substantia nigra pars reticulata 
(SNr). Also included in many treatments are the BGS's sources of dopamine, e.g., the 
substantia nigra pars compacta (SNc) _and the ventral tegmental area (VTA). In the 
classical dorsal part of the BGS in rodents, there are two pathways by which striatal 
activity originating from medium spiny projection neurons (MSPNs) controls 
thalamocortical output: a direct pathway through striatonigral MSPNs and an indirect 
. 
pathway through striatopallidal MSPNs. Direct striatonigral MSPNs are identified by the 
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presence of D1 dopamine receptors and their expression of both substance P (SP) and 
dynorphin (DYN). These D1-SP-DYN-MSPNs (Figure 2-3) send inhibitory projections 
to GPi and SNr, which inhibit motor thalamic relay cells (e.g. V A!VLo) that send 
excitatory projections to areas of the frontal cortex. The function of the direct pathway is 
to release a voluntary movement. When D1-SP-DYN-MSPNs become active, often aided 
by aDA burst from the SNc, they inhibit GABAergic projection neurons in the GPi/SNr. 
Indirect striatopallidal MSPNs are identified by the presence of D2 dopamine receptors 
and the expression of enkephalin (ENK). These D2-ENK-MSPNs (Figure 2-3) are 
tonically active send inhibitory projections to GPe. A pause in the firing of indirect 
pathway MSPNs in response to a DA burst from SNc disinhibits GPe, which sends 
inhibitory projections to GPi and SNr. Dopamine thus acts synergistically on the direct 
and indirect pathway MSPNs to promote thalamocortical transmission. 
2.2.2: Connectivity of the BGS with striatal-projection-recipient cortico-petal zones 
A unifying idea in the scheme for the BGS outlined above is that GABAergic output 
stages of the BGS (GPi, SNr, and VP) affect cortex indirectly, via the thalamus. By that 
criterion, SRCP neurons are often excluded from discussions ofthe BGS. This is, in one 
sense, justified: by definition, SRCP neurons project directly to cortex, and not, or not 
only, via thalamus. However, to the extent that these neurons are strongly affected by a 
direct projection from the striatum, they can also be regarded as a more direct BGS 
output stage to cortex. Indeed, some authors (e.g., Swanson, 2000; 2003) have proposed 
that all the striatal-projection-recipient zones of the basal forebrain can be lumped into an 
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zones 
Figure 2-2: Selected connections of cell types in pallidal and striatal-recipient cortico-petal (SRCP) 
zones of the basal forebrain. The targets in cortex include pyramidal (PY) neurons and inhibitory 
intemeurons (IN). This model circuit highlights how distinct cell types, found in the pallidum (e.g., 
VP, ventral pallidum), vmGPe (ventromedial globus pallidus, pars extema) and in SRCP zones of the 
basa:l forebrain (e.g., SI, NBM) may serve as important elements in the system that controls sleep and 
wake. Cell types that discharge at higher rates (or in stronger bursts) during sleep are depicted with 
double outlines. The well-known direct cholinergic (ACh) projection from SRCP zones of the basal 
forebrain (lower gray panel) to cortex is joined by direct GABAergic and glutamatergic projections to 
cortex. The numbers and relative proportions of these corticopetal cell types vary considerably across 
striatal-recipient zones, and may be sparse in, or absent from, subregions of VP and vmGPe in some 
species. Although most ACh input to thalamus comes from tegmental a:reas (PPT or LDT) as shown on 
the upper right side of the Figure, the MD thalamus (shown on upper left side) receives both a 
cholinergic and a GABAergic projection from SRCP zones. Note the net excitatory effect on ACh 
neurons of inputs from three elements of the non-pallidal ascending arousal system: glutamate from 
PBN/PCA, co-released ORX and DYN from LH, and NE from LC. Not shown a:re excitatory cortical 
feedbacks to thalamus and to the GABA-NPY neurons that inhibit ACh neurons in SRCP zones. 
Citations for connectivity and physiological effects a:re given in Table 2.1. See text for details. 
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Striatal zones 
Figure 2-3: Adenosine and ENK oppose the synergistic effects on arousal of ACh, DA, SP, and DYN in 
BGS. Adenosine receptors, particularly types A1R and A2AR, are expressed at several BGS sites at 
which their activations can synergistically oppose cortical arousal. The A1Rs (shown in red) are 
inhibitory and found post-synaptically on ACh neurons in pallidal and SRCP zones (e.g., NBM) and on 
the striatal D1-SP-DYN-MSPNs that give rise to the BGS's direct pathway. Activation of A1Rs at these 
neuron types reduces cortical activity. Although the A2ARs (shown in green) are excitatory, their 
complementary distribution allows them to act synergistically with the A1Rs to mediate the arousal-
reducing effects of adenosine. The A2ARs are found on dendrites and on axon terminals of the striatal 
Dz-ENK-MSPNs that give rise to the BGS's indirect pathway. Activation of these A2ARs excites Dz-
ENK-MSPNs and independently amplifies GABA release from their axon terminals in striatum, 
pallidum, and SRCP zones, whereas DAergic activation of D2Rs inhibits Dz-ENK-MSPNs. Because 
A2ARs and D2Rs in striatum are often conjoint receptor structures ("heteromers"; see Ferre et al., 
2007a,b; Albizu et al. 2010) that mediate inhibitory crosstalk between the ligands DA and adenosine, 
raising DA levels will reduce the effect of adenosine, and vice versa. Co-release of ENK by Dz-ENK-
MSPNs and of SP and DYN by D1-SP-DYN-MSPNs produces further synergistic effects. Activation of 
ENK-Rs (shown in red; these are j.t-opioid receptors) inhibits ACh neurons, whereas activation of SP-
Rs (shown in green; these are neurokinin-1 receptors) excites these ACh neurons. This excitation via 
SP-Rs is complemented by disinhibition of ACh neurons, because the DYN that is co-released with SP 
excites DYN-Rs (shown in red; these are K-opioid receptors) that are inhibitory to the sleep-active 
GABAergic neurons that inhibit ACh neurons (and cortical PYs, as shown in Figure 2-2). In striatum, 
co-released ENK and GABA mediate inhibition ofD1-SP-DYN-MSPNs by D2-ENK-MSPNs. The de-
arousing effects of adenosine in VP/GPe and SRCP zones are amplified by two further pathways: 
reduced activity of GABA PV+ neurons disinhibits striatal FS-INs, which are inhibitory to D1-SP-
DYN-MSPNs; and reduced activity of ACh neurons disfacilitates DA neurons in VTA. Consequent 
reduced release ofDA by fibers from VTA (which is also disfacilitated by adenosinergic inhibition of 
the ORX input to VTA from LH) has four de-arousing effects: increased gap junction coupling of 
striatal FS-INs, reduced inhibition of D2-ENK-MSPNs, decreased facilitation of D1-SP-DYN-MSPNs, 
and decreased excitation of cerebral cortex. These effects would be reinforced by reduced input to SCN 
via ACh projections (not shown) from pallidal and SRCP zones and PPTILDT. 
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Table 2.1: Circuits involved in basal ganglia system contributions to sleep-wake 
regulation. 
From 
VP/GPe 
VP/GPe 
GPe 
STN 
GPi 
GPi/SNr 
GPe 
Striatum (NAc) 
D1-SP-DYN-
MSPNs 
D1-SP-DYN-
MSPNs 
Dz-ENK-
MSPNs 
D2-ENK-
MSPNs 
DrENK-
MSPNs 
VP/GPe 
VP (ACh) 
VP (ACh) 
VP (Glu, CB+) 
VP (Glu, CB+) 
VP (GABA, 
NPY; Sleep-
active) 
To 
GPi 
Striatum (FS-
INs) 
STN 
GPe/GPi 
TC relay 
PPT 
TRN 
VP and GPe 
GPi 
VP (ACh) 
GPe (PV+ 
GABA) 
GPe,VP (ACh) 
D1-SP-DYN-
MSPNs 
IN 
PY 
VP (PV+ 
Cortex 
LH(ORX) 
VP (ACh) 
Main Action 
inhibition 
inhibition 
inhibition 
excitation 
inhibition 
inhibition 
inhibition 
inhibition via 
GABA,ENK 
inhibition 
excitation by 
SP 
inhibition 
inhibition by 
GABAand 
ENK 
inhibition 
inhibition 
excitation 
excitation 
excitation 
excitation 
inhibition 
Reference (Species) 
Hazrati et al., 1990; Parent and 
Hazrati, 1993; 1995 (squirrel and 
rhesus monkeys, rat) 
Bevan et al., 1998 (rat) 
Sato et al. 2000; Bevan et al., 1997 
(cynomolgus monkey, rat) 
Parent and Hazrati, 1993; Shink, 
Bevan, Bolam, and Smith, 1996 
(squirrel monkey, rat) 
Hazrati and Parent, 1991 (squirrel 
monkey, rat) 
Mena-Segovia and Giordano, 2003 
(rat) 
Hazrati and Parent, 1991; Gandia et 
al., 1993 (squirrel monkey) 
Mogenson et al. 1983; Yang and 
Mogenson, 1989 (rat) 
Aubert et al., 2000; Levesque and 
Parent, 2005 (cynomolgus and 
squirrel monkeys) 
Haber et al., 1990; Gerfen, 1991; 
Napier et al., 1995; Hasenohrl et al., 
2000; Chen et al., 2001 (rat, monkey) 
Aubert et al., 2000; Levesque and 
Parent, 2005 (cynomolgus and 
squirrel monkeys) 
Haber et al., 1990; Aubert et al., 
2000; Levesque and Parent, 2005; 
Smiley and Mes-qlam, 1999; 
Zaborszky and Cullinan, 1992; 
Henderson, 1997; Moore et al., 1999; 
Napier and Mitrovic, 1999 
(cynomolgus, squirrel, and macaque 
monkeys; rat) 
Venance et al., 2004; Taverna et al., 
2008 (rat) 
Gritti et al., 2003 (rat) 
Renny and Jones, 2008 (rat) 
Brauer et al., 1998 (rat) 
Gritti et al., 2003 (rat) 
Renny and Jones, 2006; 2008 (rat) 
Zaborszky and Duque, 2000; 
Toth et al., 2005 (rat) 
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Table 2.1 (continued): Circuits involved in basal ganglia system contributions to sleep-wake 
regulation. 
From To Main Action Reference (Species) 
VP(GABA py inhibition Renny and Jones, 2008 (rat) 
VP (GABA) LR(ORX) inhibition Renny and Jones, 2006; 2008 (rat) 
VP (SI) Cortex mixed Mesulam et al., 1983; Szymusiak and 
McGinty, 1989; Manns et al., 2003 
(rat, monkey) 
VP (SI, NBM) SCN unknown Bina et al., 1993 (rat) 
SCNviaMPA SI (VP), VTA disinhibition Deurveilher and Semba, 2005; 
Luo and Aston-Jones, 2009 (rat) 
MnPO SI (VP) inhibitory Cullinan and Zaborszky, 1991 (rat) 
LC VP (ACh) excitation Zaborszky and Cullinan, 1996 (rat) 
LC VP (GABA; inhibition Modirrousta et al., 2004; 2007 (rat) 
Sleep-active) 
LR(ORX) VP (ACh, excitation Fadel and Burk, 2010; 
GABA; Wake- Arrigoni et al. 201 0 (rat) 
active) 
LR (ORX) VTA excitation Korotkova et al., 2003; Moorman 
and Aston-Jones, 2010 (rat) 
LR(DYN) VP(GABA) inhibition Arrigoni et al., 2010 (rat) 
PBN,PCA VP (SI) excitation Fuller et al., 2011 (rat) 
PPT, LTD SNc excitation Oakman et al., 1995; 
(unilateral) Rolmstrand and Sesack, 2011 (rat) 
VTA 
(bilateral) 
VP (AChand MD thalamus mixed Gritti et al., 1998 (rat) 
GABA) 
Cortical GABA py inhibition Thomson and Bannister, 2003 
INs (mammals) 
TRN TC relay inhibition Liu et al., 1995; Jones, 2009 
(mammals) 
TC relay py excitation Jones, 2009 (mammals) 
inclusive "pallidal" part of a three-part forebrain (cortex, striatum, pallidum), and thus 
included as part of an extended BGS. Others (e.g., Alheid, 2003; Alheid et al., 1990; 
Zahm, 2006) have noted that across the resulting striatal or pallidal territories there are 
also many distinguishing features that may be as important as the similarities. Yet, 
although he did not endorse the broad use of the terms "striatal" and· "pallidal" by 
Swanson and colleagues, Alheid (2003, p. 189) agreed that a global plan for the forebrain 
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involves a pattern of interconnections from areas of cortex to GABAergic medium spiny 
projection neurons (MSPNs, characteristic of the classical striatum) to leptodendritic 
(spine sparse) GABAergic projection neurons (characteristic of the classical pallidum), 
together with direct and indirect feedback loops that may involve other structures, such as 
thalamus (as in the classical basal ganglia-thalamo-cortical system). 
Alheid also pointed out that a subset of the leptodendritic (spine sparse) projection 
neurons that are contacted by the MSPNs are corticopetal neurons that may be 
GABAergic or cholinergic (see Figure 2-2). These are thus SRCP neurons that are 
distributed, sometimes m clusters but sometimes at low densities, across the basal 
forebrain (BF), which 1s often (e.g., Zaborszky et al., 1999) defined (as here) to 
encompass MS, HDBNDB, VP, SI, and GP (all of which Swanson classifies as 
"pallidal" territories). The BF is widely known as the source of the major cholinergic 
projection to the cerebral cortices, and one of the bands containing clustered SRCP 
neurons in the BF is the nucleus basalis of Meynert (NBM), the major source of 
cholinergic inputs to the neocortex. Although the "cholinergic" territory in BF (which 
also includes GABAergic and glutamatergic cortico-petal neurons) receives 
glutamatergic inputs from cortex and other areas such as the basolateral (cortical) 
amygdala, parts of it, including NBM, receive substantial GABAergic (and neuropeptide) 
inputs from striatal territories such as the caudate-putamen, nucleus accumbens and the 
central nucleus of the amygdala. 
Such circuit details might or might not be pertinent to an understanding of any 
given function. With respect to behaviors during the awake state, it is now clear that the 
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distinctive connectivities possessed by the myriad striatal, pallidal and SRCP 
subterritories imply separate recruitment to serve distinct functions. This does not 
preclude that a significant aggregate of cortico-petal cells within these subterritories 
might also be recruited to serve a modal function shift, such as the transition from wake 
to sleep (and vice versa). Figures 2-2 and 2-3 exemplify several criteria that provide a 
simple and principled basis for identifying a set of subterritories that are most likely, 
given current data, to participate in wake-sleep transitions. The scheme in Figure 2-3 is 
based on data indicating that the accumulation of adenosine under prolonged wake 
creates sleep pressure, often via its opposition to the effects of dopamine. According to 
this principle, the putative "striatal" territories most likely to be pertinent to sleep-wake 
control should have high percentages of MSPNs that co-express "opponent" 
combinations of dopamine and adenosine receptors, notably MSPNs that co-express 
D2Rs and A2ARs, and MSPNs that co-express D1Rs and A1Rs. In the dorsal (classical) 
part of the BGS, these two types are respectively known in rodents as striatopallidal 
("indirect path") and striatonigral ("direct path") MSPNs. The putative "pallidal" and 
SRCP territories most likely to play a role in wake-sleep transitions should receive strong 
inputs from a striatal territory of the type just defined with co-expression of dopamine 
and adenosine receptors, and the SRCP zones should include, among other neuron types, 
significant numbers of GABAergic and cholinergic neurons with cortico-petal 
projections. 
By these criteria, data (e.g., Gartner et al., 2002; Rosin et al., 1998; Scammell et 
al., 2001; Shammah-Lagnado et al., 2001; Svenningsson et al., 1997; Zhou et al., 2003) 
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indicate that the following "striatal" territories should be given serious consideration: 
olfactory tubercle; caudate; putamen; nucleus accumbens including rostral pole, core and 
shell; lateral and lateral-capsular divisions of the central nucleus of the amygdala; and the 
striatal fundus, also called the lateral part of the interstitial nucleus of the posterior limb 
of the anterior commissure (IP ACl). Excluded are both the lateral stripe of the striatum, 
which (although it does project to SI) lacks high levels of A2ARs and contains MSPNs 
that possess D1Rs but lack DARPP-32 (dopamine- and cAMP-regulated phosphoprotein) 
(Furuta & Kaneko, 2006; Sonomura et al., 2007)), and the lateral septum, in which 
MSPNs expressing A2ARs do not co-express D2Rs (Svenningsson et al., 1997). (This list 
of inclusions is not meant to be exhaustive. Also, the exclusions are due to a departure 
from the scheme in Figure 2-2: we cannot claim to have definitively ruled out a role in 
sleep-wake regulation.) Of putative "pallidal" and SRCP territories that receive strong 
projections from the selected striatal zones, at least the following should be included: 
internal and external parts of the globus pallidus (GP); lateral substantia nigra; middle 
and dorsa-caudal parts of ventral pallid urn (VP); parts of the substantia innominata (SI) 
including the NBM; the juxtacapsular part of the BNSTl; and the magna cellular preoptic 
nucleus (MCPO). Excluded are the medial IPAC and medial BNST (Shammah-Lagnado 
et al., 2001). 
This subset of included pallidal and SRCP zones falls within the BF as defined by 
such authors as Zaborszky and Gritti. These zones contain a heterogeneous population of 
cholinergic and non-cholinergic (mostly GABAergic) neurons, including several types of 
corticopetal projection neurons, and interneurons. Of particular note is that much of the 
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cholinergic basal forebrain that projects to neocortex is a SRCP zone. Zaborszky et al. 
(1999, p.351) summarized afferentation as follows. For rodents, studies of synaptic 
contacts (revealed with electron microscopy) demonstrated synaptic contacts with BF 
cholinergic neurons by fibers from the amygdala (Zaborszky et al., 1984), dorsal and 
ventral striatum (Henderson, 1997; Zaborszky and Cullinan, 1992), hypothalamus 
(Zaborszky and Cullinan, 1989; Cullinan and Zaborszky, 1991), as well a 
catecholaminergic (NA-ergic or DA-ergic) fibers from locus coeruleus, VTA or SNc 
(Zaborszky and Cullinan, 1996; Zaborszky et al., 1993; Gaykema and Zaborszky, 1997; 
Rodrigo et al., 1998). Electron microscopy combined with double-labeling also showed 
that cholinergic neurons in the ventral pallidum receive a massive GABAergic input 
(Zaborszky et al., 1986). Axon terminals releasing one of the following have also been 
observed to contact cholinergic neurons: substance P (Bolam et al., 1986), enkephalin 
(Chang et al., 1987; Martinez-Murillo et al., 1988), somatostatin and NPY (Zaborszky, 
1989), acetylcholine (Martinez-Murillo et al., 1990), CGRP (Csillik et al., 1998), and 
galanin (Henderson and Morris, 1997). In the monkey (Smiley and Mesulam, 1999) 
reported GABAergic, cholinergic, and catecholaminergic synapses onto cholinergic 
neurons. Zaborszky et al. (1999) therefore endorsed the generalization that there is a 
"similarity in the afferent organization of cholinergic neurons between rodents and 
primates (p. 351)." 
The most likely sources of the major GABA, enkephalin (ENK) and SP inputs are 
the dorsal and ventral striatum (including accumbens) and the central nucleus of the 
amygdala (also a striatal territory, as noted above). MSPNs that co-express D2Rs and 
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A2ARs co-release GABA and ENK, whereas MSPNs that co-express D1Rs and A1Rs co-
release GABA and SP. This is highlighted in Figures 2-2 and 2-3. Mogenson et al. 
(1983) presented anatomical and electrophysiological evidence for a strong functional 
inhibitory linkage between MSPNs of the NAc and the VP and SI territories wherein 
many cortico-petal cholinergic neurons are found. Notably, electrical stimulation in NAc 
had strong orthodromic inhibitory effects in VP and SI at the same short latency that 
Jones and Mogenson (1980) had reported for antidromic activation of NAc cells by 
stimulation in the VP/SL Sarter et al. (2006) represented the NAc as the source of the 
most important GABAergic input to the cholinergic basal forebrain, in part on the basis 
of studies noted above, and in part on the basis of the results of Moore et al. (1999), 
which showed that local D2R blockade in NAc significantly reduced ACh release in 
cortex. Moreover, Neigh et al. (2004) showed that blocking NAc neurotransmission also 
blocked behavior-dependent ACh release in medial prefrontal cortex. 
The scheme in Figure 2-2 predicts that this well-established functional linkage 
between ventral striatum and cholinergic SRCP neurons in VP/SIINBM will be found to 
be paralleled by striatal projections to more dorsally situated SRCP neurons, within GP. 
There is significant evidence for such parallelism in Henderson (1997), which also points 
out that the neuropeptides released by striatal fibers (ENK and SP) are likely to be more 
effective than the co-released GABA in affecting cholinergic neurons, because of the 
very high expression in the latter of opioid and SP receptors. Functional connectivity 
between dorsal striatum and cholinergic neurons in GP, however, seems to have been 
under-studied, and may be difficult to assess, because of lower densities of ACh neurons 
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in the GP. Zaborszky et al. (1999) reported that the ratio of cholinergic to GABAergic 
neurons in the VP is 1:3-4, but only 1:8 in the GPe. 
Other important components of the Figure 2-2 scheme are the non-ACh cortico-
petal neurons, and BF intemeurons. Gritti et al. (2003 ), for example, reported that 
besides a cholinergic cortico-petal projection, there are distinct parvalburnin-containing 
(PV+) and calbindin-containing (CB+) projections that reach both frontal and parietal 
cortices from both GP and VP (anterior, subcommisural SI, in some usages). The PV+ 
projection was determined to be GABAergic and the CB+ projection was determined to 
be glutamatergic. It is usually assumed that GABAergic projection neurons from such BF 
regions synapse on cortical intemeurons only (Freund and Meskenaite, 1992; Jimenez-
Capdeville et al., 1997). Figure 2-2 depicts these to be the PV+ neurons identified in 
Gritti et al. (2003). They are shown to be wake-active, and are assumed to promote 
arousal by disinhibiting cortical pyramids. 
In a report that considered explanations of sleep effects of GP lesions, V etrivelan 
et al. (2010) recently proposed that there may be a population of GABAergic GPe 
neurons that synapse directly onto glutamatergic pyramidal neurons in cortex. However, 
although their anterograde tracer injected in GPe did label both cortical pyramids and 
GABAergic intemeurons, this result is inconsistent with the standard view that the 
ascending fibers from GPe that reach pyramids are cholinergic whereas those that reach 
GABAergic intemeurons are GABAergic. Nevertheless, the proposal warrants further 
investigation in light of two other findings: there is a sleep-active GABAergic population 
in pallidal and SRCP zones of BF as well as a GABAergic projection from BF and 
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preoptic hypothalamus (Gritti et al., 1998) to MD thalamus. Hassani et al. (2009) 
identified two populations of GABAergic neurons in the SI region, a wake-active 
population correlated with gamma band activity and a sleep-active population correlated 
with delta-band activity. With respect to the latter, Manns et al. (2003) reported a 
population of GABAergic neurons in SI that were active during cortical slow-wave states 
and subject to noradrenergic inhibition via cx:2-adrenergic receptors. Moreover, Szymusiak 
and McGinty (1986) reported that a kainic acid lesion in SI was wake-promoting, and 
Szymusiak and McGinty (1989) reported that a group of sleep-active cells in S-I were 
activated antidromically from the anterior cingulate bundle at a longer latency than were 
the wake-active cells in SI. To reflect these studies of neuron types in SRCP zones, 
Figure 2-2 therefore includes a second population of GABAergic cortico-petal neurons, 
which are labeled as "PV -" (non-parvalburnin-containing) and marked as (here 
hypothesized to be) the sleep-active type. They are hypothesized to project directly to 
cortical pyramidal neurons, whereas the PV+ neurons are shown to project to inhibitory 
intemeurons. 
Altogether, Figure 2-2 depicts four distinct populations of neurons in SRCP 
zones with projections to cortical intemeurons and/or pyramidal cells: two GABAergic, 
one cholinergic, and one glutamatergic. The Figure 2-2 scheme concretizes the 
hypothesis that the BGS helps control wake-sleep transitions by strongly affecting SRCP 
zones whose cortico-petal neurons mediate several wake-active, arousal-promoting 
signals (cholinergic, GABAergic and glutamatergic) as well as one sleep-active 
GABAergic signal. Figure 2-3 further illustrates that within the striatum and in SRCP 
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zones there is a dopamine-adenosine opponency that works with GABA, ENK, and SP, 
as described at length in the next section, to achieve a coherent effect on wake-sleep 
transitions. 
2.3 Dopamine-adenosine opponency in the striatal, pallidal and SRCP regions of the 
BGS 
2.3.1 The role of the somnogen, adenosine, in the striatal, pallidal and SRCP regions of 
BGS 
Adenosine is a product of energy metabolism and has been proposed as both a sleep 
homeostasis marker and a sleep-promoting agent. Bellington and Heller (1995) first 
formulated the energy hypothesis of sleep, which was reviewed and updated in Scharf et 
al. (2008). The hypothesis holds that increases in extracellular adenosine, as are observed 
in the cholinergic basal forebrain (BF), may reflect depletion of ATP in cells concomitant 
with energy depletion, which is reversed during sleep (Basheer et al., 2004). Recent work 
by Dworak et al. (20 1 0) demonstrated that ATP surges during the initial hours of sleep in 
wake-active brain regions of the rat, including cholinergic basal forebrain. Dworak et al. 
further demonstrated that sleep deprivation prevents the surge in ATP, indicating that the 
surge is due to sleep and not to a diurnal variation in ATP levels. However, there are 
several sources of extracellular adenosine and therefore the increase observed with sleep 
deprivation may not necessarily reflect depletion of cellular ATP (Scharf et al., 2008). 
Impairing adenosine transport with the adenosine uptake inhibitor, NBTI 
(Nitrobenzylthioinosine), in BF increases extracellular adenosine, suggesting a net flow 
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of adenosine from the extracellular space into the cell; impaired adenosine transport also 
decreases wake, and increases slow wave sleep, REM sleep, and delta power during 
NREM (Methippara et al., 2005; Porkka-Heiskanen et al., 1997). Enzymes related to 
adenosine metabolism, including adenosine deaminase and adenosine kinase, exhibit a 
diurnal variation but do not alter their activity under sleep deprivation (Mackiewicz et al., 
2003). Thus, although ATP itself may not be a good marker, extracellular adenosine 
seems to be a potential marker, of sleep drive. Moreover, lesions to cholinergic neurons 
in BF eliminates the increase in extracellular adenosine during wake and sleep 
deprivation (Blanco-Centurion et al., 2006), consistent with strong evidence that waking 
cholinergic activity plays a causal role in adenosine accumulation in BF (Kalinchuk et al., 
2006; 2011). 
Most studies in the BF have focused on the effects of extracellular levels of 
adenosine in the (cortex-arousing) cholinergic BF, which includes several SRCP zones, 
including SI, VP, NBM, HDB and MCPO. Adenosine in these regions of the BF 
progressively increases as time-awake is prolonged, but decreases with sleep (Porkka-
Heiskanen et al., 2002; Basheer et al., 2004). In cats (Portas et al., 1997) and rats 
(Basheer et al., 2004), perfusion of adenosine into the cholinergic BF leads to reduced 
wakefulness and increased sleep. Most evidence points to an Ar receptor dependence of 
somnogenic effects of adenosine in the cholinergic BF (e.g. Strecker et al., 2000; 
Stenberg et al., 2000; Thakkar et al., 2003). However, results from Stenberg et al. (2003), 
in which A1R knockout mice showed the same rebound in NREM and delta power 
following 6 h of sleep deprivation as wild-types, suggest that the A1Rs are not essential 
"•? 
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for sleep homeostasis. This is not surprising, because their loss could be compensated by 
A2ARs, which play a complementary role, as shown next. 
Although much sleep research has focused on adenosine acting via A1Rs on 
cholinergic cells in the BF, A1Rs are also present at other sites in the BGS, which exhibits 
very high levels of A2ARs in the dorsal striatum, the NAc (nucleus accumbens, the ventral 
striatum), the OT (olfactory tubercle, another striatal zone) and the GP of both rat and 
human brain (Rosin et al., 2003). Xie et al. (2007) reviewed the role of ARs on striatal 
medium spiny projection neurons (MSPNs) that give rise to the direct and indirect 
pathways through the BGS (as depicted in Figure 2-3). These pathways control voluntary 
activities via projections to the BGS output stages, e.g., GPi!SNr, which control thalamic 
stimulation of frontal cortex, via the synergistic actions of dopamine (DA AIRs, found on 
DI-SP-DYN-MSPNs, inhibit neuronal activity. When AIRs are activated, the inhibitory 
actions ofDI-SP-DYN-MSPNs on GPi!SNr are reduced. This action disinhibits GPi/SNr 
inhibition of thalamus, resulting in a reduction of the thalamocortical loop activity needed 
for fronto-cortical arousal. Adenosine inhibition of DI-SP-DYN-MSPNs via AIRs also 
reduces SF-mediated excitation of corticopetal ACh neurons of the pallidal and SRCP 
zones (Figure 2-3), which also de-arouses cortex. 
In contrast to its inhibitory action via AIRs, adenosine has an excitatory effect via 
A2Rs (Figure 2-3). Satoh et al. (1999) assessed A2AR-mediated adenosinergic effects 
across a band of areas and reported strong effects on sleep. The strongest effect was seen 
after infusion of a selective A2AR agonist within the rostral basal forebrain, most notably 
in a region that included the shell of the NAc and the adjacent part of the olfactory 
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tubercle, both constituents of the ventral striatum that project to SRCP zones including 
SI, NBM and BNST. The striatal D2-ENK-MSPNs express A2ARs on both their dendrites 
and on their axon terminals, which are abundant within the striatum and zones that 
receive its projections. Therefore, the action of adenosine on D2-ENK-MSPNs has two 
effects: it promotes GABAergic transmission by helping to excite D2-ENK-MSPNs to 
fire and it facilitates GABA release from D2-ENK-MSPN axon terminals in striatum, 
SRCP zones, VP and GPe (Shindou et al., 2001, 2002, 2008; Mingote et al., 2008). To 
assess the role of such A2AR activation at terminals of D2-ENK-MSPNs in the GP and 
other projection zones, it is important to establish under what conditions such activation 
can cause a change in GABA release at those terminals. A recent report (Querejeta et al. 
201 0) showed that GABA release is boosted by A2AR activation that coincides with D2-
ENK-MSPN spiking, but does not occur in the absence of spiking by D2-ENK-MSPNs. 
Moreover, this adenosinergic boost to spike-dependent GABA release occured only in the 
presence of normal DAergic innervation of the GPe. It disappeared following DA 
depletion. 
As summarized in Figure 2-3, these effects of adenosine in the BGS and 
cholinergic BF have a coherent net effect. They promote sleep by curtailing activity in 
two kinds of pathways that control cortical arousal: (1) thalamo-cortical pathways 
inhibited by GPi!SNr, and (2) pathways from pallidal and SRCP zones to cortex that are 
inhibited by both GABA and ENK, which are co-released by fibers from D2-ENK-
MSPNs. The relevance of pathway (2) was highlighted in a recent study by Osman et al. 
(2005). They mimicked ENK release by infusing morphine in SI (which includes NBM), 
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and showed that it led to a marked reduction of ACh release in prefrontal cortex, just the 
effect expected from Figure 2-3 and from known projections of ACh fibers from SI to 
PFC (e.g., Gritti et aL, 2003). The action of ENK in BF may also be pertinent to why 
adenosine levels abate during sleep. Nelson et aL (2009) recently showed that local 
morphine delivery in SI caused a concentration dependent decrease in adenosine. This is 
consistent with the hypothesis that activity of cholinergic cells or associated glia is 
responsible for the adenosine buildup that occurs during wake (Porkka-Heiskanen and 
Kalinchuk, 2011). 
The portrayal of the coherent effects of adenosine in promoting sleep in Figure 2-
3 leads immediately to a better understanding of the stimulant effects of caffeine, which 
non-selectively antagonizes both A1 and A2A receptor subtypes. Although caffeine binds 
to both receptor subtypes, results in wild-type mice compared to AIR knockout and A2AR 
knockout show that increased wakefulness due to caffeine occurs in wild-type and AIR 
knockout, but not A2AR knockouts. Thus, caffeine-mediated arousal strictly requires 
A2ARs (Huang et aL, 2005), especially those in the accumbal part of striatum (Lazarus et 
aL, 2011). This result is consistent with the earlier noted demonstration in Stenberg et aL 
(2003) that AIRs are not necessary for sleep homeostasis effects. Both reinforce the case 
that A2ARs, which are most highly expressed in the D2-ENK-MSPNs of the striatum, play 
a critical role. However, as noted, much of the effect is via A2ARs on GABAergic axon 
terminals in pallidum and SRCP zones. 
If caffeine affects signaling at AIRs on cholinergic cells in pallidal and SRCP 
zones, or at A2ARs on GABAergic terminals of D2-ENK-MSPN axons that synapse on 
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cells in pallidal and SRCP zones, then caffeine could affect c-fos expression by such 
cells. In a study of cholinergic cells in BF, Reznikov et al. (2009) reported that caffeine 
increased c-fos expression in the HDB, which projects primarily to the olfactory bulb, but 
not in other BF regions, including SI, MS, or NBM (nucleus basalis of Meynert); c-fos 
expression was also not increased in cholinergic intemeurons of the dorsal or ventral 
striatum. In an earlier study, Deurveilher et al. (2006) reported minor increases in c-fos 
expression in response to caffeine in V AChT -ir (cholinergic) neurons located in the MS-
HDB and SI-NBM regions, but no increase of c-fos expression in VAChT-ir neurons in 
other BF regions, including HDB, MCPO and ventromedial GP. However, there was 
significant increased c-fos expression in non-VAChT-ir neurons in both the MS-VDB 
(vertical limb of the diagonal band of Broca) and SI-NBM. These were almost entirely 
PV.-, but were not otherwise identified. This is important because it has been separately 
established by Furuta and colleagues (review in Furuta and Kaneko, 2006) that there is a 
class of GABAergic PV- neurons in SIIVP whose axons compose about 25% of the direct 
projection from SIIVP to cortex (Figure 2-2). At the level of the cortex, Van Dort et al. 
(2009) found that caffeine increases ACh release in prefrontal cortex under anaesthesia, 
although it was not determined whether caffeine acted via AIRs or A2ARs. Since BF 
cholinergic neurons that express AIRs project to prefrontal cortex, it can be assumed that 
their terminals are populated with AIRs. Consistent with the schemas in Figures 2-2 and 
2-3, we predict that the BF's sleep-active GABAergic PV- projection neurons possess 
A2ARs. In summary, although caffeine-blockade of adenosine receptors modestly affects 
c-fos expression in cholinergic neurons in pallidal zones such as SIINBM, it has a 
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stronger effect on PV- non-cholinergic neurons, which are likely to include cortico-petal 
GABAergic neurons (Figure 2-2). If these possess excitatory A2ARs, as predicted here, 
then disfacilitation of these neurons by caffeine block of the A2ARs would have a dis-
inhibitory (arousing) effect on cortex. 
The emphasis here on subcortical forebrain sites of action of adenosine is not 
incompatible with reports that sleep deprivation elevates adenosine in some brainstem or 
cortical sites, where it also promotes sleep. In particular, it acts via AIRs in prefrontal 
cortex to reduce ACh release and cortical arousal (Van Dort et al. 2009), especially after 
extended sleep deprivation (Kalinchuk et al., 2011), and it acts via AIRs in LH/PeF to 
suppress ORX release (Alam et al., 2009). Figures 2-2 and 2-3 show that reduced ORX 
release will remove facilitation of corticopetal ACh cells of the pallidal and SRCP zones 
(as in other arousal-promoting areas, e.g., LC and TMN; see Hoang et al., 2004). 
2.3.2 The role of dopamine in BGS and opponency by adenosine 
As reviewed in Monti and Monti (2007), the major mesencephalic DAergic nuclei are the 
SNc and the VTA, which project to dorsal striatal and mPFC/NAc (medial prefrontal 
cortex and nucleus accumbens, i.e., ventral striatum) areas. These DAergic nuclei are 
partly controlled by inputs from striatum (Haber et al., 2000), but also receive inputs 
from arousal-associated neurons in the brainstem, hypothalamus and BF. This suggests a 
role for DA in sleep and wake. For example, DA and adenosine generally have opposing 
effects on MSPNs in the striatum (Figure 2-3; see also Ferre et al., 2007a,b). Although 
Miller et al. (1983) reported that the mean firing rates of DA cells in SNc and VTA do 
not change during the sleep-wake cycle, Monti and Monti (2007) reported changes in the 
" : ~ .·. . '·.' 
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temporal pattern of DA cell firing, with increased burst firing of DA neurons with 
extended wake in both VTA and SNc. Further, Dahan et al. (2007) reported that the 
VTA fires tonically during quiet wake and NREM sleep, but shows burst firing during 
active wake and REM sleep. 
There is abundant evidence that the ambient level of DA affects wakefulness, and 
some evidence that DA level rises during extended wakefulness. Typical 
psychostimulants are wake-promoting because they prevent the re-uptake of DA, by 
blocking dopamine transporters (DATs). DAT knockouts show enhanced extracellular 
DA and a 20% increase in wakefulness compared to wild-type controls (Wisor et al., 
2001). Although sleep deprivation does not affect DATs (Volkow et al., 2008, 2009), 
binding ofthe [11C] raclopride radioligand for D2Rs and D3Rs was significantly reduced 
following sleep deprivation in human striatum and thalamus. This can be explained if 
D2Rs and D3Rs are already occupied at above normal levels due to elevated endogenous 
release ofDA during extended wake (Figure 2-4). 
Monti and Monti (2007) provide an excellent summary of D1 and D2 agonists' 
and antagonists' effects on sleep and wake. Systemic administration of D1R agonists 
induce cortical desynchronization and behavioral arousal, with an overall increase in 
wakefulness, whereas D1R antagonists reduce wake and increase both slow-wave NREM 
and REM sleep. The action of D2R agonists depends on the dose size of systemic 
administration. Low doses may primarily affect presynaptic D2 autoreceptors on DA 
terminals, whose action is to reduce DA release. Indeed, such dose levels increase slow-
wave NREM and REM sleep. High systemic doses of DA receptor agonists have a much 
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more pervasive effect by activating pre-and post-synaptic D1Rs and D2Rs. Here the net 
effect is to increase wake. The D1R-targeted low-dose D2R agonist effects are entirely 
consistent with our circuit diagrams in Figures 2-2 and 2-3. As described in section 
2.2.1, the D1R-mediated direct pathway in the BGS promotes thalamocortical 
transmission and thus arousal, so antagonizing this pathway via D1R blockade or by 
reducing DA release (by exciting presynaptic D2Rs on DA fiber terminals) would result 
in a reduction of arousal and increased sleep. Agonists acting solely on the postsynaptic 
D2Rs on striatal D2-ENK-MSPNs should promote wake through the indirect pathway, 
consistent with the high-dose effect. As the dose is increased, it will tend to suppress D2-
ENK-MSPN activation. It will also reduce striatal ACh release, via (inhibitory) D2Rs on 
the intrinsic striatal population of giant cholinergic intemeurons, also known as tonically 
active neurons (TANs, described in more detail below). The loss of striatal ACh, which 
is excitatory to D2-ENK-MSPNs, will deepen the suppression of D2-ENK-MSPNs. Such 
suppression (Figure 2-2) will release PV+ GABAergic neurons in pallidal and SRCP 
zones to inhibit both GPi/SNr and inhibitory INs in cortex. Suppressing D2-ENK-MSPNs 
will also release ACh neurons in pallidal and SRCP zones from inhibition. All these 
effects promote cortical arousal. 
Figure 2-3 indicates that reduced ORX release will also disfacilitate the VTA, 
which sends dopaminergic fibers to ventral striatum and cerebral cortex. Diurnal control 
of VTA through this link has been verified (Moorman and Aston-Jones, 2010). An 
important aspect of Figure 2-3 is the absence of a projection from the striatal D2-ENK-
MSPNs to the VTA. This is consistent with the recent report by Zhou et al. (2003), 
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which reinforced prior evidence (e.g., Lu et al., 1998) that neither the VTA nor the SNc 
receive any significant ENK input from the striatum. The absence of such a projection is 
a key complement to the Figure 2-3 scheme, because it is known that activation of mu-
opioid receptors in VTA can facilitate VTA output by inhibiting GABA release within 
VTA (Johnson and North, 1992; Madhavan et al., 2010). Note that it would be 
incompatible with the general scheme of Figure 2-3 ifthe striatal D2-ENK-MSPNs were 
responsible for such mu-opioid activation in VTA, because if such were true, then 
enhanced activity during sleep of D2-ENK-MSPNs would promote waking by 
disinhibiting VTA output. However, D2-ENK-MSPNs do not project to VTA/SNc, and 
the best known endogenous basis for activating mu-opioid receptors on GABA-INs of the 
VTA is consistent with the Figure 2-3 model of synergisms affecting states of arousal. 
Indeed, Quinn et al. (2003) showed that there is a functional ENK input to VTA that can 
be activated by mu-opioid agonists in the PVN of the hypothalamus, which is affected by 
circadian signals from the SCN. Both this SCN-PVN-VTA pathway and another, the 
SCN-MPA-VTA pathway, appear to mediate diurnal modulation, including wake-period 
activation, of VTA (Sleipness et al., 2007; Webb et al., 2009; Luo and Aston-Jones, 
2009).Although the scheme in Figure 2-3 tentatively omits the SCN-PVN-VTA (Lu et al. 
(2001) found that an ibotenate lesion ofPVN had no effect on sleep-wake), it includes the 
SCN-MPA-VTA pathway.The SCN-MPA component of the latter pathway was also 
depicted in Figure 2-2, as one basis for enhanced wake-period activation of ACh cells in 
the pallidum and SRCP zones. Note in Figure 2-2 that there is also a projection from 
such ACh cells to the SCN. This is based on work by Bina et al. (1993), who reported 
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that "after injection of fluorogold, a retrograde tracer, into the [SCN], retrogradely 
labelled neurons that were irnmunopo~itive for choline acetyltransferase were located 
throughout the rostrocaudal extent of the cholinergic basal nuclear complex, with highest 
densities in the [SI] and the [NBM]". Also consistent with the Figure 2-3 model, they 
found that SCN is further innervated by ACh fibers from PPT/LDT. 
2.3.3 Proposed dopamine-adenosine interactions to regulate cortical arousal via BGS 
As described in the previous two sections, adenosine and dopamine receptors 
interact on striatal MSPNs to modulate arousal and locomotor activity (Xie et al., 2007), 
as well as the willingness to exert effort (Mingote et al., 2008). Figure 2-3 shows how 
adenosine counteracts the DA effect in each pathway. Via D1Rs, DA promotes activity of 
D1-SP-DYN-MSPNs to inhibit GPi/SNr, but adenosine via A1Rs reduces this D1-
mediated inhibition. Via D2Rs, DA suppresses the D2-ENK-MSPNs and disinhibits 
pallidal and SRCP zones, but adenosine via A2ARs promotes inhibition of such zones. 
Caffeine facilitates dopaminergic transmission on the direct and indirect pathways by 
blocking the action of adenosine. These results imply that the role ofDA in the regulation 
of sleep and wake depends on the level of adenosine present at striatal and pallidal sites. 
Figure 2-4 describes two likely scenarios. In one simple case (Figure 2-4A), DA levels 
remain constant throughout wakefulness, while adenosine levels rise (Basheer et al., 
2004; Kalinchuk et al., 2011). As long as DA levels are large enough relative to 
adenosine levels, the direct and indirect pathways promote arousal. When adenosine 
levels become elevated enough to strongly compete with the action ofDA, such as during 
sleep deprivation, changes within the direct and indirect pathways reduce arousal. In a 
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Figure 2-4: Shifting balance between dopamine and adenosine across extended wakefulness. 
Adenosine and dopamine receptors interact on striatal MSPNs to modulate locomotor activity (Xie et 
aL 2007). The net effect of adenosine on both the direct and indirect pathways is to reduce cortical 
arousaL (A) Assuming that DA levels remain constant throughout wakefulness, when DA levels exceed 
adenosine levels, the direct and indirect pathways promote arousaL During extended wakefulness, 
adenosine levels rise in basal forebrain regions of the brain (Porkka-Heiskanen et aL 2002). When 
adenosine levels compete with the action of dopamine and are elevated relative to DA, the direct and 
indirect pathways reduce arousal. (B) However, under extended wakefulness cortical arousal can 
sometimes be maintained for sustained periods of time, especially during rewarding activities, which 
generate elevated DA levels. Such DA increases can partially counteract the increase in adenosine. 
Cognitive function may remain intact, but at the reduced performance level that is reliably seen under 
sleep deprivation. At a critical point adenosine levels may overcome DA levels, and reduce arousal to 
the point that sleep is initiated. 
second case (Figure 2-4B), increased DA levels beyond the norm, e.g., due to immersion 
in rewarding activities, extends the period of wakefulness by deferring the time at which 
adenosine gains the upper hand. In this way, wakeful function may be prolonged, but at a 
reduced performance level, as is often seen under sleep deprivation. 
It is useful to note here that the adenosine-dopamine opponency in the striatum is 
complemented by a dopamine-acetylcholine opponency. In particular, moments of high 
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DA release correlate with moments of low ACh release in striatum (Morris et al., 2004; 
Tan and Bullock, 2008). The sole known source of ACh in the striatum is a class of giant 
aspiny interneurons that are intrinsic to striatum and strongly innervated by dopaminergic 
afferents from the midbrain (Kubota et al., 1987; Chang, 1988). These cholinergic 
interneurons are often called TANs because they are tonically active neurons (Koos and 
Tepper, 2002; Goldberg and Reynolds, 2011). Similar to its effect on D2-MSPNs, DA 
acts via postsynaptic D2Rs to inhibit the striatal TANs, which release ACh ·onto both 
classes of MSPNs (Calabresi et al., 2000). Such inhibition by DA of ACh release 
synergizes with the direct effects of DA on MSPNs, to help shift the balance of striatal 
processing in favor of D1-MSPNs, relative to D2-MSPNs. This is because ACh is 
inhibitory to D1-MSPNs (via Mr muscarinic AChRs) and excitatory to D2-MSPNs (via 
~muscarinic AChRs). During sleep, tonic DA input to striatum from SNc and VTA is 
reduced relative to input during wake. According to current models (e.g., Tan and 
Bullock, 2008), the effect of such a reduction of DA input would be to facilitate tonic 
ACh release within striatum, which would facilitate D2-MSPNs, and the indirect 
pathway, relative to D1-MSPNs, and the direct pathway. Moreover, Tozzi et al. (2011) 
have reported co-expression of A2ARs with D2Rs in striatal TANs, which mimics the co-
expression seen on D2-MSPNs. Adenosine accumulation during prolonged wake can be 
expected to act via A2ARs on TANs to facilitate intra-striatal release of ACh, which 
would also help shift the balance in favor of the indirect pathway. Thus, although DA 
promotes ACh release from BF and opposes ACh release in striatum, this is consistent 
with our model, because whereas BF projections of ACh to cortex are arousing, the local 
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striatal action of TAN-released ACh is de-arousing. For completeness, it is important to 
note that the behavior of TANs, like that of MSPNs, is also affected by a number of non-
dopaminergic inputs (reviewed in Tan and Bullock, 2008). TANs also receive 
GABAergic inputs from striatal interneurons and glutamatergic inputs from the cerebral 
cortex and thalamus, most notably from the centromedian-parafascicular (CM-Pf) 
complex of intralaminar thalamus (Lapper and Bolam, 1992). During waking conditions, 
salient stimuli often activate the CM-Pf complex, which induces a burst-pause pattern in 
striatal TANs. The burst enhances ACh release and helps activate D2-MSPNs and the 
indirect pathway. This will often interrupt ongoing behavior. The subsequent TAN 
pause facilitates selection of a new behavior or attentional shift via the D1-MSPNs and 
the direct pathway (e.g., Ding et al., 2010). 
2.4 Expanding the discussion: Recognizing roles for the basal ganglia in sleep-wake 
regulation 
In the following sections, we present the growing case for BGS involvement in sleep-
wake regulation. We first review evidence that crossing the sedation threshold during 
anesthesia may be more reliably signaled by a dorsal striatal change (involving the 
putamen) than by a cortico-thalamic change. We then review and interpret evidence that 
BGS lesions can have effects on the sleep-wake system as large as the most effective 
lesions at non-BGS sites. 
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2.4.1 The BGS and overlap betvveen sleep circuits and circuits mediating effects of some 
anesthetics 
There is growing evidence that some anesthetics have their effects via sleep-wake control 
circuits, whereas others do not. For example, the clinically important anesthetic propofol 
has been shown to induce a sleep-like pattern of elevated activity in VLPO and reduced 
activity in TMN. A recent study (Zecharia et al., 2009) further showed that mice with a 
GABAA receptor mutation, which renders them relatively insensitive to propofol, showed 
reduced GABA-sensitivity specifically in the TMN, a key part of the monoamine arousal 
system that excites the thalamo-cortico system and that is strongly inhibited by VLPO -
during sleep. 
Given these results, the "standard theory", which focuses on cortical arousal via 
the brainstem-thalamus-cortex pathway, predicts that as the dose of propofol reaches the 
sedation level, there should be a functional disconnection of the thalamo-cortical loop 
that is widely believed to be critical for the genesis of high-frequency EEG components 
and waking consciousness (Steriade et al., 1993; Llinas and Steriade, 2006). However, a 
recent experimental test (Mhuircheartaigh et al., 201 0) of this prediction instead found 
that the dose level needed tq functionally disconnect thalamus and cortex is higher than 
the dose level needed to functionally disconnect the striatum- specifically, the putamen-
from other parts of the brain, and it is the latter dose level that defines the threshold for 
sedation. This result is in line with lesion studies (Vanderwolf and Stewart, 1998; Fuller 
et al., 2011) that have shown that near complete destructi<:m of the thalamus spares 
cortical responsiveness to stimuli and high frequency EEG, at least up to 35 Hz -
I 
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contrary to the predictions of standard theory. Such results raise the intriguing possibility 
that state changes within the striatum, and within the BGS targets of its projections, 
notably the pallidum, may play a major role in natural transitions between wake and sleep 
states. The next section details an endogenous basis for sleep-related state changes in 
striatum and pallidum. 
2.4.2 Effects of lesions in the BGS on sleep and wake 
Direct evidence for a role of BGS in sleep-wake regulation comes from recent lesion 
studies. Qiu et al. (2010) systematically lesioned different structures in the BGS of rats 
and quantified sleep and wake amounts across 48 hour periods. Lesions of the striatum 
restricted to the caudoputamen were found to decrease wakefulness by ~15% over a 24-hr 
period as compared to non-lesioned controls. However, striatal lesions that included both 
caudoputamen and NAc did not show changes in total sleep-wake time. Rats with lesions 
of NAc alone had increases in wakefulness of ~27%. Lesions of the GP produced the 
strongest increase in wakefulness of ~45%. Lesions in each of these structures led to a 
destabilization in the transitions between sleep and wake. 
An even more striking effect was recently observed by Fuller et al. (2011). They 
showed that: (1) extensive lesions to thalamus left normal waking EEG (up to 35 Hz) 
intact; (2) selective lesions of cholinergic or non-cholinergic corticopetal cells in BF, 
including VP/SI, also left waking EEG intact (but see Berntson et al., 2002), whereas 
combined lesions of such corticopetal cells eliminated normal waking EEG and induced a 
comatose state; and (3) the normal contribution of corticopetal cells in BF to waking EEG 
could be eliminated by lesion to a major source of such cells' glutamatergic afferents, 
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namely the PBN/PCA complex. 
These changes in sleep and wake amounts reported for recent lesions in the BGS 
and SRCP zones were significantly greater than changes observed in prior studies 
examining lesions in the BGS or in major brainstem arousal-promoting regions, as 
summarized in Table 2.2. Selective lesions of wake-promoting regions of the brainstem, 
with the just noted exception of the PBN/PCA complex (Fuller et al., 2011), have little 
effect on overall sleep and wake amounts. For example, genetic knockout (Parmentier et 
al. 2002) or neurotoxic lesions (Gerashchenko et al., 2004) of HST neurons in the TMN 
did not alter the amount of wake or NREM sleep across a 24-hr period, and had weak to 
moderate effects on the amount of REM sleep. Localized kainic acid lesions in the BF, 
including both cholinergic and GABAergic cells projecting to cortex, reduced time spent 
in deep SWS and REM, and increased time spent awake in one study (Szymusiak and 
McGinty, 1986). Selective saporin lesions of cholinergic cells in BF regions, however, 
resulted in no changes in amounts of wake, NREM or REM sleep over 24 hours (Blanco-
Centurion et al., 2006, 2007). Additionally, when these cholinergic BF lesions were 
combined with lesions to the noradrenergic neurons of the LC and histaminergic neurons 
of the TMN, some decreases in the amount of REM sleep were observed with no change 
in wake and NREM (Blanco-Centurion et al., 2007). Lesions of the LH, which primarily 
affected orexinergic neurons, resulted in moderate decreases in wake and corresponding 
increases in NREM sleep (Gerashchenko et al., 2003). The largest changes in sleep and 
wake amounts were seen in lesions of the sleep-promoting neurons of the VLPO, with 
strong increases in wake and decreases in both NREM and REM sleep observed. 
Table 2.2: Summary oflesion studies conducted in proposed arousal-promoting regions of the brain. 
Region Lesion technique Wake NREM REM Reference (Species) 
Striatum (CP) Ibotenic acid .} t 0 Qiu et al., 2010 (rat) 
Striatum (NAc) Ibotenic acid tt .} 0 Qiu et al., 2010 (rat) 
GPe Ibotenic acid ttt .}.} .}.} Qiu et al., 2010 (rat) 
STN/SNr Ibotenic acid 0 0 0 Qiu et al., 2010 (rat) 
TMN(HST) HDC-1- 0 0 tt Parmentier et al., 2002 (mouse) 
TMN(HST) Hcrt2-SAP 0 0 t Gerashchenko et al., 2004 (rat) 
vPAG (TH-ir cells) 6-0IIDA .}.} t t Lu et al., 2006 (rat) 
DRN (5-HT-ir cells) 5,7-DHT 0 0 0 Lu et al., 2006 (rat) 
vPAG+DRN Ibotenic acid .}.} t tt Lu et al., 2006 (rat) 
BF (ACh) 192-IgG-SAP 0 0 0 Blanco-Centurion et al., 2006 (rat) 
BF (ACh and GABA) Kainic acid tt .}.} .} Szymusiak and McGinty, 1986 (cat) 
BF+LC 192-IgG-SAP; anti-DBH-SAP 0 0 .} Blanco-Centurion et al., 2007 (rat) 
BF+TMN+LC 192-IgG-SAP (BF); Hcrt2-SAP 0 0 .}.} Blanco-Centurion et al., 2007 (rat) 
(TMN); anti-DBH-SAP (LC) 
BF (ACh) 192-IgG-SAP 0 0 0 Berntson et al., 2002 (rat); Fuller et al., 2011 (rat) 
BF (non-ACh) OX-SAP 0 0 0 Fuller et al., 2011 (rat) 
BF (ACh and non-ACh) 192-IgG-SAP; OX-SAP .}.}.} ttt .}.}.} Fuller et al., 2011 (rat) 
LH(ORX) Hcrt2-SAP .}.} tt 0 Gerashchenko et al., 2003 (rat) 
VLPO (cluster) Ibotenic acid ttt .}.}.} .}.}.} Lu et al., 2000 (rat) 
VLPO (extended) Ibotenic acid tt .} .}.} Lu et al., 2000 (rat) 
LDT/PPTILC Kainic acid t 0 .} Webster and Jones, 1988 (cat) 
Thalamus Ibotenic acid 0 0 0 Fuller et al., 2011 (rat) 
Lateral PBN OX-SAP .}.} tt tt Fuller et al., 2011 (rat) 
MedialPBN OX-SAP .}.} tt tt Fuller et al., 2011 (rat) 
PCA Ibotenic acid 0 0 0 Lu et al., 2006 (rat) 
Relative effect sizes: a single atrow indicates < 20% change, double anows indicate 20 - 40% and triple anows indicate >40% change 
from baseline. All lesion studies cited preserve fibers of passage. 
_.,.. 
0\ 
47 
In summary, other than wake-promoting lesions of the GABAergic VLPO, the 
most potent relative effect on the amount of NREM, REM and wake across a 24-hour 
period was a wake-promoting lesion of the GP and coma-promoting lesions either to the 
cholinergic and non-cholinergic BF corticopetal cells, or to their source of glutamatergic 
drive, the PBN/PCA complex. 
2.4.3 Reconciling the results of lesion studies with our proposed model of the BGS 
The models proposed in Figures 2-2 and 2-3, with connections detailed in Table 
2.1, can be used to understand the effects of lesions of striatum and GP on sleep and 
wake as described in Qiu et al. (20 10; also reviewed by Vetrivelan et al., 201 0). As 
described in section 2.2.1, on the direct striatopallidal pathway, D1-SP-DYN-MSPNs 
send inhibitory projections to GPi and SNr, which inhibit motor thalamic relay cells (e.g. 
V AJVLo) that send excitatory projections to areas of the frontal cortex. The function of 
the direct pathway is to release a voluntary movement. When D1-SP-DYN-MSPNs 
become active, often aided by a DA burst from the SNc, they inhibit GABAergic 
projection neurons in the GPi!SNr. This inhibition disinhibits thalamic relay cells that 
excite cortex. Therefore, this loop through the BGS promotes arousal through its effect 
on thalamic relays. Removal of the inhibitory connections from striatum to GPi, via 
striatal lesions, leaves sustained inhibition of the thalamus by GPi, and reduced thalamic 
arousal of cortex. This is consistent with Qiu et al. (20 1 0), who found that striatal lesions 
increased the amount of sleep observed over a 24-hour period. 
The major relays on the indirect striatopallidal pathway are the GP/SRCP zones 
(Figure 2-2) comprising cholinergic, PV+ GABAergic, PV- GABAergic, and CB+ 
-.- -.:;:· ··--·--·,;- ..• _ ... , 
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glutamatergic populations (Deurveilher et al. 2006; Furuta and Kaneko, 2006; Gritti et al. 
2003). These striatal-recipient zones sends GABAergic projections to both GPi/SNr as 
well as to cortical intemeurons that inhibit pyramidal neurons in cortex. Striatal input 
inhibits these GABAergic projection populations, removing inhibition of cortical 
intemeurons, and thereby increasing inhibition of cortical pyramids and reducing cortical 
arousal. A lesion to the GPe (or SRCP zone) corticopetal GABAergic neurons will mimic 
the effect of inhibition of this neuronal population by striatal input: reduced arousal via 
disinhibition of cortical intemeurons that inhibit pyramidal neurons. Cholinergic neurons 
of the GPe (or SRCP zone) send excitatory projections to pyramidal neurons, but recent 
evidence shows an inhibitory effect of ACh on cortical intemeurons (Xiang et al., 1998; 
Salgado et al., 2007). Lesions of these neurons in GPe will directly reduce cortical 
arousal by severing the direct excitatory projection to pyramidal neurons, and indirectly 
reduce arousal by disinhibiting intemeurons. 
The effects just described would appear to be inconsistent with the GPe lesion 
results reported by Qiu et al. (2010): they found increased wake across a 24-hour period. 
The apparent inconsistency of Qiu et al.'s GPe-lesion results with known GPe efferent 
pathways may be reconciled if closer attention is paid to local circuits in pallidal and 
SRCP zones and to the probable differential effects of the lesion across cell-types 
(Figure 2-2). Kaur et al., (2008) showed that ibotenic acid disproportionately destroyed 
GABAergic over cholinergic neurons: 43% ofPV+ neurons were destroyed, compared to 
21% of ACh neurons. A similar pattern was observed by others who also used large doses 
(Ofri et al., 1992; Rattan and Tejwani, 1992). At the much lower dose of ibotenic acid 
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used by Qiu et al., it can be expected that most cholinergic neurons survived. Thus, 
whereas such a lesion would reduce cortical activity via the PV + GABAergic pathway to 
cortical intemeurons, the cholinergic pathway from GPe would continue to promote 
cortical arousal. Moreover, Zaborszky and Duque (2000) presented evidence for a 
negative feedback regulation of BF cholinergic neurons via cortical excitation in BF of 
NPY + GABAergic neurons that inhibit the BF cholinergic neurons (Figure 2-2). A lesion 
that destroyed VP/GPe GABA neurons while sparing the cholinergic neurons could 
easily cause a boost to ACh release in cortex that would compensate for loss of BF 
GABA neurons' inhibition of cortical INs. Moreover, although the 8 to 1 ratio of 
GABAergic to cholinergic neurons Zaborszky et al. (1999) in GPe might suggest a 
stronger GABAergic cortico-petal projection from GPe, many GPe GABAergic neurons 
do not project to cortex. A more important caveat is that removing GABAergic GPe 
neurons that inhibit TRN via GPi/SNr should have a reductive effect on arousal via the 
thalamic pathway to cortex. 
An alternate pathway through the VP exists. VP regions send both cholinergic and 
GABAergic projections (Figure 2-2) to mediodorsal (MD) thalamus (Gritti et al., 1998), 
which projects to frontal cortex (e.g., Xiao et al., 2009). Although the functional 
significance of the dual VP projections to MD thalamus remains to be tested, the model 
in Figure 2-2 assumes that the GABAergic projection is sleep-active, whereas the 
cholinergic projection is wake-active. Assuming the scenario described above, in which 
GABAergic neurons are preferentially destroyed by ibotenate lesion, their loss combined 
with the surviving cholinergic projections to MD would both promote thalamocortical 
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activity, hence arousal. This result is consistent with the Qiu et al. fmding that ibotenate 
lesions in VP/GPe increased wakefulness. Also, the VLPO projects to MD thalamus 
(Gritti et al., 1998) and contributes to arousal regulation, independently from the 
pathways described here. 
The results of Qiu et al. can also be explained if there exists a strong direct 
GABAergic projection from GPe to cortical pyramidal cells: an active pool of such cells 
in GPe would directly inhibit these pyramidal cells, and its removal by ibotenate lesions 
would promote cortical arousal. Although until recently it was thought that GABAergic 
projection neurons from the VP/GPe region synapsed on cortical intemeurons only 
(Freund and Meskenaite, 1992; Jimenez-Capdeville et al., 1997), Vetrivelan et al. (20 1 0) 
recently identified a population of GABAergic GPe neurons that synapse directly onto 
pyramidal neurons. As depicted in Figure 2-2, these GABAergic GP neurons are here 
proposed to be PV- and to belong to the sleep-active population identified by Benny and 
Jones (2008). The hypothesis of a major sleep-active, de-arousing GABAergic signal to 
cortex from GP, which parallels that from SI, is consistent with Qiu et al. 's view that the 
wake-promoting effects of GPe lesions are primarily due to removal of the direct effect 
on cortex of corticopetal neurons in the GP. 
The interpretation by Qiu et al. (20 1 0) of their GPe lesion results ignored the 
above mentioned cholinergic projections to cortex. They instead concluded that the only 
relevant cortical projections from GPe were GABAergic (Barroso-Chinea et al., 2008). 
To reach that conclusion, Qiu et al. (2010) downplayed any involvement of the MD 
thalamus, citing a report by Vanderwolf and Stewart (1988) that neurotoxic lesions to the 
.- ".-;·.· •• ,-" .. !·.· •• 
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thalamus do not prevent cortical activation. Yet that 1988 report strongly emphasized the 
survival of the cholinergic innervation of the cortex in their study, and they stressed 
evidence indicating a key role for the cholinergic projection from BF to cortex in the 
production of wake-like cortical activation. Both Qiu et al. (2010) and a subsequent 
review by Vetrivelan et al. (2010) also emphasized that lesions to GPi, STN or SNr, 
performed separately, did not affect sleep or wake. Because all three regions are 
downstream of the GPe on the indirect pathway, Qiu et al. (2010) concluded that the 
main contribution of GPe to cortical arousal is via a direct projection, rather than via the 
thalamus. Although we believe that a direct-projections hypothesis might prove correct-
albeit in a form (Figures 2-2 and 2-3) that emphasizes the cholinergic and glutamatergic 
projections as well as the GABAergic- great caution is needed before ruling out any 
trans-thalamic contributions in normal animals. This is especially true when the 
mediating structures (e.g., GPi or SNr) have only been damaged separately, because 
surviving structures often compensate. There are many instances of lesion studies in 
which functional recovery, usually weeks after a lesion, is complete enough to warrant 
concluding that the lesioned site was not strictly necessary for some function. Yet in 
many such cases, manipulations other than lesions in those sites have reliable and strong 
effects on the function of interest. A good example is the superior colliculus (SC): the 
recovery of saccadic eye movements, weeks after SC lesion, has not led researchers to 
reject the principle that it is a key normative pathway for the genesis of saccades 
(Schiller, 1998). 
In summary, by noting that the GPe lesions in Qiu et al. (20 1 0) would have 
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affected primarily GABA neurons while sparing ACh neurons, it is possible to reconcile 
the result with known circuitry and prior observations of separate pools of corticopetal 
wake- versus sleep-active neurons in the pallidum (Szyrnusiak and McGinty, 1986, 1989; 
Manns et al., 2003; Benny and Jones, 2008). Among the GABA neurons destroyed in 
GPe would be NPY GABA-INs that inhibit ACh neurons, as well as a sleep-active 
population of corticopetal PV- GABA neurons that inhibit pyramidal neurons in cortex. 
These two arousal-promoting effects could easily overwhelm arousal-opposing 
ramifications of the same lesion, e.g., those due to removal of corticopetal PV+ GABA 
neurons that inhibit inhibitory cortical INs. 
2.4.4 Reconciling the role of dopamine in sleep-wake regulation with the results of BGS 
lesion studies 
Regarding the effects of dopamine within the BGS, Qiu et al. (2010) and Vetrivelan et al. 
(2010) hypothesized that DAis wake-promoting via D1Rs. This is consistent with the 
observation that DA excites D1-SP-DYN-MSPNs to disinhibit thalamus via GPi!SNr 
inhibition. They also proposed, however, that DAis sleep-promoting via D2Rs. The latter 
proposal can be expected to be very controversial, because DA effects are usually 
synergistic via D1Rs and D2Rs. As we argued above, increased striatal DA acting via 
D2Rs would generally suppress activity of D2-ENK-MSPNs of the indirect pathway. 
Contrary to the proposal of Vetrivelan et al., this would promote cortical arousal via 
multiple pathways (Figures 2-2 and 2-3). Consistent with our model in Figures 2-2 and 
2-3, the review of Rommelfanger and Wichmann (2010) cited abundant evidence that 
activation in GPe of D2Rs (which reside on, and suppress GABA release from, the axon 
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terminals of striata-pallidal D2-ENK-MSPNs) increased activity of most GPe neurons. 
Moreover, Qu et al. (20 1 0) recently showed a significant reduction in wakefulness in D2R 
knockout mice, consistent with our view that D2R activation synergizes with D1R 
activation to promote wake/arousal. These effects directly contradict Vetrivelan et al. 's 
prediction that DA is sleep-promoting via D2Rs in the BGS. Moreover, because 
adenosine and DA compete at D2RJA2AR heteromers (Ferre et al., 2007a,b; Albizu et al., 
2010) on striatal D2-ENK-MSPNs (Figure 2-3), high adenosine during sleep will block 
D2R action, and release D2-ENK-MSPNs to inhibit pallidal (GPe, VP) and SRCP 
neurons. During wake, low adenosine enables DA to act fully to inhibit D2-ENK-MSPNs 
viaD2Rs. 
Vetrivelan et al. (2010) cite evidence that some GABAergic GPe neurons 
project directly to cortical pyramidal neurons, and, by assuming that GPe has only this 
one type of cell, they conclude that DA would promote sleep via D2Rs. As clarified in 
Figures 2-2 and 2-3, this assumption is wrong. There is strong evidence (e.g., Gritti et al., 
2003) of several distinct subsets of GABAergic neurons in GPe (and VP), and 
GABAergic cells that project directly to cortical pyramids appear to be rarer than others 
that project to cortical INs, to striatal INs, or to GPi/SNr. Although removing this rarer 
type would promote arousal, it may actually be the sleep-active type (Benny and Jones, 
2008; Manns et al., 2003) that is inhibited by NE from LC during wake (see Figure 2-2 
input to the GABA PV- type in VP/GPe). Moreover, how or whether the pyramid-
inhibiting GPe cells may be affected by D2R activation is U!lknown. Note also that DA 
acts to suppress the release by D2-ENK-MSPNs of enkephalin, which inhibits ACh cells 
54 
in pallidal and SRCP zones. Thus DA acts via D2Rs to disinhibit cholinergic activation 
of cortex. 
Finally, Vetrivelan et al. (2010) proposed that large lesions to the SN (the primary 
source of DA for dorsal elements of the BGS, including striatum and GPe) increase 
wakefulness. Although this does not speak to the normative role of BGS DA levels in 
sleep-wake cycles or arousal, it would be interesting if true. However, the SN lesion 
effects are subject to alternative interpretations, based on multiple cells types affected by 
the cited lesions. Indeed, the most recent report cited by Vetrivelan et al., that of 
Gerashchenko et al. (2006), actually attributed the wake-promoting effect of the SN 
lesions to loss of GABAergic neurons of the SNr- not to the attendant loss of DA cells in 
the SNc. A second cited report, by Lai et al. (1999), also involved damage to regions 
such as SNr, and was unable to definitively attribute sleep effects to DA cell loss. A 
third, that of Sakata et al. (2002), actually involved a lesion to the VTA, which affected 
diurnal rhythms of blood pressure, while sparing sleep-wake rhythms - consistent with 
other reports of non-effects of VTA lesions. (However, this too is non-definitive, 
because VTA also includes many non-DAergic projection neurons; see review in Sesack 
and Grace, 2010). Note that the loss of GABAergic SNr neurons (as occurred in 
Gerashchenko et al. and in Lai et al.) would disinhibit thalamus as well as locomotor 
centers, and thereby lead to hyperactivity and sleep-reduction, consistent with our model 
in Figures 2-2 and 2-3. Finally, although MPTP lesions affect noradrenergic cells in 
addition to dopaminergic cells, Vetrivelan et al. claimed support from two MPTP studies 
for their proposal that DA acts via D2Rs in the BGS to promote sleep. However, the cited 
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study of Almirall et al. (1999) was correlative, and not definitive regarding mechanism. 
Even more critical, the cited conclusion in Monaca et al. (2004), of a direct link between 
MPTP-induced DA loss in BGS and disordered sleep- more wake, but also longer PS 
(paradoxical sleep, i.e., REM) - was later retracted on the basis of more definitive 
research from the same lab. Notably, Laloux et al. (2008, p. 635) concluded "that there is 
no correlation between the dopaminergic neuronal loss and PS alteration in MPTP-
treated mice". In summary, a careful weighing of the evidence leads us to conclude that 
DA normally is arousing, and there is overwhelming evidence that within the BGS it 
achieves its arousing effect via synergistic actions on D1R and D2Rs. 
All these points do not contradict the observation that a low dose of doparninergic 
agonists, when administered in aDA depleted system, may be de-arousing via D2Rs. The 
reason is that terminals of dopaminergic fibers contain D2Rs that act as autoreceptors that 
inhibit DA release. A low dose can be big enough to stimulate such high-affinity 
autoreceptors in aDA-depleted animal while also being too low in the same DA-depleted 
animal to activate lower-affinity DrRs or the postsynaptic D2Rs that are in competition 
with adenosine receptors (Figure 2-3). Such a mechanism can explain the low dose 
effects (e.g., of apomorphine) cited by Vetrivelan et al., yet is entirely consistent with our 
thesis that DAis normally arousing via synergistic actions ofDrRs and D2Rs in the BGS. 
Dopamine sources beyond the VTA and SNc must also be considered. Indeed, 
Lai et al. (1999) reported that lesions that destroyed DAergic and other cells in the VTA 
and SNc failed to reduce time awake. In fact, their lesions tended to produce insomnia, 
which the authors attributed to lesion-induced loss of known GABAergic projections 
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from VTA, SN, and nearby regions of the ventral midbrain to wake-promoting neurons in 
the posterior-lateral hypothalamus, which includes the TMN. Some DA effects on sleep-
wake are mediated by the ventral periaqueductal grey (vPAG; see Figure 2-1) area, 
which contains DA neurons that have diverse projections to several brain regions 
implicated in arousal, including midline and intralaminar thalamus (Mantyh, 1983; Krout 
and Loewy, 2000), the medial prefrontal cortex (Herrero et al., 1991), the cholinergic 
basal forebrain (Eberhart et al., 1985; Semba et al., 1988; Lu et al., 2006), the VLPO 
(Cameron et al., 1995), the LH orexin (also known as, hypocretin) cells (Cameron et al., 
1995), the pontine LDT cholinergic cells (Satoh and Fibiger, 1986), and the LC (Lu et al., 
2006). Lu et al. (2006) reported that lesions ofthe DA neurons in the vPAG significantly 
increase SWS and REM sleep (Table 2.2). Thus, vP AG DA neurons may promote wake 
through one or more of its projections. Electrophysiological studies are needed to 
determine whether the firing activity of vP AG neurons changes between sleep and wake. 
2.5 Interactions between the BGS and ascending arousal system 
In the next section, we discuss projections to BGS arising from ascending arousal system 
nuclei. Although not part of our main hypothesis regarding the effect of dopamine-
adenosine opponency in the extended BGS on sleep-wake regulation, the BGS receives 
several projections from brainstem nuclei of the ascending arousal system, as depicted in 
Figures 2-1 and 2-2, which may modulate BGS during wake-sleep switching. Emerging 
evidence regarding modulation of the BGS from the serotonergic dorsal raphe nucleus 
(DRN) and histaminergic tuberomamillary nucleus (TMN) are reviewed below. We also 
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discuss changes in firing rates across sleep and wake states in ascending arousal system 
nuclei and BGS to further understand the role of the BGS in wake-sleep switching. 
2.5.1 The serotonergic (5-HT) projection to BGS sites 
The dorsal raphe nucleus (DRN) is a wake-active component of the flip-flop switch (see 
Figure 2-1), and it inhibits the sleep-active VLPO via the release of serotonin (5-HT) 
during wake. Serotonin also has complex effects in the BGS, and has been implicated in 
secondary symptoms of Parkinson's disease. Wang et al. (2009) reported that unilateral 
lesion of the DAergic nigrostriatal pathway significantly increased the mean firing rate of 
DRN 5-HT neurons compared with unlesioned rats. Eskow et al. (2009) found that 
selective lesions in the DRN dose-dependently attenuated the expression of LID (L-dopa 
induced dyskinesia) without affecting the antiparkinsonian efficacy of L-dopa. Bishop et 
al. (2009) showed that cellular and behavioral effects of 5-HTrAR agonists (which reduce 
LID) partly depend on 5-HTrARs within the striatum. In striatum, serotonin also excites 
FS-INs (fast-spiking intemeurons, presumably GABAergic) via 5-HT2cRs (Blomeley and 
Bracci, 2009). Bonsi et al. (2007) reported that in rats 5-HT released by fibers projecting 
from the raphe nuclei has a potent excitatory effect on striatal cholinergic intemeurons, 
via 5-HT2cRs, 5-HT6Rs, and 5-HT7Rs. In the rat GP, Chen et al. (2008) found that 5-HT 
excited neurons by enhancing an intrinsic current, namely the hyperpolarization-activated 
inward cation conductance. This effect was blocked by 5HT 4R and 5HT 7R antagonists. 
Effects of 5-HT on synaptic currents were more complex and dose dependent, but 
included a pre-synaptic suppression of GABAergic inhibition of GP neurons. In rat VP, 
Bengtson et al. (2004) found that 5-HT had opposing effects on cholinergic and non-
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cholinergic neurons: it was excitatory to non-cholinergic (presumed GABAergic) 
neurons, but inhibitory to cholinergic neurons. From such observations, it appears that 
the various effects of 5-HT do not synergize to either promote or oppose arousal. 
Moreover, the role ofthe DRN in the flip-flop switch is also in need of reassessment. As 
described elsewhere, Lu et al. (2006) established that a DAergic cell group in the vP AG, 
which borders both the DRN and the VTA, is highly active in wake, and inhibitory to 
VLPO. They noted that the intermingling of DA and 5-HT cells at the borders of DRN 
and vPAG raises the possibility that some past wake-promoting effects attributed to 5-HT 
neurons in DRN might have been mediated by DA neurons. 
2.5.2 The histaminergic projection to BGS sites 
Another key modulator of arousal during the sleep-wake cycle is histamine (HST). HST 
is generally regarded as wake promoting, and most discussions (e.g., Haas et al., 2008) 
emphasize that HST is diffusely distributed, from several clusters of cells in the 
tuberomammillary nucleus (TMN) of the hypothalamus, to the cerebral cortex, the BF, 
the GP, and both ventral and dorsal parts ofthe striatum (Figure 2-1). Ofthe three best-
studied HST receptors, types Hr and H2 are generally excitatory, whereas type H3 is 
inhibitory. Often, but not always, H3Rs are inhibitory autoreceptors on terminals of EST-
releasing axons emanating from, or branching within, TMN. Such autoreceptors also 
exist on somata of HST neurons in TMN, and blocking their action (e.g., with 
thioperamide) in TMN leads to a higher firing rate in the spontaneously wake-active HST 
neurons. The effects of HST in the extended BGS have been partially characterized. In 
the basal forebrain, including the NBM and VP, and in both the GPi and GPe, HST has 
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been shown to have an excitatory effect via H1Rs and H2Rs on cholinergic and other 
neurons (Ramesh et al., 2004; Chen et al., 2005). With the exception of the effect in GPi, 
these effects -will increase cortical arousal, consistent with the model in Figure 2-2 and 
with results (Qiu et al., 2010; Table 2.2) sho-wing that ibotenic acid lesions in GP -
which spare GP cholinergic neurons but neither the GABAergic intemeurons that inhibit 
them, nor the GABAergic neurons that project from GP to cortex - can have a large 
wake-promoting effect. 
In the striatum, a more complex picture has emerged. First, H3Rs are located on 
terminals of cortico-striatal and thalamo-striatal afferents (Ellender et al., 2011), as well 
as on MSPNs, whereas H1Rs and H2Rs are located on giant cholinergic intemeurons, also 
known as the striatal TANs (tonically active neurons). The H3Rs on MSPNs have been 
shown to antagonize DA effects on both D1-MSPNs and on D2-MSPNs (Ferrada et al., 
2008), whereas the H1Rs and H2Rs located on the cholinergic TANs are excitatory 
(Ogawa et al., 2009). Because DA and ACh have opposing effects on the two MSPN 
types (review in Tan & Bullock, 2008), there is a HST-ACh cascade in the striatum that 
parallels, but has actions opposite to, the DA-ACh cascade in the striatum. Through this 
path, by itself, HST release in the striatum could enhance D2 MSPN excitability relative 
to D1 MSPN excitability. A different set of interactions, however, emerged in a recent 
experiment. Ellender et al. (20 11) found that HST acted via H3Rs on terminals of cortico-
striatal and thalamo-striatal afferents to down-modulate cortical relative to thalamic 
excitation of MSPNs. It also attenuated striatal feedback inhibition relative to 
feedforward inhibition. These latter two effects could be quite consequential for 
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switching the striatum from a sleep mode to a wake mode. Strong feedback inhibition 
during sleep relative to wake could help explain the stronger cortex-entrained cyclic 
MSPN activations during sleep (Mahon et al., 2006). Moreover, because intralaminar 
thalamic inputs to striatum synapse preferentially on D1-MSPNs of the direct pathway 
(Sidibe and Smith, 1996) while also inhibiting TANs (and ACh release) via intemeurons 
(Sidibe and Smith, 1999; Tan and Bullock, 2008), the Ellender et al. results support the 
hypothesis that HST promotes switching from a sleep mode that favors D2-MSPN and 
indirect pathway activity to a wake mode that favors D1-MSPNs and direct pathway 
activity. This effect could be marked because feedb'ack inhibition is considerably 
stronger from the indirect to the direct path MSPNs than vice versa (Taverna et al., 2008). 
There are undoubtedly more subtle functional implications of these interactions 
during wake. Three of these neuromodulators are being released by neurons that are 
tonically active during waking: DA cells in VTA or SNc, ACh cells (TANs) in striatum, 
and HST cells in TMN. Because they are tonically active, they can all exhibit phasic 
deviations both above and below the baseline. If the phasic HST and DA deviations from 
baseline rise and fall together, their effects could be quite different than if the phasic HST 
and DA deviations were of opposite sign. Simulation studies will be needed to map and 
analyze such modes of operation. 
Another factor to consider is differential HST modulation of ventral versus dorsal 
striatum. It is usually assumed, based on observations of the HST-positive TMN neurons 
presumed to project to striatum, that the baseline HST signal to all striatum is negligible 
during sleep but becomes progressively stronger with higher levels of arousal during 
,,.·. 
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waking. There is direct evidence for higher wake-period than sleep-period release of 
HST in striatum (Morisset et al., 2000), and some manipulations in T11N produce similar 
effects in striatum and other HST-recipient zones. For example, the HST projections to 
both dorsal striatum and NBM are sensitive to CB1R (cannabinoid receptor) agonists 
applied in T11N (Cenni et al., 2006). However, some reports call into question the long-
held assumption that the T11N projection to striatum can be regarded as just like T11N 
projections to other areas. Notably, Giannoni et al. (2009) recently showed that whereas 
thioperamide blockade of H3Rs in T11N boosted HST release in cortex, NBM 
(cholinergic BF) and T11N, it had no effect in dorsal striatum. The same was true during 
bicuculline blockade of GABA release in T11N. In contrast, bicuculline (but not 
thioperamide) in T11N did increase HST release in ventral striatum (NAc). This is 
important because of the GABAergic projection from VLPO to known sleep-regulating 
HST cells in T11N. Local perfusion ofthioperamide in cortex and NBM led to enhanced 
HST release in each, but not in dorsal or ventral striatum. The insensitivity of HST 
release in ventral and dorsal striatum to local thioperamide may mean that H3Rs are 
sparse on HST-releasing terminals in striatum, or, if present, may be among the H3R 
isoforms (Bakker et al., 2006) that are insensitive to such H3R ligands as thioperimide. 
The differential effects in ventral vs. dorsal striatum of T11N bicuculline perfusion 
suggest that these two striatal compartments are innervated by distinctive subsets of HST 
neurons. In summary, there is now evidence that there are separable HST projections 
from T11N to ventral vs. dorsal striatum; both of these differ in their properties from the 
"standard" projections from T11N to cortex and NBM. 
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The existence of these multiple pathways raises the issue of functional differences 
among the HST cells of the TMN. For example, the interpretation of the role of the HST 
projection to striatum would change markedly if the TMN cells giving rise to the 
projection were sleep-active rather than wake-active. This question is pertinent because 
reports (e.g., Sakai et al., 2010) indicate that ~45% ofTMN neurons are sleep-active. So 
far, what sparse evidence exists favors the conclusion that "W[ake]-specific neurons and 
other types of neurons in the TM of WT mice are, respectively, histaminergic and non-
histaminergic" (e.g., Sakai et al., 2010, p. 7). Although based on sparse observations, this 
generalization, together with the data ofMorisset et al. (2000), suggest that the projection 
to striatum from TMN is dominated by wake-active HST cells, consistent with the widely 
held view, but the work of Sakai and colleagues does not rule out the possibility that 
there is a sleep-active projection to striatum mediated by non-histaminergic neurons. 
2.5.3 Firing patterns across sleep and wake in BGS and the ascending arousal system 
Although lesioning studies provide a wealth of information about the anatomical regions 
that may be implicated in the regulation of arousal, electrophysiological evidence is 
necessary to understand the mechanisms by which this regulation is effected. Table 2.3 
outlines the firing patterns of the brain regions included in our proposed circuitry. The 
firing activity of the brain regions comprising the flip-flop switch were discussed 
previously in Saper et al. (2001). In brief, the wake-promoting groups, LC, DRN, TMN, 
LH and LDT/PPT, all have increased firing during wake compared to NREM sleep. 
Additionally the LDT/PPT is active during REM sleep, with firing rates increased 
relative to wake. In contrast, the VLPO is most active during NREM sleep with reduced 
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firing during wake. VLPO neurons are more active during deep NREM sleep compared 
to light NREM sleep. Under sleep deprivation, the firing rate of VLPO is increased 
during NREM sleep compared to sleep after normal wake; there is no change in the 
discharge rate of these neurons during the extended wakefulness (Szymusiak et al., 
1998). 
There are well-known changes in firing rate and pattern in the thalamocortical 
system across sleep and wake. Both thalamic relay nuclei (McCarley et al., 1983; Domich 
et al., 1986) and intralaminar nuclei (Glenn and Steriade, 1982) fire tonically during wake 
and REM sleep, generating desynchronized rhythms at the cortical level. During NREM 
sleep, these neurons switch to a bursting pattern of firing that contributes to slow, 
synchronized oscillations in cortex. Firing rates are higher during wake and REM 
compared to NREM. TRN cells, which inhibit thalamic relay cells, also have a tonic 
firing pattern during wake and a burst pattern during NREM sleep (Marks and Roffwarg 
1983); however, the firing pattern during REM sleep appears to be species-dependent 
(Marks and Roffwarg 1983; Domich et al., 1986). The firing rate across sleep and wake 
in TRN does not change. Recent studies have measured firing patterns across sleep and 
wake in BGS regions of unanesthetized, behaving animals. The Figure 2-3 connectivity 
predicts an intricate pattern of changes, but their exact nature could only be predicted by 
intricate biophysical models. Mahon et al. (2006) reported that rat striatal MSPNs were 
active during both wake and NREM sleep. Although mean firing rate did not change 
across NREM sleep and wake (activity during REM was not measured), discharge 
activity changed from cyclic bursting during sleep to irregular firing during wake. 
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Table 2.3: Firing rates during wake (W), NREM (N) and REM (R) 
Region w N R Notes Reference (Species) 
LDT/PPT t 0 tt el Mansari et al., 1989 (cat); 
Steriade et al.. 1990 (cat~: 
LC tt t 0 Aston-Jones et al., 1991 (rat, 
monkey) 
DRN tt t 0 McGinty and Harper, 1976 
(cat); Urbain et al., 2006 (rat) 
TMN tt 0 0 Takahashi et al., 2006 (mouse) 
LH tt t 0 Steininger et al., 1999 (rat); 
Modirrousta et al., 2005 (rat) 
VLPO 0 tt t? Discharge rate is higher in deep Szymusiak et al., 1998 (rat) 
(cluster) NREM sleep compared to light 
NREMsleep 
VLPO 0 t? tt Saper et al., 2001 (rat) 
(extended) 
TC relay and tt t tt Tonic firing pattern during wake and Glenn and Steriade, 1982 (cat); 
intralaminar REM; burst firing during NREM Domich et al., 1986 (cat); 
McCarley et al., 1983 (cat) 
TRN t t t Tonic firing pattern during wake and Marks and Roffwarg, 1993 
bursting during NREM; during REM, (rat); Domich et al., 1986 (cat) 
firing pattern is species-dependent 
(bursting in rat, tonic in cat) 
PY tt t tt Tonic firing pattern during wake and Steriade et al., 1993 (cat) 
REM; burst firing during NREM 
Striatal t t ? Tonic firing pattern during wake; Mahon et al., 2006 (rat) 
MSPNs bursting during sleep 
Striatal FS-INs Tonic firing pattern during wake; Berke et al., 2004 (rat) 
bursting during sleep 
STN t t ? Tonic firing pattern during wake; Urbain et al., 2000 (rat) 
bursting during sleep 
GPe tt t ? Tonic firing pattern during both wake Urbain et al., 2000 (rat) 
andNREM 
BF (ACh t 0 tt Burst firing during wake and REM Szymusiak et al., 2000 (rat, 
corticopetal) cat); Lee et al., 2005 (rat) 
BF tt t ? Hypothesized to be same as GPe Urbain et al., 2000 (rat) 
(GABAergic 
corticopetal) 
BF -1, tt Tonic firing during NREM Szymusiak and McGinty, 1989 
(GABAergic (cat); Manns et al., 2003 (rat) 
corticopetal) 
vPAG ? ? ? No studies found 
Part of this table reproduced from Saper et al. (2001). "?"indicates a lack of data. 
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Although broadly consistent with the model in Figure 2-3, this study is not a 
definitive test because the striatal MSPNs were not identified on the basis of 
immunohistochemistry for expression of SP, ENK or DYN, and therefore it is unknown 
whether these putative MSPNs project to nigral (direct pathway) or pallidal (indirect 
pathway) regions. The model suggests, however, that despite no change in the firing rate 
across all MSPNs, that there is a shift in the balance such that a greater number of spikes 
would be generated by the indirect pathway MSPNs compared to the direct pathway 
MSPNs during sleep. Also consistent with the model outlined in Figure 2-3 is the report 
by Berke et al. (2004) of a dramatic switch across sleep-wake cycles in the behavior of 
striatal FS-INs. Notably, FS-INs also show much more bursting during sleep. This could 
be due jointly to reduced inhibition from VP/GPe and reduced DAergic inhibition of gap-
junction coupling among FS-INs. Indeed, Urbain et al. (2000) found that the GP- unlike 
cortex, thalamus, and striatum -fired tonically during both sleep and wake and had a 
lower mean firing rate during NREM sleep compared to wake. In contrast, the STN does 
not change firing rate across sleep and wake but shifts from tonic discharge in wake to 
burst firing during NREM (like cortex, thalamus, and striatum). Many regions exhibiting 
separate tonic vs. burst modes, in wake vs. sleep, receive efferents from GP, VP or other 
SRCP zones, including striatal FS-INs (that inhibit striatal MSPNs), cortical FS-INs, 
pallidal/nigral FS-projection neurons and TRN neurons. Since cortical FS-INs, TRN 
neurons, and striatal MSPNs switch from synchronized bursting to tonic/irregular mode 
during wake, this switching could be due to the increased activity of GP NP /SRCP zone 
neurons (Figures 2-2 and 2-3). The hypothesis is that a higher mean firing rate 
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associated with wake in these regions results in tonic mode activity, while a lower mean 
firing rate is associated with sleep and burst firing in areas receiving projections from 
them. This hypothesis is consistent with the model in Figures 2-2 and 2-3, and with the 
results reviewed in Vanderwolf and Stewart (1988), which challenged the idea of 
thalamic control of mode switching (see also Fuller et al. 2010). One caveat is that the 
types of the GP neurons recorded in Urbain et al. (2000) were not identified. Since they 
showed increased activity during wake, they were not the sleep-active GABAergic 
neurons described in Renny and Jones (2008), but may have included cholinergic, 
glutamatergic, and wake-active GABAergic, neurons (Figure 2-2). Increased wake 
activity of cholinergic BF neurons (Table 2.3) has been reported by Syzmusiak et al. 
(2000) and Lee et al. (2005). 
2.6 Clinical applications of BGS sleep-wake regulation 
2.6.1 Non-motor symptoms of Parkinson's disease 
Parkinson's disease (PD) is a degenerative disorder of the central nervous system 
associated with both motor and non-motor symptoms. The primary (motor) symptoms of 
PD are caused by decreased activation of the motor cortex, which is partly traceable to 
insufficient formation and action of DA within the BGS (e.g., Bartels and Leenders, 
2009). Sleep disturbances, including excessive daytime sleepiness, insomnia and 
disturbed REM sleep are common non-motor symptoms of PD (Chaudhuri and Schapira, 
2009; Wells et al., 2009). A recent review by Arnulf and Leu-Semenescu (2009) 
highlights a potential role of ascending arousal system brain regions in the sleepiness 
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observed in PD. That many PD patients fall asleep during the daytime directly into REM 
sleep (Arnulf et al., 2002), as commonly observed in narcolepsy, suggests a role for the 
orexinergic system in the LH (Chemelli et al., 1999), which has been shown to have 
substantial cell loss (23-62%, Arnulf and Leu-Semenescu, 2009) in PD. Cell loss in other 
arousal regions, including the noradrenergic LC, the serotonergic DRN, the cholinergic 
PPT and the cholinergic BF have also been noted in PD, as reviewed in Arnulf and Leu-
Semenescu. It is unclear whether damage to these areas precedes or follows damage to 
dopaminergic-rich regions of the BGS. 
PD patients are often treated with levodopa (L-dopa, a precursor to dopamine) 
or DAergic agonists to ameliorate primary motor symptoms. It has been hypothesized 
that sleep disturbances associated with PD, including altered sleep-wake cycles, 
nighttime insomnia and daytime somnolence, may be due to the effects of these 
treatments, rather than to the disease itself (Cantor and Stern, 2002; Santiago et al., 
2010). This is supported by evidence that the dosage level of L-dopa or other DAergic 
agonist may determine the extent to which sleep disturbances are experienced. L-dopa 
levels less than 3 00 mg or greater than 600 mg have been associated with a decrease in 
slow-wave sleep in PD patients (Diedrich et al., 2009) and daytime sleepiness levels (as 
measured objectively by the Multiple Sleep Latency Test and the Maintenance of 
Wakefulness Test) were also shown to depend on DAergic load (Razmy et al., 2004). 
Figure 2-3 helps understand how too much or too little DA acting on the BGS could have 
the effects described. Consider that high L-dopa-boosted levels of DA at D1Rs and D2Rs 
on striatal MSPNs would promote cortical arousal on both the direct and indirect 
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pathways: vra augmentation of D1-MSPN-mediated inhibition of GPi!SNr, which 
disinhibits thalamus-to-cortex excitation; via reduction of D2-MSPN-mediated inhibition 
ofVP/GP/SRCP zones, whose corticopetal outputs have a net excitatory effect on cortex; 
and via augmented VP/GPe inhibition of GPi!SNr, which again boosts thalamic 
excitation of cortex. This increased cortical arousal could lead to nighttime insomnia. 
Much lower DA levels, associated with low doses of L-dopa in a PD patient, would have 
the opposite effect on the pathways just described, leading to reduced cortical arousal that 
could cause daytime somnolence. Also consistent with the model in Figure 2-3, current 
evidence (reviewed in Taverna et al., 2008) suggests that DA depletion in PD boosts 
striatal GABA release via intemeurons (FS-INs). Various reports indicate that daytime 
somnolence is also experienced in untreated PD patients (e.g. Dhawan et al., 2006; Happe 
et al., 2007). Bblow we reprise further indications that reduced DAergic transmission 
decreases cortical arousal. 
Recently, A2AR antagonists have emerged as a potential treatment for the 
primary motor symptoms of PD, as elegantly reviewed by Jenner et al. (2009). As 
predicted by our model in Figure 2-3, AzAR antagonists reduce GABAergic transmission 
in the indirect pathway, leading to increased cortical activity. Most studies of A2AR 
antagonists as a PD treatment have tested its administration in conjunction with 
dopaminergic therapy. Both A2AR antagonists and DA independently act to reduce the 
effect of adenosine; the most effective treatment studied to date is concomitant 
administration of an A2AR antagonist, istradefylline, with what, by itself would be a sub-
optimal infusion of L-dopa. Together, these improve motor function while minimizing 
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dyskinesia and other side effects of high L-dopa doses (Jenner et al. 2009). The use of 
caffeine and other A2AR antagonists, with or without DAergic therapy, may also 
ameliorate cognitive dysfunctions associated with PD, including memory deficits 
(Takahashi et al., 2008; Prediger, 2010), via increased cholinergic transmission from the 
pallidal and SRCP areas to cortex (Figure 2-3; see also Barone, 2010). Few 
experimental studies to date have explored the use of A2AR antagonists as a monotherapy, 
or its effect on sleep-related non-motor symptoms of PD. Our model (Figure 2-3) 
suggests that A2AR antagonists would increase cortical arousal by blocking adenosine's 
promotion of pallidal/SRCP inhibition of cortex. Depending- on time of administration, 
A2AR antagonists could either heighten nighttime insomnia symptoms or improve 
daytime somnolence. 
2. 6.2 Cognitive dysfunction due to sleep deprivation 
As described above, one of the non-motor symptoms of PD is cognitive dysfunction, 
particularly slowed reaction time (RT) and memory deficits (Takahashi et al., 2008; 
Prediger, 201 0). These same changes in cognitive ability are observed following acute 
sleep deprivation (sleep loss over a single continuous waking episode) and chronic sleep 
restriction (sleep loss accumulated over several days or weeks) (Belenky et al., 2003; Van 
Dongen et al., 2003; Santhi et al., 2007; Cohen et al., 2010). The neural circuits 
underlying cognitive functions are task-specific, but in all cases include a role for a right 
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frontoparietal attentional network, activation of which relies on regions of cortex, 
thalamus and BGS. Sleep deprivation has been observed to produce reduced glucose 
metabolism in the BGS (Wu et al., 1991). Note that the ventral pallidal/SRCP zones of 
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the extended BGS include parts of the SI that have long been implicated in attention (e.g., 
Sarter, 2008). The BGS may therefore play a unique role in the effect of sleep deprivation 
on cognitive function. As reported by Basheer et al. (2004), extracellular adenosine 
increases in SRCP zones of BF as time awake is extended. Increased adenosine leads to a 
reduction in cortical activity, both directly through the BGS and indirectly through 
thalamocortical pathways (Figure 2-3). It is hypothesized, therefore, that the increase in 
adenosine with sleep deprivation leads to cognitive dysfunction via these BGS pathways 
to cortex and thalamus. 
Caffeine and other A2AR antagonists are able to improve cognitive function in 
PD (Takahashi et al., 2008; Prediger, 201 0) by acting at striatal and pallidal sites. 
Caffeine is also effective at reducing decrements in cognitive function due to sleep 
deprivation. On a simple visual RT (reaction-time) task following 44 hours of sleep 
deprivation, caffeine acted with the shortest lag, in comparison to two other 
pharmaceutical agents, modafmil and dextroamphetamine, to improve RT (Killgore et al. 
2008). All three treatments also improved performance on tasks of executive function 
following sleep deprivation (Killgore et al., 2009). Mechanisms of action for both 
modafinil and dextroamphetamine involve increases in DAergic transmission (Qu et al., 
2008; Heal et al., 2009); in particular D1 and D2 receptors have been shown to be 
essential for the arousal effects of modafinil (Qu et al., 2008). The particular sites of 
action are unclear; however our model in Figure 2-3 predicts that modafinil acting 
through D1Rs and D2Rs on the dendrites and axon terminals of striatal projection neurons 
would produce increases in cortical activity necessary to improve cognitive function. 
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Although cognitive deficits are observed under sleep deprivation, near-optimal 
task performance remains intermittently possible. Whereas RT averaged across trials 
increases with increasing sleep deprivation (Van Dongen et al., 2003), fast RTs on 
individual trials are still observed (Chee et al., 2008). Moreover, flv1RI of activations of 
brain regions during such fast RT trials does not differ between tests conducted during 
rested wakefulness and tests conducted during sleep deprivation (Drummond et al., 
2005). Activation during slow RTs, however, does differ across these testing conditions. 
Brain regions activated during slow RT trials under sleep deprivation are those associated 
with the default mode network (D:MN). This network, which dominates during times of 
quiet rest (Horovitz et al., 2009), includes posterior cingulate (PCC), precuneus, mPFC, 
medial temporal lobe and bilateral inferior parietal cortex (IPC) (Gujar et al., 2010; Lim 
et al., 201 0; Sfunann et al., 201 0; Vincent et al., 2007). More generally, studies show that 
the DMN must be suppressed for optimal task performance, and failure to suppress it 
correlates with impaired behavioral performance (Polli et al., 2005; Weissman et al., 
2006). Greater activation of the DMN on slow RT trials reflects a decreased ability to 
deactivate it, whether directly or as a consequence of decreased competition from an 
under-aroused task (lateral fronto-parietal) network. 
A resting-state network spanning the basal ganglia (including the pallidum, 
putamen, STN, and SN) and thalamus has been shown to be positively correlated with the 
left and right lateral frontoparietal network, and anti-correlated with the DMN (Robinson 
et al., 2009). The BGS, therefore, may be critically involved in switching between the 
DMN, dominant during slow RT trials, and the frontoparietal attention network that is 
"<:~;.. ··'" 
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most active during optimal RT trials. Furthermore, this switching may be mediated by 
DA: administration of L-dopa has been shown to reduce functional connectivity between 
the caudate and regions of the DMN (Kelly et al., 2009). Given the proposed role of DA 
in promoting arousal, this decrease in connectivity between the DMN and caudate, which 
gates the frontoparietal network, suggests a mechanism in which the BGS promotes 
optimal performance during a task. Tomasi et al. (2009) found that greater DAT levels in 
striatum (and thus faster DA clearance), including caudate, were associated with less 
deactivation of the DMN during an attentional task. Reductions in the availability or 
effectiveness of DA during extended wakefulness may therefore impair effective 
competition between these two networks, resulting in reduced ability to maintain optimal 
task performance. In fact, DA effectiveness decreases as adenosine accumulates. As 
noted in Figure 2-3, A2ARs and D2Rs in striatum are often conjoint receptor structures 
("heteromers"; see Ferre et al., 2007a,b; Albizu et al., 2010) which mediate inhibitory 
crosstalk between the ligands DA and adenosine. Rising DA levels will reduce the effect 
of adenosine, and vice versa. 
2. 7 Conclusions 
The classical picture of an ascending arousal system emphasized projections that coursed 
from brainstem via thalamus to cortex. Moreover, the basal ganglia system (BGS) has 
long been thought of as affecting cortex only via thalamus. In recent years, these pictures 
have been transformed by demonstrations that thalamus is less essential than once 
believed, and by discoveries of direct projections from the brainstem and the basal 
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forebrain to the cortical parts of the forebrain. The best known of these are the projections 
from cholinergic cells that are spread in a long broad band that can be parsed, based on 
distinct projection targets, into sub-populations referred to individually as Chl-4. 
Although more often called the NBM (nucleus basalis of Meynert), population CH4 
(Mesulam et al., 1983) falls within the substantia innominata, now subsumed by some 
neuroanatomists (e.g., Swanson, 2000) as part of a broad ventral pallidum territory 
distinguished by receipt of projections from dorsal or ventral striatum regions. The NBM 
label is often incorrectly interpreted as exclusionary, as if ACh cells were not 
intermingled with other cell types, and as if the "nucleus" had sharp boundaries. In fact, 
other cell types are intermingled, and many of these non-ACh cells are also corticopetal 
cells. Just as important, the ACh cells are not confined to the nucleus in many species 
(notably rodents), so the subcortical forebrain zones with non-negligible numbers of 
corticopetal neurons -including cholinergic, GABAergic and glutamatergic (Figure 2-2) 
- are much more extensive than the region typically denoted by NBM. Included are such 
areas as the ventromedial GPe. Because the ventromedial GPe and "ventral pallidal" 
territories such as NBM are extensively innervated by striatal e:fferents (Figure 2-3), a 
large number of corticopetal neurons fall within an extended BGS. 
Recent rodent data show that lesions in the BGS can have as large an effect on 
relative sleep-wake durations as lesions in any other part of the highly distributed system 
that controls transitions among arousal states. Prior interpretations of these effects 
attributed them primarily to a GABAergic cortico-petal projection from GPe to cortex. In 
this review, we have instead presented a systems perspective that reveals the opponent 
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actions of adenosine and dopamine in striatal-pallidal circuits. This shows how striatal 
inputs to SRCP zones can affect multiple cortico-petal projections, as well as important 
indirect projections, such as that via MD thalamus. This approach synthesizes a large 
number of isolated observations within the framework of an emerging model of 
contributions by an extended BGS to sleep, wake, heightened vigilance, and learning. 
Key to the synthesis is an appreciation of adenosine as a potent sleep-promoter. 
Figure 2-3 presents an especially interesting nexus of interactions. The BGS is as old as 
the vertebrate brain (Reiner, 2009), and the marker for a striatal compartment of a BGS is 
the co-existence oftwo opponent classes of medium spiny projection neurons (MSPNs): 
one that co-releases GABA and ENK, and one that co-releases GABA and SP. Figure 2-
3 shows how these opponent cell types are controlled by the dopamine-adenosine 
balance, and how the opioid ENK and the neuropeptide SP have opponent effects on 
cholinergic and GABAergic projections from SRCP zones to the cerebral cortex. It also 
reveals a sleep-reinforcing feedback, by which the effects of increasing adenosine lead to 
reduced output from DA neurons that project to striatum. Further research directed at the 
sleep vs. wake firing patterns of distinctive cells types- such as ventral striatal D2-ENK-
MSPNs vs. Dl-SP-DYN-MSPNs- is needed to test qualitative predictions of this model. 
Such studies will make it possible to construct computational models capable of 
simulating how the brain passes through a full range of physiological states from coma to 
maximal vigilance. 
Throughout this paper we assume, except where noted, that the specified circuitry 
can be extrapolated to explain mechanisms of arousal in humans. However, the major 
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anatomical findings reviewed in this paper are primarily from rodent or cat data. 
Regarding the cross-species relevance of the scheme in Figures 2-2 and 2-3, the most 
important known caveat concerns the direct projections from GPe to cortex. Whereas 
Gritti et al. (2003) showed multiple types of cortico-petal neurons in rodent GP, in 
primates there are few to no cholinergic neurons in GPe proper (Parent et al., 1979), and 
Sato et al. (2000) found no evidence for any cortico-petal projections from GPe. Given 
these observations, our model predicts that a primate GPe lesion would not have the same 
dramatic effect on sleep and wake amounts across 24 hours as a rodent GPe lesion was 
shown to have in Qiu et al. (2010). More generally, only sparse data exist in primates on 
the proportions of the various cell types whose axons form the key basal forebrain (BF) 
projections to the cerebral cortices (Figure 2-2), but there is at least some primate data on 
the BF "suggesting that cholinergic as well as non-cholinergic neurons project to 
prefrontal cortices (Ghashghaei and Barbas, 2001, p. 606)". Also unclear is how 
differences between rodent and primate circuitry may relate to species differences in 
function, notably sleep architecture. For example, extensive work has been done on the 
electrophysiology of the thalamocortical circuit underlying sleep and wake states in 
rodent and cat. The general understanding is that both thalamic relay cells and thalamic 
reticular cells fire in a tonic pattern during wake and in a bursting pattern during NREM 
subtype slow wave sleep (SWS). REM sleep, however, is disparate between the two 
species: in cat, a tonic pattern is observed, such that REM sleep appears similar to wake, 
while in rat, a bursting pattern is observed (Marks and Roffwarg, 1993). The pattern of 
discharge in humans and non-human primates, such as the macaque (Ramcharan et al., 
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2000), during wake and NREM sleep is similar to that of rats and cats; the pattern of 
discharge during REM in humans is similar to wake, as in the cat. Importantly, the 
pattern of sleep itself is different across cats, rats and primates. Cats exhibit crepuscular 
behavior with their most active periods at dawn and dusk. Most rodents are nocturnal, 
sleeping mostly during the light period. Furthermore, rodent sleep is polyphasic, meaning 
that sleep occurs in several bouts across a 24-hr period. Humans are diurnal and sleep in 
one consolidated bout. There are also vast differences in total sleep durations and REM 
sleep durations across species (Siegel, 1995). It remains to be understood how underlying 
anatomical and/or physiological differences entail different sleep patterns across species. 
Although proposed models for underlying differences (Savage and West, 2007; Phillips 
et al., 2010) have begun to appear, it is unknown how such differences will affect 
extrapolation from animal models to humans, particularly in clinical applications. 
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CHAPTER3 
STATISTICAL AND NEURAL MODELING OF A VIGILANT 
ATTENTION TASK TO CHARACTERIZE HOW RESPONSE 
LATENCIES, ANTICIPATIONS, AND LAPSES DEPEND ON INTER-CUE 
INTERVALS, TIME-ON-TASK, SLEEP DEPRIVATION AND WAKE-
PROMOTING AGENTS 
3.1 Introduction 
Attentiveness depends on complex ascending arousal signals that contain phasic and 
tonic components that vary on multiple time scales ranging from milliseconds to days 
(e.g., Parikh and Sarter, 2008). One task that can be used to assess fluctuations in 
attentiveness on a broad range of time scales is the psychomotor vigilance task (PVT), 
which has been used extensively as a sensitive index of changes in attentiveness 
associated with sleep loss in humans (Dinges and Powell, 1985; Belenky et al., 2003; 
Van Dongen et al., 2003; Wyatt et al., 2004; Dorrian et al., 2005; Santhi et al., 2007; 
Cohen et al., 2010). The PVT is a simple reaction time (RT) task that requires rapid 
execution of the same pre-planned action to each onset of a stimulus (visual or auditory) 
that reappears after a variable interval ranging from 1000 to 9000 milliseconds (ms). 
Outcome measures from the PVT include mean or median RTs across ann-minute task 
(the most common implementation utilizes n = 1 0); lapses, which are often defined as 
RTs greater than 500 ms; and anticipations, often defined as RTs less than 100 ms. The 
latter are also calledfalse alarms, because the short (sometimes negative) RT is less than 
the physiologically-possible response time and indicates that the participant did not wait 
for cue onset before initiating response generation. 
"'"'_--··-
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Multiple studies have demonstrated that the PVT is sensitive to both the length of 
time that an individual has been awake and the circadian phase at which the task is 
administered. Mean or median RT and the number of lapses all increase as the length of 
time awake increases, and mean or median RT and the number of lapses are higher when 
the circadian drive for sleep is high [e.g., at core body temperature minimum, which is a 
marker of endogenous circadian phase (Wyatt et al., 2004)]. Anticipations also increase 
with sleep deprivation (Doran et al., 2001). Moreover, time awake and circadian phase 
interact: performance on the PVT is significantly more impaired when extended time 
awake coincides with an adverse circadian phase (Cohen et al., 2010). Consecutive days 
with reduced sleep also impair PVT performance (Belenky et al., 2003; Van Dongen et 
al., 2003; Cohen et al., 201 0). Some effects of acute and chronic sleep loss and circadian 
phase on cognitive performance can be reversed by stimulants such as caffeine and 
modafinil (Wyatt et al., 2004; Wesensten et al., 2005; Killgore et al., 2009; Grady et al., 
2010). 
Classical studies of simple RT tasks have explored trial-to-trial changes within a 
session. The distribution of response times depends on the distribution of the inter-
stimulus intervals separating two trials (Schupp and Schlier, 1972). For example, in a task 
paradigm in which the inter-stimulus interval (lSI) varies unpredictably and is determined 
by sampling from a rectangular distribution ranging over several seconds, slow RTs are 
associated with a short preceding lSI and fast RTs are associated with a long preceding 
lSI (Drazin et al., 1961; Requin and Granjon, 1969; Schupp and Schlier, 1972; Niemi and 
Naatanen, 1981). This phenomenon has been observed in a 10-minute version of the 
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PVT, which has an ISI range with rectangular distribution from 1 to 9 seconds and has 
been reported to be unaffected by 54 hours of sleep deprivation (Tucker et al., 2009). In 
contrast, however, an auditory RT study found that 63 hours of sleep deprivation had a 
greater effect on responses to stimuli following 1.5-second and 2-second ISis than on 
responses following a very short 0.05-second ISI (Cochran et al., 1992). 
The same study that found no effect of 54 hours of sleep deprivation on the RT-
ISI relationship found a significant effect of sleep deprivation on the time on task (TOT) 
_ effect. The TOT effect refers to the observation that RTs increase as the length of a task-
performance session is extended. Tucker et al. (2009) found no difference in mean RT 
comparing the first 5 minutes of the 1 0-minute PVT and the last 5 minutes of the PVT 
when participants were well-rested, but found a significant increase in mean RT in the 
last 5 minutes of the task when participants were sleep deprived. Other studies (Paus et 
al., 1997; Lim et al., 2010) have observed a TOT effect even in well-rested participants 
when the task session is sufficiently long (e.g., 20 minutes). 
The statistical methods employed in prior analyses of the effects of sleep 
deprivation on RT-ISI and RT-TOT relationships use mean RTs and therefore assume 
normal distribution of RTs, despite evidence that the RT distribution is non-normal 
(Santhi et al., 2007). Furthermore, the standard method of quantifying lapses in attention 
on the PVT applies a cut-off value of 500 ms for all individuals, despite significant inter-
individual differences in baseline response times. The analyses presented in this paper 
thus improve on prior analyses exploring the effect of ISI and TOT on PVT RTs under 
sleep deprivation by (1) applying statistical methods that do not assume normal 
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distribution of RTs and (2) using subject-specific cut-offs for lapses in attention. The 
analyses presented in this paper also extend prior work by exploring lSI and TOT effects 
on anticipations and assessing the effects of two phannacological stimulants on RT-ISI 
and RT-TOT relationships: caffeine, which acts on the adenosinergic system (e.g. 
Fredholm et al., 1999), and modafinil which has some actions on the dopaminergic 
system (Wisor et al., 2001). A simple neural network model is constructed and simulated 
to help understand processes that may underlie the lSI -dependent generation of lapses 
and anticipations in a sleep-deprived state. 
3.2 Methods 
3.2.1 Data sets used for analysis 
All studies were conducted in the Brigham and Women's Hospital inpatient General 
Clinical Research Center or Center for Clinical Investigation. All studies were approved 
by the Partners Healthcare Human Subjects Committee and all participants gave written 
informed consent. Procedures were in compliance with U.S. Health Insurance Portability 
and Accountability Act regulations and the Declaration of Helsinki. All participants were 
healthy according to medical history, physical exam, blood chemistries, psychological 
screening tests and visits with a clinical psychologist. Full details are included in the 
original publications. 
Data set 1: St. Hilaire et al. (unpublished data) studied 12 young healthy 
participants (6 males, 23 ± 3 years, range 18 - 30 years) on a 9-day protocol, of which 
wake periods (WP) 2, 3 and 4 (all before experimental intervention) were used for the 
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present analysis. Participants were scheduled to three baseline days of 16 hours wake and 
8 hours sleep (WP 1-3) scheduled at their habitual sleep/wake time. Following baseline, 
participants were scheduled to a 50-hour sleep deprivation on WP4 followed by an 8-
hour recovery sleep episode. The intervention began after this sleep episode and was not 
included in the present analysis. Light levels were 90 lux during wake on WP1 and 2 and 
the first 8 hours of WP3. For the final 8 hours of WP3, light levels were decreased and 
remained at <3 lux for the remainder of the study, except during sleep episodes which 
were in <0.03 lux and except during the intervention. The psychomotor vigilance task 
(PVT, see below) was administered every 2 hours during each WP starting ~3 hours after 
scheduled wake. 
Data set 2: Grady et al. (2010) studied 18 young healthy participants, from which 
we used data from 17 participants (9 males, 24 ± 4 years, range 18- 30 years) for this 
analysis. Participants were scheduled to a 29-day protocol, of which WPs 2, 3 and 4 were 
used for the present analysis (two days before plus first day of experimental intervention). 
Participants were scheduled to 3 baseline days (WP 1- 3) of 16 hours awake and 8 hours 
of sleep, followed by 14 cycles (WP 4- 17) in which they were scheduled to 28.57 hours 
of wake and 14.28 hours of sleep for a forced desynchrony (FD) total day length ofT = 
42.85 hours. Starting on the first T=42.85-hr day, participants were randomized to receive 
either placebo (N=9) or modafinil (N=8). Participants in the placebo-treated group 
received two placebo tablets at scheduled wake time and again 9.5 8 h after scheduled 
wake and 19.16 h after scheduled wake. Participants in the modafinil-treated group 
received both a placebo tablet and a 100 mg modafinil tablet at wake time and again 9.58 
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h after scheduled wake and then two 100 mg modafinil tablets 19.16 h after scheduled 
wake. The PVT was administered every 2 hours during wake starting ~ 2 hours after 
scheduled wake. 
Data set 3: Wyatt et al. (2004) studied 16 young healthy participants (16 males, 24 
± 4 years, range 18-30 years) on on the same protocol as described for Data set 2, but 
during the T = 42.85-hr FD days participants were randomized to receive either caffeine 
(N=8) or placebo (N=8), administered as 0.3 mg per kg per hour during wake starting 1 
minute after scheduled wake and ending 1.57 hours before scheduled sleep. During 
baseline and T=42.85-hr wake episodes, participants were kept in dim light (<15 lux) and 
<0.03 lux during each sleep episode. As in the previous study, the PVT was administered 
every 2 hours during wake starting ~ 2 hours after scheduled wake. Data from WP 2, 3 
and 4 were used for the present analysis. 
3.2.2 Psychomotor vigilance task 
The psychomotor vigilance task (PVT) requires participants to sustain attention to a high 
signal rate with a variable inter-stimulus interval uniformly distributed (statistically 
rectangular) from 1000 to 9000 ms for a period of 10 minutes. Participants were told to 
remain visually fixated on a rectangle centered on the computer screen and respond with 
a button press each time a stimulus appeared within the rectangle. That stimulus was the 
onset of a digital clock display of elapsed time in ms since stimulus onset. Participants 
were instructed to respond as quickly as possible to the stimulus. Upon each successful 
response, the clock display stopped incrementing, and the final value (the RT) displayed 
for a duration of 1 second, as feedback to the participant. If a participant responded 
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before stimulus onset, 'Anticipation' was displayed for 1 second to inform the participant 
ofthe response error. (As noted below, the definition of"anticipation" for purposes of the 
data analysis was broader.) Following a successful response or anticipation, the stimulus 
disappeared from within the fixation rectangle to signal the start of the next trial. The lSI 
was the time interval between offset of the clock display during trial n-1 and onset of the 
clock display during trial n. 
3.2.3 Data pre-processing 
The results reported in the original publications of Data sets 2 and 3 (Data set 1 
unpublished) focused on how summary statistics (e.g. mean or median RT, number of 
attentionallapses) aggregated across 10-minute PVT sessions varied as a function of time 
awake and circadian phase. The present analysis focuses on response patterning within 
each 10-minute PVT session. 
Baseline data: For Data set 1, the baseline mean was determined by taking the 
average of the mean RTs observed for PVT sessions administered during the two 16-hr 
baseline wake episodes (WP 2 and 3) scheduled just prior to the 50-hr sleep deprivation. 
For Data sets 2 and 3, the baseline mean was determined by taking the average of the 
mean RTs observed for PVT sessions administered during the two 16-hr baseline wake 
episodes (WP 2 and 3) scheduled just prior to the first FD cycle. 
Experimental data: Data were derived from the 50-hour sleep deprivation in Data 
set 1 or the first wake episode during the forced desynchrony portion of the protocol (WP 
4) in Data sets 2 and 3. 
A PVT trial is defined as the interval from fixation onset to the end of the 1 
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second feedback following a response. Each response for each PVT trial was classified as 
RT in milliseconds (ms), lapse or anticipation. For most published analyses of PVT 
responses, lapses have been defined as any response greater than 500 ms. However, use 
of such a single value is problematic, due to individual differences in mean RT. For this 
analysis, in order to ensure that a "lapse" meant an uncommonly long RT for the 
individual responsible, a lapse was defined as any response with an RT that was greater 
than twice the baseline (i.e., rested condition) mean RT (excluding anticipations) for that 
participant. By this definition, lapses were almost non-existent during the baseline 
assessments. For analysis of baseline and experimental conditions, anticipations were 
defined to include any responses that the participant must have begun to initiate prior to 
the onset of the stimulus. Negative RTs and positive RTs less than 100 ms were classified 
as anticipations (Santhi et al., 2008), because such fast RTs are faster than is 
physiologically possible for button pressing in reaction to visual cue onset. For analysis 
of the experimental conditions, all remaining responses, i.e., any response with a RT 
greater than or equal to 100 ms, and less than or equal to the subject-specific cutoff for 
lapses, were included as normal RTs. Lapses were further processed by coding every 
lapse trial as a '1' and every non-lapse trial as a '0'. Anticipations were separately 
processed in the same manner, with each anticipation trial coded as a '1' and each non-
anticipation trial coded as a '0'. Lapses and anticipations were treated this way, as 
categorical variables, in order to avoid statistical problems associated with highly skewed 
distributions (due to ultra-long or short responses). For normal RTs, statistical analysis 
(described below) was conducted on raw RTs (in ms). 
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To assess response patterning in relation to time awake, each 1 0-minute PVT 
session was binned by the elapsed time since the start of the current wake episode at 
which it was administered, and each PVT trial within that session was assigned to that 
time awake bin. To look at response patterning in relation to lSI, the preceding lSI for 
each PVT trial was binned in 1-second intervals across the 1000 - 9000 ms range of ISis. 
To look at response patterning in relation to TOT, each PVT trial was binned according 
to the elapsed time since the start of the PVT session: 'Early' if the PVT trial occurred in 
the first 2 minutes ofthe task and 'Late' if the trial occurred in the final2 minutes (data 
in the middle 6 minutes of the task were not used for analysis). For Data sets 2 and 3, 
each response was further categorized by whether the participant was receiving a drug 
(caffeine or modafmil) or placebo. 
3.2.4 Statistical analysis 
Before beginning our analysis, we used PROC UNIVARIATE in SAS 9.2 (Cary, North 
Carolina, United States) to test for normality for RT distributions. For all three data sets, 
tests for normality (Kolmogorov-Smimov, Cramer-von Mises and Anderson-Darling) 
failed. Because of their categorical scoring, lapses and anticipations were also non-
normal. Therefore, we used a generalized estimating equation (GEE) to estimate the 
parameters of a generalized linear model (GLM) with repeated measures using the PROC 
GLM procedure in SAS 9.2. lSI, TOT, length of time awake, and drug condition (for 
Data sets 2 and 3) were defined as independent variables and RT, lapses and anticipations 
were defined as outcome variables for each GLM tested. lSI, TOT and drug were further 
defined as categorical variables. For categorical variables, the GLM requires that a 
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reference level be defmed; statistical significance for each level of each categorical 
variable is computed relative to the reference leveL 'Early' was defined as the reference 
level for TOT and 'placebo' was defined as the reference level for the drug condition. 
The defined reference level for lSI depended on the outcome variable modeled. Based on 
preliminary analyses (St. Hilaire et aL, 2009a,b), we expected RT and lapses to decrease 
with increasing lSI and anticipations to increase with increasing lSI; therefore for RT and 
lapses we defined the highest lSI bin, lSI = 8 seconds as the reference level and for 
anticipations we defined the lowest lSI bin, lSI = 1 second as the reference leveL Models 
for outcome variable RT assumed a gamma distribution and models for lapses or 
anticipations assumed a binomial distribution. The compound symmetry (CS) covariance 
structure was used, which assumes that every observation collected from an individual is 
equally correlated with every other observation from that individual. The full model for 
each outcome variable for lSI effects included lSI, drug condition, time awake and awake 
x lSI and drug x lSI interactions. The full model for each outcome variable for TOT 
effects included TOT, drug condition, time awake and awake x TOT and drug x TOT 
interactions. 
For Datasets 2 and 3, we additionally tested whether there was a significant effect 
of the drug on the variance of RTs. Equality of variance was tested using the Folded F-
Test in PROC TTEST (SAS 9.2). 
RT data in Figure 3-1 and throughout this chapter have been normalized by the 
participant's baseline mean for display purposes only: statistical analyses utilized raw 
RTs (again, excluding RTs classified as anticipations or lapses) in ms. Lapses and 
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anticipations have been plotted as the percentage of total responses here and throughout 
the paper for display purposes only; analyses were conducted on data as described above. 
3.2.5 A simple neural network model ofRT, lapses, and anticipations 
A simple neural network model was constructed to generate basic aspects of the response 
patterning (RT, lapses, anticipations) revealed by the results described below. The model 
simulates an integrate-and-fire process that results in response genesis in the PVT. A 
fixation stimulus is presented, followed by a cue stimulus following a variable lSI 
ranging between 1 and 9 seconds. A RT or anticipation is recorded when the activity 
level, X, in a modeled response neuron exceeds a predefined threshold. Neural activity, 
X, was modeled by the following differential equation for a signal integration process: 
dX 
-= (1-X)E -XI 
dt 
(3.1) 
Here, E represents an excitatory input and I represents an inhibitory input. The equation 
bounds activity in the range 0 to 1, and the threshold at which cell activity X generates a 
movement command was set to 0.20. 
The excitatory input, E, was modeled as: 
(3.2) 
The function 0.0025rEtrepresents the time-dependent increase of an internally generated 
signal, a cue-onset expectancy (review in Niemi and Naatanen, 1981), which 
progressively primes cell activity X as time accumulates since the onset time (t=O) of the 
fixation stimulus. Such ramping expectancy signals have been observed in many parts of 
the brain during ISis with a fixed upper bound (e.g., Tinsley and Everling, 2002; 
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Hikosaka et al., 1989) and the prefrontal cortex has been implicated in normal RT-ISI 
relations (Stuss et al., 2005). The coefficient rE represents a random variable 
rE ~ 1 + N (0, a-E) generated for each trial. That is, the noise value for the time-dependent 
increase of the cue-onset expectancy for each trial is dravm from a normal distribution 
with a mean of zero and a standard deviation of CJ£. The use of noise makes this a 
stochastic neural model. The function Sc represents the absence or presence of the cue 
stimulus: Sc = 0 during the lSI, when only the fixation stimulus is present, and Sc = 1 
when the cue stimulus is visible. The coefficient kE represents the salience of the cue 
stimulus. This saliency coefficient determines how strongly the cue stimulus excites cell 
activity X towards threshold when the cue stimulus is on. 
The inhibitory input, I, was modeled as: 
(3.3) 
where time t=O marks the onset of the fixation stimulus. The function SF represents the 
presence or absence of the fixation stimulus, which normally inhibits cell activity X 
strongly enough to prevent a premature response even in the presence of the cue-onset 
expectancy signal of Eq. 3.2. This inhibition via signal SF disappears as soon as the 
fixation stimulus is replaced by the cue to respond. Thus SF= 1 during the lSI, when the 
fixation stimulus is on, and SF= 0 when the cue stimulus is on. Strong evidence for the 
existence of such an inhibitory signal linked to the fixation cue can be found in the 
literature (e.g., Kobayashi et al., 2001) on the gap effect: when a gap occurs between 
fixation offset and cue onset, then for a while after fixation offset, i.e., while the 
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inhibition dissipates, the RT to cue onset declines relative to what is observed if fixation 
offset exactly coincides with cue onset. The coefficient k1 sets the maximum inhibitory 
effect, which occurs when the fixation stimulus has the most internal salience, around the 
time of its onset. Because it divides kr, the time-dependent growth function, 1 + 0.005r1t, 
produces a time-dependent waning in the salience of the fixation stimulus, and thus 
waning inhibition of response generation, as the length of the lSI increases. Commonly 
accepted bases for such waning are spike-frequency adaptation and short-term synaptic 
depression (e.g., Puccini et al., 2006; Benda et al., 2010) in sensory pathways, by which 
the fixation stimulus excites response inhibition. The coefficient r1 represents a random 
variable lJ ~ 1 + N ( 0, a-1 ) generated for each trial. As for the time-dependent increase of 
the cue-onset expectancy, the noise value for the time-dependent waning in the salience 
of the fixation for each trial is drawn from a normal distribution with a mean of zero and 
a standard deviation of CJi. 
Eq. 3.1 for cell activity X was solved by numerical integration using the fourth-
order Runge-Kutta method, with a time-step of 0.001. A single 10-minute PVT session 
was simulated by running the model for 100 trials using a random lSI drawn from a 
uniform distribution with range between 1000 and 9000 ms. Different values for 
parameters kE, h 0'£ and a-1 were tested to simulate the PVT results under both rested and 
sleep-deprived conditions. 
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3.3 Results 
3.3.JISI and TOT effects during 50 hours of sleep deprivation 
Analysis of PVT trials from 12 participants scheduled to 50 hours of continuous sleep 
deprivation (Data set 1) revealed an lSI effect on RTs, lapses and anticipations. RT was 
significantly higher for lSI bins= 1-2 s, 2-3 s, 3-4 s (all p<0.0001) and 4-5 s (p=0.016) 
compared to the reference lSI bin= 8-9 s (Figure 3-lA); the frequency of lapses was 
significantly higher at lSI bins= 1-2 s (p=0.0007) and 2-3 s (p=0.033) compared to the 
reference lSI bin = 8-9 s (Figure 3-lB); and the frequency of anticipations was 
significantly higher for all lSI bins except lSI bin = 2-3 s and 4-5 s compared to the 
reference lSI bin= 1-2 s (Figure 3-lC)(all p<0.03). 
A significant TOT effect was observed for RTs, lapses and anticipations. RTs in 
the last 2 minutes of the PVT session ('Late') were higher than RTs in the first 2 minutes 
of the PVT session ('Early')(Figure 3-lD). Significant increases in the frequency of 
lapses and the frequency of anticipations from 'Early' to 'Late' were also observed 
(Figure 3-lE,F). 
A significant effect of the length of time elapsed since wake was found for all 
three outcome variables, with RTs (p<0.0001), lapses (p<0.0001) and anticipations 
(p=0.0063) all increasing as the length of time awake increased. There were no 
significant awake x lSI interactions observed for any of the three outcome variables. 
Significant awake x TOT interactions were observed for lapses but not for RTs or 
anticipations. Figure 3-2 shows TOT effects on RTs, lapses and anticipations (Figure 3-
2A-C, respectively) at three different lengths of time awake: at 3 hours, 23 hours and 47 
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hours after scheduled wake. The latter two are 24 hours apart and thus at approximately 
the same circadian phase. 
3.3.2 IS! and TOT interactions with modafinil 
Analysis of PVT trials from 17 participants scheduled to 28.57 hours of continuous sleep 
deprivation while receiving either modafmil or placebo (Data set 2) revealed significant 
lSI effects on RT, lapses and anticipations. RT was significantly higher for lSI bin= 1-2 
s compared to the reference lSI bin= 8-9 s (Figure 3-3A); the frequency of lapses was 
significantly higher for lSI bins= 1-2 s, 5-6 sand 7-8 s compared to the reference lSI bin 
= 8-9 s (Figure 3-3B); and the frequency of anticipations was significantly higher for all 
lSI compared to the reference lSI bin= 1-2 s (Figure 3-3C). 
A significant TOT effect was observed (Figure 3-3DEF) for RTs (p<0.0001) but 
not for lapses (p=0.50) or anticipations (p=0.17). 
No statistically significant effect of the drug on RT was observed (p=0.16). 
However, the group receiving modafinil exhibited significantly less RT variability 
compared to the placebo group (F=2.19, p<0.00012). Modafinil also had a significant 
effect on lapses, with a lower frequency of lapses observed in the group receiving the 
drug (p<O.OOOl). Significant drug x lSI interactions also were observed for lapses, with 
significant differences at lSI bins = 2-3 s, 4-5 s, 5-6 s, 6-7 s and 7-8 s for the modafinil 
group compared to the reference lSI bin = 8-9 s (all p<0.004). For anticipations, there 
was no significant main drug effect (p=0.15), and no significant drug x lSI interactions 
observed. 
The drug x TOT interaction for RTs did not reach statistical significance (p=0.52), 
92 
but RT slightly decreased with TOT in the placebo group and increased with TOT in the 
modafmil group (Figure 3-3D). 
A significant main effect of the length of time elapsed since wake was found for 
RTs (p<0.0001), lapses (p=0.0021) and anticipations (p=0.03), all of which increased 
with time awake. No significant awake x ISl interactions or awake x TOT interactions 
were observed for any of the outcome variables. 
3.3.3 lSI and TOT interactions with cajfeine 
Analysis of PVT trials from 16 participants scheduled to 28.57 hours of continuous sleep 
deprivation while receiving either caffeine or placebo (Data set 3) revealed that RT was 
significantly higher for ISI bins = 1-2 s (p<0.0001), 2-3 s (p<0.0001) and 3-4 s (p=0.03) 
compared to the reference ISl bin= 8-9 s (Figure 3-4A). The frequency of lapses was 
significantly higher for lSI bin= 1-2 s compared to the reference lSI bin= 8-9 s (Figure 
3-4B)(p=0.0005). The frequency of anticipations was significantly higher for ISI bins = 
7-8 s (p=0.039) and 8-9 s (p=0.040) compared to the reference ISl bin= 1-2 s (Figure 3-
4C). 
A significant TOT effect was observed (Figure 3-4DEF) for lapses (p=0.02) but 
not for RTs (p=0.22) or anticipations (p=0.94). 
There was a trend towards a significant effect of the drug condition on RT 
(p=0.074); the group receiving caffeine had slightly lower RT values and slightly less RT 
variability compared to the placebo group (F=l.08, p=0.0003). The drug effect on lapses 
was not significant (p=O.ll), but the plot shows a trend towards a lower frequency of 
lapses observed in the group receiving. There was not a significant drug effect observed 
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for anticipations (p=0.26). There were no significant drug x lSI interactions for RTs, 
lapses or anticipations. The TOT effect on lapses did not significantly differ by drug 
condition (p=0.20). 
A significant effect of the length of time elapsed since wake was found for RTs 
(p=0.009) and lapses (p<O.OOOl) but not anticipations (p=O.l4), with RTs and lapses both 
increasing as the elapsed time awake increased. No significant awake x lSI interactions 
were observed for any of the outcome variables; awake x TOT interactions were 
significant for RTs (p=0.005) and lapses (p=0.0072) but not anticipations (p=O.l4). 
Figure 3-5 shows TOT effects on RTs, lapses and anticipations (Figure 3-SABC, 
respectively) at three different lengths of time awake: at 2 hours, 16 hours and 26 hours 
after scheduled wake. 
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Figure 3-1: Effect of inter-stimulus interval and time on task on the PVT during a 50-hour sleep 
deprivation. RTs (panel A), lapses (panel B) and anticipations (panel C) are plotted as a function of the 
inter-stimulus interval (ISI) from 1 - 9 s and as a function of time on task (first two minutes vs. last 
two minutes, panels D - F, respectively). Data have been aggregated across all lengths of time awake 
during the 50-hr sleep deprivation. For this and all subsequent figures within this chapter, unless 
otherwise noted, boxes indicate 25th, 50th and 75th percentiles, filled squares indicate mean, and error 
bars indicate S.D. RTs are plotted as deviation from subject-specific baseline mean, lapses and 
anticipations are plotted as the percentage of their occurrence across all response trials. 
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Figure 3-2: Time on task effects across a 50-hr sleep deprivation. RTs (panels A, D, G) lapses (panels 
B, E, H) and anticipations (panels C, F, I) are plotted as a function of time on task (first two minutes 
vs. last two minutes) for different lengths of time awake: 3 hours after scheduled wake (panels A-C), 
23 hours after scheduled wake (panels D-F) and 47 hours after scheduled wake (panels G-I). 
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Figure 3-3: Effect of inter-stimulus interval and time on task on the PVT during the administration of 
modajinil or placebo. RTs (panel A), lapses (panel B) and anticipations (panel C) are plotted as a 
function of the inter-stimulus interval (ISI) from 1 - 9 s and as a function of time on task (first two 
minutes vs. last two minutes, panels D - F, respectively), for modafinil (black) and placebo (gray) 
groups. 
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Figure 3-4: Effect of inter-stimulus interval and time on task on the PVT during the administration of 
ccif.feine or placebo. RTs (panel A), lapses (panel B) and anticipations (panel C) are plotted as a 
function of the inter-stimulus interval (ISI) from 1 - 9 s and as a function of time on task (first two 
minutes vs. last two minutes, panels D - F, respectively), for caffeine (black) and placebo (gray) 
groups. 
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Figure 3-5: Time on task effects across 28 hours of wakefulness under the administration of caffeine or 
placebo. RTs (panels A, D, G) lapses (panels B, E, H) and anticipations (panels C, F, I) are plotted as a 
function of time on task (first two minutes vs. last two minutes) for different lengths of time awake: 2 
hours after scheduled wake (panels A-C), 16 hours after scheduled wake (panels D-F) and 26 hours 
after scheduled wake (panels G-I), for caffeine (black) and placebo (gray) groups. 
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3.4 Model simulations 
The simple neural network model was developed to describe four properties observed in 
PVT data: 1) the decrease in RT as a function of lSI increase; 2) the increase in RTs 
under sleep deprivation; 3) the increase in lapses under sleep deprivation, with the most 
lapses occurring at shorter ISis; and 4) the increase in anticipations under sleep 
deprivation, with the most anticipations occurring at longer ISis. 
3. 4.1 Simulating RT under rested conditions 
For this case, the following parameters were used: kE = k 1 = 1, CJE = 3, CJ1 = 0. A total of 
20 1 0-minute PVT sessions were simulated, and model predicted RTs were averaged 
over each lSI bin. These results are plotted in Figure 3-6A,D. The model generates the 
RT-ISI relationship observed in the data, with longer RTs at short lSI and shorter RTs at 
long lSI. The mean RT across all 20 simulated 10-minute PVT sessions was ~190 ms. 
Lapses were defined as any RT greater than two times this mean RT, i.e. ~380 ms. The 
model under these parameter values generated a few anticipation responses (RT < 100 
ms) at higher lSI and did not generate any lapses. 
3.4.2 Simulations of anticipations 
To begin exploring the genesis of response patterning under sleep-deprived conditions 
(e.g., increases in RT and in the number oflapses or anticipations) different values for kE, 
kJ, CJE and CJ1 were tested. It was found that one way to increase the number of 
anticipations generated by the model was by decreasing the internal salience of the 
fixation stimulus, represented by k1. Figures 3-6B,E show the results for k1 = 0.50 with 
k £, 0'£ and CJ1 fixed as above. Results are plotted as the percentage of anticipation 
100 
responses recorded at each lSI as a function of the total responses over 20 1 0-minute 
PVT sessions. This parameterization of the model generated a higher number of 
anticipations compared to the rested condition parameters. However, the range of non-
anticipation RTs was decreased compared toRTs generated under rested conditions. No 
lapses were generated under these parameter values. 
3.4.3 Simulations oflapses 
The model was able to generate lapses when the salience of the cue stimulus, represented 
by kE, was reduced while fixing the remaining parameters at the values used for the rested 
condition. Results for kE = 0.5 are plotted in Figure 3-6C,F. The highest percentage of 
lapses was observed at the shortest lSI. Non-lapse, non-anticipation RTs were increased 
compared to rested conditions. However, few anticipation responses were generated at 
the highest lSI. 
3.4.4 Simulations oflapses, anticipations, and elevated RTs 
We analyzed the frequency of anticipations and lapses across a 50-hr sleep deprivation 
(Data set 1) to determine changes in the ratio of anticipation and lapse responses with 
increasing wakefulness. As shown in Figure 3-7B, a low percentage of anticipations 
were observed in the first 16 hours prior to wake extension, whereas very few lapses were 
observed during this time (Figure 3-7A). Plotting the ratio of anticipations to lapses 
(Figure 3-7C) in the first 16 hours of wake shows that non-normal RT responses are 
dominated by anticipations. Beyond 16 hours awake, however both anticipations and 
lapses increased, and lapses came to dominate anticipations. By approximately 24 hours 
of wakefulness until the end of the sleep deprivation, the ratio of lapses to anticipations 
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was stable, indicating that they co-varied with length of time awake and circadian phase. 
In particular, the ratio of anticipations to lapses held at ~7:1, and the Pearson correlation 
between the final12 observations in Figure 3-7A,B (i.e., for time awake> 24 hours) was 
r = 0.83 (SAS PROC CORR, p = 0.0009). 
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Figure 3-6: Model predictions of reaction time as a function of lSI. RTs (panels A- C) and the percent 
of lapses (filled bars) and anticipations (open bars) (panels D -F) predicted from the model using 
different parameterizations: rested conditions kE = k1 = 1, O"£ = 3 and Oj = 0 (panels A and D); increased 
anticipations kE = 0.5, k1 = 1, O"£ = 3 and Oj = 0 (panels Band E); increased lapses kE = 1, k1 = 0.5, rrE = 
3 and rr1 = 0 (panels C and F). RT plots use the same convention as described in Figure 3-1. 
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Figure 3-7: Ratio dj anticipations to lapses across a 50-hr sleep deprivation. The average number of 
lapses (panel A) or number of anticipations (panel B) as a percentage of the total number of responses 
within a 10-minute PVT session are averaged across 12 subjects and plotted as a :function of the length 
of time awake. The ratio of anticipations to lapses is plotted in panel C. 
Combinations of different values of the fixation salience and cue salience alone were 
unable to reproduce these observed changes in the ratio of anticipations to lapses. We 
therefore tested parameterizations of the model in which the noise term on the rate of the 
cue-onset expectancy signal, crE, was increased, to generate an increase in anticipations, 
and combined with reduced values of the cue salience, to generate lapses. Results from 
two parameterizations are plotted in Figure 3-8: with crt= 5 and kE = 0.47 (Figure 3-
SA,C) and with crt = 8 and kE = 0.30 (Figure 3-SB,D). The ratio of anticipations to 
lapses is 1:7 for the first set of parameters and 1:8 for the second set of parameters, with 
the absolute number of lapses and anticipations about twice as high for the second set of 
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parameters. These two parameterizations, therefore, represent the model at two different 
lengths of time awake, for which the ratio of anticipations to lapses is stable even though 
the absolute numbers of anticipations and lapses vary markedly. 
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Figure 3-8: Different model parameterizations predict the ratio of anticipations and lapses at different 
lengths of time awake and circadian phase. RTs (panels A, C) and the percent of lapses (filled bars) 
and anticipations (open bars) (panels B, D) predicted from the model using different parameterizations 
to simulate response patterning under sleep deprivation: kE = 0.47, kr= 1, a-E = 5 and a:r = 0 (panels A 
and B); kE = 0.3, k1 = 1, CY£ = 8 and a:r = 0 (panels C and D). The ratio of anticipations to lapses is 
similar in each parameterization (see text for details). 
3.4.5 Minimal model to generate observations 
We tested which components of the simple network model were necessary to generate the 
behavior observed in the experimental data. When the time-dependent increase of the 
cue-onset expectancy was removed from Eq. 3.2, the model was unable to predict the 
appropriate RT-ISI relationship. When the entire inhibitory component (Eq. 3.3) was 
removed from the model, meaning both the time-dependent waning in the salience of the 
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fixation stimulus and the fixation stimulus itself, many of the properties of the 
experimental data could be predicted, including the RT-ISI relationship, the increase in 
lapses with a decrease in the salience of the cue stimulus, and an increase in anticipations 
with an increase in the noise term on the rate of the cue-onset expectancy signal, 0'£. 
Without the inhibitory component, smaller values of 0'£ were able to generate the 
appropriate ratio of anticipations to lapses; for example, for the values of h = 0.4 7 and kE 
= 0.30 tested in Figure 3-8, a 1:7 ratio of anticipations to lapses could be obtained for CYi 
= 0.80 and CYi = 1.37, respectively. These results would therefore suggest that model 
predictions are driven solely by the excitatory processes. This minimal model, however, 
does not predict non-lapse reaction times at the shortest lSI; non-lapse reaction times are 
observed in the experimental data at short lSI. When the fixation stimulus, but not the 
time-dependent waning in the salience of this stimulus, is retained in Eq. 3.3, model 
predictions for non-lapse RTs at short lSI improve; however, at the shortest lSI no non-
lapse RTs can be achieved. These results therefore suggest that both the time-dependent 
excitatory and inhibitory processes are needed to generate the full range of observations 
from the experimental data. 
3.5 Discussion 
This paper presented analyses of reaction times (RTs), lapses and anticipations on the 
PVT on three time scales: (1) the single trial scale on the order of seconds, during which 
we looked at inter-stimulus interval (lSI) effects; (2) the session scale on the order of 
minutes during which we looked at time on task (TOT) effects; and (3) the circadian 
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scale on the order of hours, during which we looked at time awake and circadian phase 
effects. We also examined the effect of the wake-promoting stimulants modafinil and 
caffeine at all three time scales. We reported a stochastic neural model that simulates our 
observations of RTs, lapses and anticipations with respect to lSI and time awake. A 
summary of each of these results is now provided. 
The main findings of the inter-stimulus interval analysis demonstrated a negative 
relationship between lSI and RT: slow non-lapse reaction times (RTs) and lapses were 
associated with short lSI and fast non-anticipatory RTs and anticipations were associated 
with long ISis. 
Observations of TOT effects were somewhat study-dependent. In participants 
completing a 50-hr sleep deprivation (Dataset 1), significant TOT effects were observed 
in all three outcome variables (RTs, lapses and anticipations); in the two 28.57 hr 
extended wake episodes (Datasets 2 and 3), there was a significant TOT effect on RT 
only in Dataset 2 and there was a significant TOT effect on lapses only in Dataset 3. 
Awake x TOT interactions were also study-dependent, and were observed for RTs and/or 
lapses but not for anticipations. No significant drug interactions on the TOT effect were 
observed. 
Although RTs, lapses and anticipations increased with increasing time awake, 
their interactions with lSI did not change with time awake. 
Non-significant reductions in RTs were observed in groups receiving modafinil or 
caffeine compared to their respective placebo groups. However, both moda:finil and 
caffeine had the beneficial effect of significantly reducing the RT variance while 
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preserving the more favorable (fast) part of the RT distribution. Significant reductions in 
lapses were observed in the group receiving modafmil compared to placebo, and these 
reductions differed by IS I. In the caffeine group, a trend towards reductions of lapses was 
observed. Neither modafinil nor caffeine had any effect on anticipations compared to 
their respective placebos. 
These results build on previous reports on the effect of sleep deprivation on the 
interactions between RT, lSI and TOT. Although Tucker et al. (2009) did not find an 
interaction between lSI and sleep deprivation, only two lengths of time awake at one 
circadian phase were compared. The present analysis extended these results using more 
sophisticated statistical models to reveal differential effects of lSI and TOT on lapses and 
anticipations compared to normal RTs. To our knowledge, the only other study that has 
explored the effect of stimulants on the lSI relationship was Cochran et al. (1992), who 
reported that d-amphetamine improved reaction times on an auditory task with variable 
lSI, and that the amount of improvement increased as the lSI increased. The original 
analyses of Datasets 2 and 3 (Wyatt et al., 2004 ; Grady et al., 2010) found significant 
reductions in RTs and lapses with caffeine and modafinil, respectively, across time 
awake, but did not explore lSI or TOT effects. 
The simple neural network model was able to capture the effect of sleep 
deprivation on reaction times, lapses and anticipation responses, with the appropriate 
relationship to lSI for each response type. The modeled bases of the lSI relationship were 
a time-dependent increasing excitatory component and a time-dependent decreasing 
inhibitory component on response cell activity. Given the extensive evidence for these 
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two processes from neurophysiological recordings made during RT-task performances in 
non-human primates), time-dependent excitatory and inhibitory processes might be 
regarded as essential component processes of any realistic RT model. In such a model, 
lapses and anticipations naturally arise, respectively, at short and long ISis if there is a 
reduction in the internal salience of the fixation and cue stimuli in combination with 
elevated noise. The model's reduced internal salience of the incoming stimuli 
corresponds to a commonly observed cortical consequence of reduced ascending arousal 
by acetylcholine (e.g., Broussard et al., 2009 ; Gulledge et al., 2009). This reduction is an 
established consequence of sleep deprivation and is partly attributable to an increase in 
adenosine during extended wakefulness (Rainnie et al., 1994; Strecker et al., 2000; Van 
Dort et al., 2009). Different combinations of parameters, particularly the cue salience and 
the rate of increase of the excitatory term may reflect performance on the PVT under 
different lengths of time awake and circadian phase combinations. The increase in noise 
may also reflect reduced cortical acetylcholine, which acts to improve signal-to-noise 
ratios (e.g., Eggermann and Feldmeyer, 2009), or perhaps a general trend towards state 
instability, another proposed effect of sleep deprivation (Doran et al. 2001). The simple 
model serves the purpose of showing how several key aspects of response patterning, 
including the apparent "opposites" of lapses and anticipations, can emerge from a few 
underlying processes when the consequences of elapsing times (ISis) are factored in. 
Other models have been proposed to simulate one or more of the effects of sleep 
deprivation on PVT performance. The diffusion decision RT model introduced by 
Ratcliff (for review, see Ratcliff and McKoon, 2008) posits a noisy, non-monotonic 
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("diffusion") process by which evidence accumulates over time from a starting point to 
one or more decision criterion boundaries. In a recent paper (Ratcliff and Van Dongen 
2011), this model was fit to RT distributions from PVT data collected from participants 
who underwent a 36-hr sleep deprivation. The effect of sleep deprivation was modeled by 
a simultaneous decrease in the mean value of a parameter representing the rate at which 
evidence accumulates and increase in its variance, which resulted in a significant 
decrease of the ratio between the two (the "drift" ratio, analogous to a signal-to-noise 
ratio). The model was successfully fit toRT distributions across different lengths oftime 
awake, and could account for the proportion of lapses in attention using both a 500 ms 
and 1500 ms cut-off. However, the authors did not attempt to account for anticipations, 
and it appears that the model could not do so without additions. Nor was the model tested 
for lSI or TOT effects. 
Another model that simulated PVT performance during an 88-hour sleep 
deprivation was an adaptation of the ACT-R architecture (Gunzelmann et al. 2009). The 
ACT-R cognitive architecture utilizes condition-action rules (called "productions") and 
auxiliary memory modules as a basis for modeling a variety of cognitive tasks (Anderson 
et al., 2004). Lapses were generated in this model by reducing the parameter representing 
arousal or motivation. A parameter representing the threshold at which a response is 
executed was also decreased in conjunction with the decrease in arousal; this change 
served as a compensation for the arousal decrease, such that normal response times can 
be generated despite the increased incidence of lapses. Anticipations did not arise 
naturally in the model. As the authors noted, "because the respond production requires 
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that a stimulus be attended on the screen, it is unable to produce false starts" 
(anticipations). The mechanism they added to produce false alarms does not appear able 
to predict more anticipations at longer ISis. However, the authors did not assess their 
model for lSI or TOT effects. 
Both modafmil and caffeine reduced RTs, RT variability and the number oflapses 
during sleep deprivation in comparison to their respective placebos, but had no effects on 
anticipations; these drugs effects were not simulated with the simple neural network 
model proposed here due to the more complex underlying mechanisms presumed to 
mediate these effects. Because both drugs were shown to reduce RT variability under 
sleep deprivation, one potential application of the drug effect within the simple model 
would be to reduce the increase in the noise term associated with the time-dependent 
excitatory process. However, although both drugs are stimulants and had similar effects 
on RTs, lapses and anticipations, they appear to act via different mechanisms: caffeine is 
an established antagonist of adenosine (which is associated with sleep drive (Basheer et 
al., 2004; Boonstra et al., 2007), and accumulating evidence suggests that among the 
several actions of modafinil (which include effects on glutamate, norepinephrine, and 
histamine transmission), one action is to inhibit DAT (the dopamine transporter), and 
thus to boost ambient dopamine, which is wake promoting and motivating (Young and 
Geyer, 2010). One brain site where both adenosine antagonism and DAT antagonism 
could have a strong effect on simple RT is the lateral-dorsal striatum (part of the basal 
ganglia), due to both its pivotal role in the voluntary release of well-practiced actions, and 
its very high expression of adenosine receptors, DAT, and dopamine receptors. Thus, 
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common or distinct effects on RTs and lapses may be due to different mechanisms of 
action of these drugs, although differences may also arise from the method of 
administration or drug half-life. Simulating these factors will require a much more 
complex model. The time on task effect was also not included in the simple model.· Time 
on task likely involves additional processes acting over a time course of minutes, whereas 
the time-dependent processes of the excitatory and inhibitory components modeled here 
considered only a time scale of seconds. 
In conclusion, our analyses and modeling results support evidence that 
attentiveness depends on complex ascending arousal signals that contain phasic and tonic 
components acting on multiple time scales from milliseconds to days. Measures of 
reaction times, lapses in attention and anticipations extracted from the PVT can be used 
to study changes in attentiveness across time scales within and across individuals. The 
simple neural network model proposed here suggests that time- and state-dependent 
excitatory and inhibitory processes can mediate the observed relationships between inter-
stimulus interval and RTs, lapses and anticipations. The model is fully compatible with 
the hypothesis that state-dependent changes in these processes are in turn mediated, in 
part, by the negative effect, during sleep deprivation, of adenosine accumulation on the 
cortical release of acetylcholine. Further modeling work is necessary to understand the 
more complex neurotransmitter mechanisms underlying the effect of wake-promoting 
agents and the mechanisms, operating on the order of minutes, that generate the time on 
task effect. 
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CHAPTER4 
A NEURAL MODEL OF THE EFFECTS OF SLEEP DEPRIVATION ON 
MOTOR PREPARATION AND RESPONSE INCORPORATING 
ADENOSINERGIC, DOP AMINERGIC, AND CHOLINERGIC EFFECTS 
4.1 Introduction 
Preparation and execution of planned and reactive movements requires a complex set of 
interactions among multiple brain regions, including parietal and frontal cortices, the 
basal ganglia system (BGS) and thalamus. BGS connections with cortex are organized 
into distinct circuits or loops which reciprocally interconnect diverse cortical areas to 
control the flow of information between and within each loop (Middleton and Strick, 
2000). BGS connections with motor cortical areas, for example, are central to the control 
of movement; degeneration of BGS nuclei have been implicated in disorders of the 
voluntary movement system (Albin et al., 1989; Skaper and Giusti, 2010). 
Behavioral observations on simple and choice reaction time (RT) tasks show that 
sleep deprivation disrupts the ability to plan and execute movements. As one example, on 
the psychomotor vigilance task (PVT), a simple RT task that has been used extensively in 
sleep deprivation paradigms as a sensitive index of changes in sustained attentiveness to 
visual or auditory stimuli presented at a high signal rate for several minutes, sleep 
deprivation leads to long RT and lapses in attention comingled with anticipatory (false 
alarm) responses (Dinges and Powell, 1985; Belenky et al., 2003; Van Dongen et al., 
2003; Wyatt et al., 2004; Dorrian et al., 2005; Santhi et al., 2007; Cohen et al., 2010). As 
was reported in Chapter 3, both lapses in attention and anticipations increase as a 
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function of time awake and co-vary with circadian phase, suggesting a common influence 
subserving the generation of both response types. 
The BGS has recently been implicated as an important component of sleep-wake 
regulation (Qiu et al., 201 0; Vetrivelan et al., 201 0), with lesions to striatal and pallidal 
areas resulting in reduced and increased wakefulness, respectively. In addition to direct 
projections to cortex, the BGS also connects with several brainstem and thalamic regions 
of the ascending arousal system, as was reviewed in Chapter 2. Furthermore, the 
endogenous somnogen adenosine (Portas et al., 1997; Strecker et al., 2000; Stenberg et 
al., 2000; Porkka-Heiskanen et al., 2002; Thakkar et al., 2003; Basheer et al., 2004; 
Boonstra et al., 2007) has many of its effects in striatal and pallidal regions of the BGS 
(Xie et al., 2007), where it acts in opposition to dopamine, a potent mediator of most 
psycho stimulant effects (e.g. Hyman et al., 2006). The adenosine antagonist, caffeine 
(Fredholm et al., 1999; Xie et al., 2007), and modafinil, a wake-promoting substance with 
actions via the dopaminergic system (Wisor et al., 2001; Young and Geyer, 2010), both 
reduce the sleep-loss-induced increase in response times on the PVT (Wyatt et al., 2004; 
Grady et al., 2010), further implicating key involvement of the BGS in the sleep 
deprivation effects on motor response. 
In Chapter 3 we explored the effects of sleep loss on response patterning on the 
PVT, specifically the effect of the variable inter-stimulus interval (lSI) drawn from a 
rectangular distribution ranging from 1000 to 9000 ms. Our findings concur with results 
from classical studies on simple reaction time (Drazin et al., 1961; Requin and Granjon, 
1969; Schupp and Schlier, 1972) that lapses in attention (i.e. long RTs) were more 
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frequent following short ISis and anticipations (i.e. short RTs) were more frequent 
following long ISis. Although sleep deprivation did not alter this observed relationship to 
lSI (also reported in Tucker et al., 2009), the wake-promoting agent modafinil, but not 
caffeine, modified the lSI effect on lapses in attention but not anticipations. Both drugs 
reduced the size of the increased incidence of lapses and anticipations during sleep 
deprivation. A proposed simple network model was able to reproduce the observed lSI 
effects on lapses in attention and anticipations using only two components: a time-
dependent excitatory component that increased activity across the lSI and was strongly 
activated by the introduction of the target stimulus, and a time-dependent inhibitory 
component activated by the fixation stimulus with waning activity across the lSI. These 
two components are directly analogous to the direct and indirect pathways of the BGS, 
which promote and inhibit motor response, respectively. Effects of caffeine and 
moda:finil, and thus involvement of adenosine and dopamine interactions, were not 
explored in this simple model. 
Here we propose an extension of the Telencephalic Laminar Objective Selector 
model (TELOS, Brown et al., 2004), which was developed to explain how laminar 
circuitry in frontal cortex interacts with parietal cortex, BGS, thalamus and the superior 
colliculus to generate planned and reactive saccadic eye movements, to address the 
effects of sleep deprivation arising from adenosinergic, dopaminergic and cholinergic 
actions in the BGS. In particular, we focus on four key additions to the model that enable 
it to generate lapses in attention and anticipation responses under sleep deprivation, with 
the appropriate relationship of both response types to the inter-stimulus interval. The 
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additions include: (1) a preparatory process, attributed to interactions between 
hippocampus and prefrontal cortex, that primes activity in the BGS direct pathway in 
preparation for the upcoming stimulus; (2) habituative (thus waning) excitation of the 
BGS indirect pathway during the fixation interval; (3) basal ganglia (BG)-influenced 
cholinergic cell populations in the basal forebrain whose cortical projections modulate 
attention to fixation and cue stimuli; and ( 4) adenosinergic interactions, primarily in the 
BGS direct and indirect pathways, that modulate cholinergic cortical arousal as well as 
cue-dependent BGS signaling. 
The proposed model was first used to simulate saccadic eye movements during 
basic oculomotor tasks, to verify that new elements of the model did not alter the ability 
to reproduce empirical phenomena that were successfully simulated by prior 
implementations of the model (Brown et al., 2004; Silver et al., 2012). The new model 
was then used to simulate the PVT under well-rested conditions, increasing levels of 
sleep deprivation, and the effect of caffeine under sleep deprivation. The PVT requires 
manual response to the target stimulus with a button press with the thumb of the 
dominant hand. The PVT is implemented here as an oculomotor task, with the output of 
the motor response (a saccadic eye movement) generated from the model representation 
of the superior colliculus. Results from this model are expected to be directly comparable 
to forelimb movement. Simple RT dependencies on stimulus variables are qualitatively 
similar for oculomotor and manual responses (e.g., Engelken et al., 1991; Ludwig et al., 
2004), although there is a quantitative divergence for choice RTs (Kveraga et al., 2002); 
saccadic and manual RTs respond similarly to deep brain stimulation in the subthalamic 
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nucleus (STN) of the basal ganglia (Antoniades et al., 2012); and both saccadic and 
manual RTs are elevated after extended sleep deprivation (De Gennaro et al., 2000; 
Bocca & Denise, 2006). Finally, the model was simulated to generate predictions for a 
task not yet studied under sleep deprivation: the countermanding, or stop signal, task tests 
the ability to inhibit initiation of a cued voluntary response on a small fraction of trials, 
during which a "stop" cue appears shortly after a "go" cue. In rested subjects, BGS areas 
including the striatum and the STN have been implicated in stop-signal processing (e.g., 
Li et al., 2008; Kenner et al., 2010), and the model's predictions for this task can be 
tested in future research on effects of sleep deprivation. 
4.2 Methods and Model Description 
4.2.1 Description of the psychomotor vigilance task (PVT) 
The primary goal of the current research was to use a neurobiologically constrained 
circuit model to simulate the psychomotor vigilance task (PVT) under rested and sleep 
deprived conditions, and to assess its ability to generate the behavioral trends and drug 
effects observed experimentally in Chapter 3. The PVT requires participants to sustain 
attention to a task with a high signal rate with a variable inter-stimulus interval 
distributed from 1000 to 9000 ms for a period of 10 minutes. Participants were told to 
remain visually fixated on a rectangle centered on a computer screen and respond as 
quickly as possible with a button press each time the target stimulus appears within the 
fixation rectangle. The target stimulus is a digital clock display of elapsed time in ms 
since stimulus onset. Upon each successful response, the clock display stops 
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incrementing, and the final value (the RT) is displayed for a duration of 1 second, as 
feedback to the participant. If a participant responds before stimulus onset, 'Anticipation' 
is displayed for 1 second to inform the participant of the premature response error. 
Following a successful response or anticipation, the stimulus disappears from within the 
fixation rectangle to signal the start of the next trial. 
The PVT was implemented within the model by assuming in the external visual 
representation that the fixation stimulus always appears in position (x,y) = (1, 1) and the 
target stimulus always appears in position (x,y) = (2, 1) of the 3 x 3 visual grid (see 
Figure 4-1). At each time step, the current external visual stimulus is transformed into an 
internal representation that activates either the NoGo response plan or the Go response 
plan based on whether the internal visual representation occurs in a fixation-related cell, 
(x,y) = (1,1), or a target-related cell, (x,y) f. (1,1), respectively. Go and NoGo plans 
compete with each other to prevent an incorrect response, i.e. a premature response when 
the fixation stimulus is on or a failure to respond when the target stimulus is on. When 
the NoGo plan is initiated by the presence of the fixation signal, target-related response 
cells exhibit ramping activity for the duration of the fixation interval in preparation for 
the upcoming target stimulus. The appearance of the target stimulus activates a Go plan 
which leads to a burst in the already primed target-related cells. When the activity in 
these cells exceed a threshold (indicated by the dashed line in Figure 4-1), a gate is 
opened to allow a response to be executed. 
Under rested conditions (Figures 4-1A,B), strong cholinergic inputs to the 
internal visual representation enhance the salience of the fixation and the target stimuli. 
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Simultaneous cholinergic input to the response preparation cells keeps ramping activity 
during the fixation interval below the gated threshold to prevent a premature response. 
Under rested conditions, two response types are expected: fast RTs (Figure 4-lA) and 
slow RTs (Figure 4-lB). Fast RTs are typically observed following a long fixation 
interval: during the long fixation interval, ramping activity increases towards the gated 
threshold such that cell activity is close to threshold at the end of the fixation interval. 
Vlhen the Go plan is activated, a burst in activity quickly opens the gate to elicit a fast 
RT. Slow RTs are typically observed following a short fixation interval because ramping 
activity in preparation cells does not have sufficient time to approach the gated threshold. 
Under sleep deprivation (Figures 4-lC,D), cholinergic inputs are reduced by the 
presence of adenosine. As a result, the salience of the visual stimuli is reduced in the 
internal visual representation, and the ability to ensure a moderate rate of preparatory 
ramping is reduced. Fast and slow RTs are still possible, but the occurrence of two 
additional response types, anticipations and lapses, increase. Anticipations are responses 
recorded before the target stimulus onset and thus can be elicited with recruitment of the 
Go plan when the ramping activity during the fixation interval increases above the gate 
threshold (Figure 4-lC). Lapses in attention, which are defined as significantly slow 
RTs, occur when the reduced salience of the fixation and target stimuli delay the ability 
of the preparation cells to burst in response to a Go signal, leading to a longer time to 
reach the gate threshold to execute a response. 
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Figure 4-1: Schematic representation of the flow of information as the model performs the PVT task 
while rested or sleep deprived. Low adenosine allows normal waking acetylcholine (ACh) levels in 
rows A and B. RT is relatively fast if motor preparation time is long (A), but relatively slow if motor 
preparation time is short (B). In the Response Preparation plot, the horizontal dashed line represents 
the threshold for response initiation. The gray box indicates the fixation interval, whereas the vertical 
black line at the end of the gray box represents the time of GO cue onset. High adenosine (due to many 
hours awake) causes below-normal ACh in rows C and D. Preparatory activity ramps faster, and if it 
lasts long enough, leads to an anticipation (false alarm) in C. If the preparatory interval is short, as in D, 
the RT is very long (a lapse) because the Go cue evokes such a weak response, as indicated by the light 
gray square in the Internal Visual Representation column for case D. See main text for further details. 
In this and subsequent figures, arrowheads indicate excitatory links and circle line terminators indicate 
inhibitory links. 
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4.2.2 Description ofbasic oculomotor tasks 
Previous implementations of the TELOS model (Brown et al., 2004; Silver et al., 2012) 
simulated a set of basic oculomotor tasks, which we also simulate here to demonstrate 
that the basic properties of the model hold under the current set of revisions and additions 
to the model equations (Figure 4-2). The fixation task requires individuals to foveate the 
fixation stimulus for a fixed time interval during which a distracting target stimulus 
appears in one of four peripheral locations (Figure 4-2A). Successful fixation occurs if 
no RT is recorded either during the presentation of the target stimulus or in the interval 
immediately following the offset of the target stimulus. The saccade task (Figure 4-2B) 
requires individuals to saccade to a target stimulus, the onset of which coincides with the 
offset of a fixation stimulus, thus sharing similarities to the PVT. In the saccade task, the 
time for the fixation interval is normally less than 1000 ms, and the target stimulus can 
appear in one of four peripheral locations. The RT on the saccade task is measured as the 
difference in time between the onset of the target stimulus and the onset of the saccade. 
In the overlap task (Figure 4-2C), the fixation stimulus is presented for a fixed interval 
and the target stimulus appears prior to the offset of the fixation stimulus. In the version 
of the overlap task simulated here, adapted from Bocca and Denise (2006), individuals 
must saccade to the target stimulus when it appears despite the continued presence of the 
fixation stimulus. The RT is measured as the time between the onset of the target 
stimulus and the onset of the saccade. The gap task (Figure 4-2D) requires individuals to 
withhold a saccade until the onset of a target stimulus that follows a no-stimulus (gap) 
interval that is imposed between the time of fixation-stimulus offset and target stimulus 
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onset. The RT is measured as the time between the onset of the target stimulus and the 
onset of the saccade; an incorrect response is recorded if the RT occurred during the gap 
interval. 
A Fixation task 
F 
T ----------~~~~~~--------------
E 
B Saccade task 
F 
T --------------------~~~~~~~----
E 
c Overlap task 
F 
T 
E 
D Gap task 
F 
T _________________________ ..... 
E 
0 1000 2000 3000 
Time (ms) 
Figure 4-2: Temporal structure of four basic oculomotor tasks simulated using the updated TELOS 
model. For each task depicted, bar F represents the interval during which the fixation stimulus was on, 
bar T represents the interval during which the target stimulus was on, and trace E indicates a typical 
onset time of the eye movement. Trace E shows no onset time during the fixation task in panel A 
because that task requires active inhibition of saccades to the target stimulus. 
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4.2.3 Description of the stop-signal reaction time task 
The stop-signal (or countermanding) task has been implemented as both an oculomotor 
task, requiring a saccadic eye movement, and as a task requiring manual response such as 
a button press (e.g., Aron and Poldrack, 2006; Li et al., 2008). On the stop-signal task, a 
fixation stimulus is presented for a fixed interval, followed by a target stimulus to which 
individuals are instructed to respond as quickly as possible. On a subset of trials (i.e. 
"stop" trials), the target stimulus is followed, after a sub-second delay, by a stop stimulus 
that requires the individual to withhold response. On successful stop trials, the individual 
is able to withhold response; on unsuccessful stop trials individuals are unable to 
withhold response and an RT is recorded. The stop signal delay (SSD) measures the time 
interval between the onset of the target stimulus and the onset of the stop stimulus. In 
typical implementations of this task (e.g., Li et al., 2008), the SSD is dynamically 
adjusted in a stepwise manner over several trials to determine the SSD at which the 
individual can successfully withhold response on ~50% of trials. For example, in Li et al. 
(2008) the SSD was initially set at 100 ms and for each stop trial, if an individual 
successfully withheld response the SSD was increased by 64 ms on the next stop trial; if 
an individual was unable to withhold response, the SSD was decreased by 64 ms for the 
next stop trial. The stop signal reaction time (SSRT) is measured as the difference 
between the median RT across all trials in which the stop signal was not presented (i.e. 
"go" trials) and the SSD at which ~50% of stop trials resulted in successful stops. 
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4.2.4 Model description 
The updated TELOS model describes multiple interacting cortical and subcortical areas, 
including parietal and prefrontal cortices, the frontal eye fields, multiple basal ganglia 
loops, the thalamus and superior colliculus. The model is comprised of multiple 
populations of cells representing each of these brain regions. A simple representation of 
the flow of information from detection of the stimulus to response execution through 
each brain region is depicted in Figure 4-3. The full set of model equations is included 
in the Section 4.6, and more detailed depictions of some model stages appear in Figures 
4-4, 4-5, 4-7 and 4-9. 
4.2.4.1 Posterior parietal cortex: fixation and cue onset detection 
When a visual stimulus (fixation or cue) is presented to the model, it first excites cells in 
area 7a of posterior parietal cortex (PPC) (Silver et al., 2012). Three populations of 7a 
cells interact to produce a signal that marks stimulus onset at some visual field location 
x,y. Inputs I xy first excite a population of cells at the PPC input layer, PX:, that respond 
for the duration of the visual input. These cells excite intemeurons, P~, which also 
respond for the duration of the visual input. Both P:, and P~ project to the PPC output 
layer P~ , which responds with transient high activity immediately following the onset of 
the stimulus. This activity then equilibrates to a lower, non-zero level for the remaining 
duration of the input. The initial transient high activity is due to the balance of 
converging excitatory and inhibitory signals from PX: and P~, respectively. Transient 
onset cell activities P~ serve as the driving input to another stage of PPC, the lateral 
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intraparietal cortex (LIP), with cell activities P~. These cells retain representations of 
visual input that compete with each other, and may compete or cooperate with cues 
representing a stored planned movement from frontal eye field (FEF) output cells, F;; 
(Brown et al., 2004; Silver et al., 2012). As described below, representations in LIP cells 
and FEF cells reach consensus about the motor response to be executed before motor 
production can occur. 
Visual 
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• Saccade 
output 
Figure 4-3: Schematic representation of the major brain regions included in the updated TELOS model 
and their interactions. The model includes six major brain regions. The posterior parietal cortex (PPC) 
receives the visual input and is responsible for detection of a visual cue that signals the need for an eye 
movement. The PPC transmits this visual information to the frontal eye fields (FEF), the hippocampus 
(HPC) and pre-frontal cortex (PFC), which are responsible for planning the movement. Information 
from these regions is transmitted to the basal ganglia, which controls the opening of two gates, one in 
the thalamus and one in the superior colliculus (SC). Once the SC gate is open, a saccadic eye 
movement is performed. See main text for further details. 
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4.2.4.2 Frontal eye fields: planning of motor response 
Once a stimulus has been received by the PPC, the LIP cell activities P~ excite 
corresponding plans in the FEF plan layer, represented by cell activities F~ (Bullier et al., 
1996; Marconi et al., 2001; Silver et al., 2012). To execute the plan, sustained activity in 
FEF plan layer cells F~ must excite FEF output cells, F~ , but cannot do so until the 
thalamic gate, T, which is normally closed by strong inhibition from the basal ganglia 
system (BGS), has been released from that inhibition. Such release allows the FEF 
output cells to respond strongly to the plan layer signals. The thalamic gate is normally 
allowed to open whenever FEF plan layer cells F~ and LIP cells P~ reach a consensus 
to make a saccade toward a stimulus location x,y that outcompetes other locations whose 
activation are relatively weak (Brown et al., 2004; Buschman and Miller, 2007; Silver et 
al., 2012). Once FEF output occurs, motor response generation is mediated by the 
superior colliculus (SC), and the SC sends feedback to corresponding FEF postsaccadic 
cell, F:, , which when activated inhibit activity in FEF plan and output layers to reset in 
preparation for the next visual inputs and competitive selection of the next saccadic 
target. 
4.2.4.3 Basal ganglia: Gating of motor response 
Cortical afferents to the striatum of the BGS include projections from both parietal 
(Cavada and Goldman-Rakic, 1991) and frontal cortices (Parthasarathy et al., 1992; 
Strick et al., 1995). The BGS is responsible for controlling movements through a gating 
process. These gates are normally closed due to high spontaneous firing in the pallidal or 
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nigral cells (of the BGS) that inhibit thalamus, and near-zero spontaneous firing of striatal 
cells that can directly inhibit the pallidal/nigral cells. A motor production is initiated 
when frontal and parietal regions promote the same plan. This yields convergent 
excitation of striatum, which tips the balance between excitation and inhibition within the 
striatum towards net excitation, which produces opening. In the original version of 
TELOS (Brown et al., 2004), the BGS avoided premature execution of plans by ensuring 
that FEF and P PC reach a consensus before allowing motor generation. In the present 
version of the model, however, additional mechanisms have been incorporated which 
allow motor responses to be executed when FEF reaches consensus with P FC, even 
under conditions in which parietal regions have competing plans. These additional 
mechanisms are described below. 
BGS gate opening in the model depends on opposite actions of the direct and 
indirect pathways (Brown et al., 2004; Frank, 2005; Frank et al., 2001; Mink, 1996). The 
direct and indirect pathways of the BGS begin with two distinct GABAergic populations 
of medium spiny projection neurons (MSPNs) in the striatum (Figure 4-4). MSPNs on 
the direct pathway express D1 (dopamine type 1) receptors (D1Rs) and project directly to 
the internal segment of the globus pallidus (GPi) and the substantia nigra pars reticulata 
(SNr). The GABAergic GPi/SNr are tonically active output nuclei of the BGS that inhibit 
populations of cells that gate motor production, e.g. thalamus or SC (Bullock and 
Grossberg, 1991; Hikosaka and Wurtz, 1983; Horak and Anderson, 1984). Activation of 
MSPNs on the direct pathway inhibits GPi/SNr cells, thereby disinhibiting thalamic or 
SC cells. 
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Figure 4-4: The direct and indirect pathways of the thalamic-projecting basal ganglia with several 
sites of action for dopamine and adenosine. Adenosine and dopamine receptors have opponent effects 
within the BGS. Dopamine acting via D1Rs expressed on striatal direct MSPNs promotes the opening 
of the thalamic gate via inhibition of global pallidus internal (GPi). Adenosine acting via A1Rs, which 
are expressed on striatal direct MSPNs and form heteromers with D1Rs, suppresses the activity of 
striatal direct MSPNs to oppose opening of the thalamic gate. Dopamille acting via D2Rs expressed on 
striatal indirect MSPNs inhibits their activity, thus having a synergistic effect with dopamine acting on 
D1Rs. Adenosine A2ARs are expressed on striatal indirect MSPNs, form heteromers with D2Rs and 
promote activity of striatal indirect MSPNs, thus acting synergistically with A1Rs and in opposition to 
the effects of dopamine to keep the gate closed. Adenosine A2ARs found on inhibitory striatopallidal 
terminals facilitate inhibition at synapses onto striatal direct MSPNs, globus pallidus external (GPe) 
neurons, and cholinergic neurons. 
The indirect pathway MSPNs express dopaminergic D2 receptors (D2Rs) and 
inhibit cells in the extemal segment ofthe globus pallidus (GPe). The GPe inhibit cells in 
both the GPi!SNr and the sub-thalamic nucleus (STN) which in turn sends excitatory 
projections to GPi!SNr and back to GPe (Wichmann and DeLong, 1996). The balance of 
STN and GPe inputs to GPi!SNr normally disinhibits GPi/SNr, to keep the gate closed. 
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When the indirect pathway is activated, inhibition of GPe removes the inhibitory action 
of GPe on GPi/SNr, which strengthens GPi/SNr inhibitory output to thalamus or SC. 
GPi!SNr can be inhibited only by converging inhibition from both GPe and direct 
pathwayMSPNs. 
The model includes two loops through the BGS, one that projects to thalamus to 
open the gate that allows the flow of information from the FEF plan layer to FEF output 
layer, and one that projects to SC to allow SC to execute a motor response (Figure 4-5). 
The thalamus-projecting BGS loop controls the thalamic gate, T. The thalamic gate is 
held closed by tonic inhibition from GPi cell activities, BGPi. The thalamic gate can be 
opened when activity in BGPi is sufficiently reduced by converging inhibition arising from 
GPe cell activities, BGPe, and striatal direct pathway MSPNs, B 8D. Indirect pathway 
MSPNs, BSI, on the thalamus-projecting BGS loop receive specific projections from 
fixation-related FEF plan layer cells to provide a constant source of inhibition to GPe cell 
activities, BGPe. BGPe is released from this inhibition when the striatal indirect pathway 
MSPNs become inactive, that is, when the fixation stimulus is extinguished and no longer 
drives parietal input to fixation-related FEF plan layer cells. B8D is activated when there 
is sufficient converging activity from target-related FEF plan layer cell activities, F;, 
and corresponding target-related LIP cell activities, P~. B8D can also be activated by high 
activity levels in PFC output cells, C0 , (described below) which boost activity in both 
fixation-related and target-related FEF plan layer cells. Once direct pathway striatal 
MSPN activation suppresses GPi cell activities below a certain threshold, the thalamic 
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Figure 4-5: The thalamic-projecting and collicular-projecting basal ganglia loops. The updated 
TELOS model includes two basal ganglia loops. The thalamic-projecting loop controls the opening of 
the thalamic gate to allow a motor plan arising from FEF to activate the collicular-projecting loop. The 
collicular-projecting loop controls the activation of the superior colliculus to execute a saccade. 
gate, T, can be released from inhibition. Thalamic cell activity and FEF plan layer cell 
activity converge to activate FEF output layer cell activities, F:;. The FEF output layer 
cell activities are then able to activate a motor response in the superior colliculus, Sxy, but 
are unable to do so until a second BGS gate is opened via the collicular-projecting BGS 
loop. 
In the collicular-projecting BGS loop, indirect pathway striatal MSPNs respond to 
the representation of the fixation signal in LIP cell activities, P~, by inhibiting GPe, 
o:;•, which results in disinhibition of SNr, G':;r. While G':;r is active, SC activity is 
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suppressed. During fixation, therefore, it is difficult for FEF output layer cell activities or 
LIP cell activities to inhibit a;;rvia activation ofthe striatal direct MSPNs, a:_:. When 
no fixation signal is present, however, strong converging activity in corresponding FEF 
output layer cells LIP cells can activate a:_: to inhibit a;:r and allow the second gate 
controlling SC activity to open and thereby produce a motor response. 
The two BGS loops are critical for holding the model in a state of preparedness as 
information is gathered to decide which motor response to execute and to detect the task 
conditions which signal the appropriate time to execute this response. For the PVT task, 
this process depends largely on the presence and absence of the fixation stimulus. When 
the fixation stimulus is present, the thalamic and collicular gates are held shut; motor 
response plans are prepared and held until the fixation cue is extinguished and the target 
stimulus appears. Motor responses can, however, be executed without the appearance of 
the target stimulus when the combined waning activity in striatal indirect pathway 
MSPNs and preparatory activity in striatal direct pathway MSPNs reduce GPi/SNr 
activity sufficiently to release the thalamic gate from inhibition. These mechanisms are 
described in more detail below. 
4.2.4.4 The hyperdirect cortico-STN-GPi pathway 
The STN projection to GPi represents the hyperdirect pathway which has been proposed 
as a pathway by which strong excitatory effects originating in cortex can bypass the 
striatum to modulate activity of basal ganglia output nuclei (Nambu et al., 2002). The 
STN has been implicated as an important relay for the stop signal response (Eagle and 
Baunez, 2010); however, there has been disagreement' over the role of the STN in fast 
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and slow stop signal reaction times (SSRTs). An fMRI study by Aron and Poldrack 
(2006) suggested that higher S1N activation was associated with short SSRTs, but in 
another study (Li et al., 2008) higher S1N activation was associated with long SSRTs. 
The S1N as implemented by Brown et al. (2004) receives excitatory input from 
FEF output cells which fire once a response has been executed; thus this projection serves 
to excite S1N following a saccade to provide an excitatory boost to GPi that closes the 
open thalamic gate. In the present implementation of the model, an additional excitatory 
cortical input to S1N has been included; this excitatory cortical input is activated in 
response to the appearance of visual input that represents the stop stimulus during the 
stop-signal task. This activation of the hyperdirect pathway is necessary to successfully 
inhibit an already planned GO response. As the indirect pathway has also been implicated 
in the stop-signal task (Li et al., 2008), a similar excitatory cortical input, activated by the 
stop stimulus, has also been routed to the model's striatal indirect pathway MSPN. 
4.2.4.5 Adenosinergic and dopaminergic control ofbasal ganglia 
Dopamine and adenosine receptors are expressed on both the direct and indirect pathway 
striatal MSPNs (Figure 4-4) and have antagonistic interactions via receptor heteromers 
(Ferre et al., 2007; Fuxe et al., 2007; Xi et al., 2007). On the striatal direct pathway 
MSPNs, dopamine acting via D1Rs promotes MSPN activity leading to an increased 
release of GABA at the striatonigral terminal. Adenosine acting via A1Rs reduces GABA 
release at the striatonigral terminals and also inhibits D1R signaling (Fuxe et al., 2007) 
via A1R-D1R heteromers. On the striatal indirect pathway MSPNs, dopamine acting via 
D2Rs reduces GABA release at the striatopallidal terminals. Adenosine acting via A2ARs 
. ~·-·· .. '· - . 
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both promotes GABA release at the striatopallidal terminals (Shindou et al., 2001; 2008) 
and reduces D2R signaling to prevent reduction of GABA release at the striatopallidal 
terminals via dopaminergic activation (Fuxe et al., 2007). Dopamine signaling thus acts 
synergistically on direct and indirect pathway to facilitate the opening of the BG gate via 
inhibition of GPi, while adenosine signaling acts synergistically on direct and indirect 
pathway to prohibit the opening of the BG gate. 
Adenosine is a product of energy metabolism that has been proposed as both a 
sleep homeostasis marker and a sleep-promoting agent (Bellington and Heller, 1995; 
Boonstra et al., 2007; Scharf et al., 2008). Extracellular levels of adenosine in the basal 
forebrain (BF) progressively increase as time-awake is prolonged, but decreases with 
sleep (Porkka-Heiskanen et al. 2002, Basheer et al. 2004). The present implementation of 
the model assumes that increasing levels of adenosine during sleep deprivation disrupts 
the balance of direct and indirect pathway activities, biasing the BGS towards the indirect 
pathway to keep the gate closed. This implies longer latencies to the opening of the BG 
gates under sleep deprivation. This indirect pathway bias due to adenosine, therefore, 
suggests one mechanism by which sleep deprivation leads to long RTs and lapses in 
attention observed on the PVT (Figure 4-6). 
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Figure 4-6: Simulated traces of cell activations within the thalamic-projecting basal ganglia loop 
under rested conditions and sleep deprivation during the PVT. Panel A shows cell traces during a PVT 
trial in which the target stimulus appears at 1000 ms (dashed vertical line) for both rested (dashed lines) 
and sleep-deprived (solid lines) conditions. In the latter condition, the RT = 510 ms, thus representing a 
lapse in attention. Panel B shows cell traces during a PVT trial in which the target stimulus appears at 
9000 ms (dashed vertical line) for both rested and sleep-deprived conditions. In the latter condition the 
RT = -452 ms. The negative RT value indicates that the response was executed prior to the onset of the 
target stimulus, thus representing an anticipation. 
In the original implementation of the TELOS model, dopaminergic reward and 
non-reward signals were incorporated to facilitate learning of saccade movements during 
oculomotor tasks (Brown et al., 2004). Dopamine was modeled as burst and pause signals 
in the BGS striatum and the frontal cortex in response to unpredicted rewarded and non-
rewarded events, and these signals affected learning. Neither dopamine nor adenosine 
were included in the model as factors that could affect RT performance, as such. The 
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present implementation of the model assumes tonic dopaminergic levels that interact with 
rising levels of adenosine during sleep deprivation (Porkka-Heiskanen et al. 2002, 
Basheer et al. 2004) to modulate MSPN activations, and adenosine acts at additional sites 
outside the model striatum. Although disruption of dopamine-mediated reward learning 
by adenosine may underlie changes in reward learning observed during sleep deprivation 
(e.g. Hagewoud et al., 2010) such learning effects were not the focus of the present 
modeling work. 
4.2.4.6 Basal forebrain: Tonic and phasic cholinergic signaling 
The cholinergic basal forebrain (BF) consists primarily of the medial septum/vertical 
limb of the diagonal band (MSNDB), the horizontal limb of the diagonal band of Broca 
(HDB), and the nucleus basalis ofMeynert/substantia innominata (NB:M/SI) (Mesulam et 
al., 1983; Zaborszky et al., 1999). As discussed in detail in Chapter 2, the BF is located 
ventrally to the striatum and sends diffuse cholinergic projections to the cortex, including 
parietal and frontal areas (Zaborszky et al., 1999). A1Rs expressed on cholinergic BF 
neurons suppress cholinergic activity when activated by adenosine (Strecker et al., 2000; 
Stenberg et al., 2000; Thakkar et al., 2003). In the model, therefore, the cholinergic signal 
arising from BF is reduced under sleep deprivation due to the presence of extracellular 
adenosine. 
Cholinergic inputs to PPC modulate the salience of the internal representation of 
the visual stimuli (Figure 4-7) via both excitatory and inhibitory effects (McCormick and 
Prince, 1986; Xiang et al., 1998). In PPC, high levels of acetylcholine strongly inhibit the 
inhibitory PPC interneuron activity, P~. Acetylcholine also modulates the excitatory 
·-·-·---;.--' 
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projection from P}; to P; and from P; toP~. Within frontal cortex, cholinergic inputs to 
FEF plan layer cell activities, F~, modulate the sensory-to-motor excitation by LIP. 
These effects therefore act synergistically within PPC and FEF to promote strong 
activity in response to visual input. Consequently, when cholinergic inputs are reduced by 
adenosine, the salience of the visual input is reduced. This reduction of cholinergic 
activity therefore suggests another mechanism by which increasing levels of adenosine 
lead to long RTs and lapses in attention on the PVT; the reduced signals from LIP and 
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Figure 4-7: Model schematic of cells in the posterior parietal cortex (FPC). Cells in the PPC convert 
the external visual stimulus into an internal representation to select the appropriate motor response plan. 
Reduced cholinergic input to PPC during sleep deprivation reduces the internal representation of the 
visual stimulus. Simulated cell traces show the relative levels of activity in each PPC model cell type 
during rested (dashed lines) and sleep-deprived (solid lines) conditions during the PVT for a trial in 
which the onset of the target stimulus occurs at 2000 ms (dashed vertical line). 
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FEF converging on striatal direct pathway MSPNs mean that prolonged activation is 
necessary in order to inhibit the GPi/SNr, and open the BG gate. 
As described in prior reports (Parikh et al., 2007; Parikh and Sarter, 2008) phasic 
increases in cholinergic activity are observed following the onset of a behavioral shift 
associated with detection of a target stimulus. In the model, therefore, phasic cholinergic 
bursts in activity are activated by excitation from FEF output layer cell activities, F;:,, 
which fire in response to successful opening of a BG gate and response execution. 
4.2.4.7 Hippocampal projections to pre-frontal cortex: Expectancy of target stimulus 
onset 
A simple neural network model was proposed in Chapter 3 to describe the processes 
underlying the relationship between the length of the RT and the preceding inter-stimulus 
interval (lSI). This simple model proposed that a time-dependent excitatory process 
which increased monotonically over the fixation interval was necessary to reproduce the 
observations that faster RTs followed longer ISis and slower RTs following shorter ISis 
(see Figure 4-1). Such ramping expectancy signals have been observed in many parts of 
the brain during ISis with a fixed upper bound (e.g., Tinsley and Everling, 2002; 
Hikosaka et al., 1989), including in the pre-frontal cortex (PFC), which has been shown 
to be a necessary substrate for the normal RT-ISI relationship (Stuss et al., 2005; Vallesi 
et al., 2007). The hippocampus, meanwhile, has strong projections to PFC (e.g., Barbas, 
2000) and has been implicated as a region of the brain that monitors expectancy of an 
unconditioned stimulus in trace conditioning studies (Clark et al., 2001; 2002; Knight et 
al., 2004), but only for trace intervals longer than 400 ms (Gerwig et al., 2008). The 
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hippocampus has also been identified as a match-mismatch detector (Kumaran and 
Maguire, 2007). The present implementation of the model thus reflects the hypothesis 
that one potential pathway by which ramping activity is generated in PFC is via the 
hippocampal match-mismatch detection mechanism. 
In the model, the hippocampus monitors visual input via LIP projections (Suzuki 
and Amaral, 1994) to determine whether the current input represents a fixation- or target-
related stimulus. The hippocampus match-mismatch detection favors novelty; therefore, 
when the fixation-related stimulus is detected by the hippocampus, the expectation for the 
target-related stimulus is violated, leading to a phasic burst in hippocampal activity, W. 
Across the fixation interval, non-occurrence of the expected stimulus generates a series of 
phasic bursts in the hippocampus; these phasic signals are integrated by the PFC, cD, 
resulting in a ramping ofPFC activity. The overall slope of the ramping activity in PFC is 
determined by the noisy value of the coefficient on the excitatory term, which is drawn 
from the half-Gaussian-like distribution depicted in Figure 4-8. This PFC activity 
modulates the corticostriatal projection from FEF plan cells to direct pathway striatal 
MSPNs. Direct pathway striatal MSPNs receive low level activity from target-related 
FEF plan layer cell activities which are primed in response to the fixation stimulus. Thus 
the action of the ramping activity in PFC is to boost the low-level activity in striatal direct 
pathway MSPNs to further prepare for the upcoming target stimulus. 
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Parameter rc 
Figure 4-8: The distribution of the coefficient rcfrom the PFC equation. For each PVT trial simulated 
by the model, the rate of increase of preparatory activity in PFC is partly determined by the parameter 
rc, which is drawn randomly from a right skewed unimodal distribution. The distribution's right skew 
contributes to the model's ability to simulate the high ratio of lapses to anticipations observed under 
high levels of sleep deprivation. 
A study by Furey et al. (2000) reports that reaction times (RTs) were reduced on a 
working memory task in the presence of physiostigmine, an acetylcholinesterase inhibitor 
(which promotes ACh accumulation), and furthermore that these reduced RTs were 
associated with reduced task-specific regional cerebral blood flow in both left 
hippocampus and right PFC. These results therefore have two implications: 1) a role for 
hippocampus and PFC in working memory RTs and 2) modulation of hippocampus and 
PFC by cholinergic inputs. This study also reported that physiostigmine-related reduced 
RTs were associated with increased regional cerebral blood flow in visual areas, 
suggesting differential effects of cholinergic projections to visual areas and 
hippocampus/pre-frontal areas. These differential effects may be due to differences in the 
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location of cholinergic a:fferents; reports have suggested for example that cholinergic 
projections to visual areas arise from the nucleus basalis ofMeynert (Pearson et al., 1983; 
Selden et al., 1998) whereas cholinergic projections to hippocampus and PFC arise from 
medial septum (Gaykema et al., 1990; Linke et al., 1994). 
To model the reduction of hippocampus and PFC activity by acetylcholine, the 
model assumes cholinergic inputs arising from BF inhibit hippocampus and PFC via an 
excitatory effect on their intemeurons (Figure 4-9). Strong cholinergic input excites 
hippocampal and PFC intemeurons to reduce activity in the hippocampal and PFC output 
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Figure 4-9: Model schematic of hippocampus (HPC) and prefrontal cortex (PFC) model cell types. 
Cells in the HPC compare the internal representation of the visual stimulus from lateral intraparietal 
cortex (LIP) to a working memory representation of the expected target stimulus and respond with a 
burst in activity when LIP input does not signal the presence of the target stimulus. HPC activity is 
integrated by PFC to produce preparatory activity across the fixation interval. Reduced cholinergic 
input to inhibitory HPC intemeurons increases HPC activation, leading to increased preparatory activity 
in the PFC. Cell traces show the relative levels of activity in HPC and PFC during rested (dashed lines) 
and sleep-deprived (solid lines) conditions during the PVT for a trial in which the onset of the target 
stimulus occurs at 2000 ms (dashed vertical line). 
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cell activities. Weak cholinergic input due to the suppression of cholinergic BF activity 
provides less excitation to the intemeurons, thereby leading to increased activity in both 
hippocampus and PFC under sleep deprivation relative to rested conditions. PFC neurons 
also receive recurrent excitation that is increased by increasing levels of adenosine. The 
net effect of adenosine along this pathway, therefore, is to increase PFC ramping activity 
on striatal direct pathway MSPNs, which ultimately results in increasing activation of the 
striatal direct pathway MSPNs during the fixation interval. 
4.2.4.8 Habituation 
In the simple neural network model that was developed to identify potential processes 
mediating the RT-ISI relationship in Chapter 3, a time-dependent inhibitory process 
which decreased monotonically over the fixation interval was also proposed. The waning 
process served to remove inhibition of response cell activity as the time into the fixation 
interval increased and thus to facilitate excitation of cell activity once the target stimulus 
appeared. To include this type of process in the present model, it has been assumed that 
activity-dependent reduction in synaptic efficacy on the fixation-related FEF plan cell 
projection to indirect pathway striatal MSPNs occurs as the fixation interval is extended 
(Grossberg, 1968; 1972; Lovinger and Choi, 1996). This habituation of the synapse 
weakens fudirect pathway inhibition of GPe over time, and this allows increasing 
inhibition of GPi/SNr by GPe. As habituation increases inhibition of GPi/SNr along the 
indirect pathway, the PFC ramping activity thus acts in synergy to increase inhibition of 
GPi/SNr along the direct pathway. The net effect of these two processes can lead to 
anticipation responses, as long as the fixation interval is long enough for striatal direct 
' :;:: ' 
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pathway MSPNs to reach a significant level of activity despite a lack of driving input 
from the target-related FEF and LIP plans. 
As reported by Lovinger and Choi (1996), adenosine acting via A1Rs expressed 
on p;e-synaptic corticostriatal axon terminals initiates short-term synaptic depression. 
This effect of adenosine has been included in the model via the habituation term, ff, 
which reduces the strength of the projection from fixation-related FEF plan layer cells to 
striatal indirect pathway MSPN s over the course of the fixation interval. This results in 
faster habituation of the indirect pathway striatal MSPNs to the fixation plan in the 
presence of elevated adenosine. The net effect of faster habituation with increasing sleep 
deprivation is that increased inhibition of GPi/SNr via the indirect pathway during the 
fixation interval combined with inhibition arising from the striatal direct pathway MSPN 
will lead to an increase in anticipation responses under sleep deprivation. 
4.2.4.9 Superior colliculus: response execution 
The model SC contains a population of cells with activities, Sxy, which are excited by 
FEF output layer cell activities, F;j,, and LIP cell activities, P~. Vlhen SC cell activity, 
Sxy, exceeds the threshold e = 0.20, the model triggers a motor response with a response 
time, RT, measured as the time from the onset of the cue to the time at which the 
threshold was reached, in ms. Suprathreshold Sxy excites FEF postsaccadic cell activities, 
F:, , which are responsible for inhibiting FEF plan and output layer cells once a motor 
response has been executed. This clears the plan from FEF and prepares the system for 
the next trial. 
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4.3 Results 
4.3.1 Model simulations ofbasic oculomotor tasks 
The present model builds upon the TELOS model, first presented by Brown et al. (2004) 
and recently updated by Silver et al. (2012) to perform sequences of plans held in spatial 
working memory. The first simulations confirm that the current model can explain a set 
of basic oculomotor tasks that were summarized by Hikosaka et aL (1989), including the 
fixation task, saccade task, overlap task and gap task (Figure 4-2). The ability to simulate 
these four tasks demonstrates that the model can hold fixation when presented with a 
distractor cue (fixation task, Figure 4-2A) and can saccade reactively toward cues 
(saccade task, Figure 4-2B) and withhold saccades until task conditions permit their 
execution (overlap task, Figure 4-2C; gap task, Figure 4-2D). For all simulations of the 
following oculomotor tasks, unless otherwise noted, the ramping constant, rc, in the PFC 
equation was held constant at rc = 0. 001. 
In simulations of the oculomotor tasks, the appearance of the fixation point 
activates cells in PPC areas 7a and LIP. The model assumes that the oculomotor system is 
foveating the fixation point at (x,y) = (1,1) at the start of a simulation; therefore, fixation-
related activity in LIP activates the fixation plan in FEF, which stimulates the indirect 
pathway striatal MSPNs to hold the thalamic gate closed. Simultaneously, LIP activates 
the collicular-projecting indirect pathway striatal MSPNs to prevent a saccade. In the 
fixation task, the fixation signal is presented at t = 0 and persists until the end of the trial 
at t = 2000 ms. A distractor cue is presented for 500 ms starting at t = I 000 ms. The 
distractor cue activates target-related FEF plan layer cells and LIP cells to excite direct 
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pathway striatal MPSNs that can activate thalamus via GPi/SNr. This will open the 
thalamic gate and allow a saccade (as in the overlap task, see below) unless learning in 
the :fixation task has led to greater fixation-cue-driven activation of the indirect pathway 
in participants exposed to the fixation task contingency, which withholds reward 
whenever the participant errs by looking at the distractor. Such an adjustment will occur 
due to a dopamine-dependent learning law in the TELOS model (Brown et al., 2004) and 
other models that use similar learning rules (e.g., Frank, 2005; Hong and Hikosaka, 
2011). Thus, for the model to successfully avoid looking at the distractor during the 
:fixation task, it was necessary to increase the coefficient on the excitatory term in Eq. 
4.17 for the indirect pathway as an approximation for learning: the 3.5BH ("Lw;F~J 
pq 
used in all other simulations became 12BH (~W,!;/,:; J for the fixation-task simulation. 
In the saccade task, the fixation signal is presented at t = 0 and is extinguished at t 
= 2000 ms. At t = 2000 ms, a target cue is presented at the location (x,y) = (2,1). Without 
the :fixation signal driving indirect pathway striatal MSPN activity, the direct pathway 
striatal MSPN activity is strongly activated to inhibit GPi, allowing the thalamic gate to 
open. The target cue initiated a saccade at t = 2291 ms, so the RT between fixation offset 
and saccade onset was 291 ms. 
In the version of the overlap task presented here, adapted from Bocca and Denise 
(2006), the fixation signal is presented at t = 0 and remains on until t = 2700 ms. At t = 
2200 ms, the target cue is presented at the location (x,y) = (2,1). The presence of both the 
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fixation and target stimuli generate activation of both the direct and indirect pathway 
striatal MSPNs. Stronger activation of the target stimulus, due to waning of the fixation 
stimulus, enables the direct pathway striatal MSPNs to open the thalamic gate. A saccade 
was initiated at t = 2498 ms, so the RT between target onset and saccade onset was 298 
ms. 
In the version of the gap task presented here, also adapted from Bocca and Denise 
(2006), the fixation signal is presented at t = 0 and extinguished at t = 2200 ms. A silent 
period of 300 ms follows where neither the fixation signal or the target are presented, 
during which time fixation to (x,y) = (1,1) must be maintained. The target is presented at 
t = 2500 ms, at which time a saccade is permitted. The model generates a saccade at t = 
2749 ms, so the RT between fixation offset and saccade onset was 549 ms, and between 
target onset and saccade onset was 249 ms. When the fixation point is removed before the 
saccade target appears, as in the gap task, activity in the indirect BGS pathway subsides 
before the target excites FEF and PPC sufficiently to open the gate. This advance 
removal of the fixation point allows the system to produce a saccade with a much shorter 
latency (than in the saccade task), known as the gap effect (Saslow, 1967; Pratt et al., 
1999; Bocca and Denise, 2006; Jin and Reeves, 2009). 
The study by Bocca and Denise (2006) reported that saccades on both the overlap 
and gap tasks increased following ~28 hours of sleep deprivation. The effect of sleep 
deprivation was simulated on these two tasks by comparing RTs generated from 75 trials 
for a= 0 to a= 0.20. For these simulations, the ramping constant, rc, in the PFC equation 
was drawn from the distribution in Figure 4-8. Simulation results are plotted in Figure 4-
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lOA and compared to the experimental results reported by Bocca and Denise (2006) in 
Figure 4-lOB. Both the model simulations and the experimental results show that RTs 
generated from the gap task are faster than RTs generated from the overlap task, and RTs 
increase for both tasks under sleep deprivation. 
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Figure 4-10: Model predictions of the overlap and gap tasks under rested and sleep-deprived 
conditions. The overlap task (filled squares) and the gap task (open circles) were simulated as described 
in Figure 4-2 for 75 trials each, with the parameter rc of the PFC equation drawn from the distribution 
in Figure 4-8. Panel A reports results from model simulations and panel B reports results from Bocca 
and Denise (2006). Note the difference in scale on they-axis between panels A and B. 
4.3.2 Model simulations ofPVTunder rested wakefulness 
To simulate the PVT, the model assumes that the oculomotor system is foveating the 
fixation rectangle at (x,y) = (1, I) at the start of each PVT trial. The target stimulus 
appeared at the time, t, marking the end of the fixation interval. In the actual PVT, the 
target stimulus appears in the same spatial location as the fixation rectangle. For the 
purposes of simulation, the model assumes the target stimulus for the PVT appears in the 
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location (x,y) = (2,1). The duration of the fixation interval for each trial was randomly 
drawn from a uniform distribution between 1000 and 9000 ms at 1-s intervals. For all 
simulations of the PVT, the ramping constant rc in the PFC equation was randomly 
drawn from the distribution in Figure 4-8 at the start of each trial. 
To simulate performance on the PVT under non sleep-deprived rested conditions, 
baseline levels of dopamine ( 5 = 0) and adenosine (a = 0) were assumed. Figure 4-llA 
reports the distribution of RTs plotted as a function of the length of the fixation interval 
(inter-stimulus interval, ISI) for 75 PVT trials at each lSI. The model predicts slower RTs 
at shorter ISis with the latency decreasing with increasing lSI. Figure 4-llB shows the 
number of anticipations observed at each ISI bin. Any responses less than or equal to 100 
ms were counted as anticipation responses. Anticipations are rarely observed (<1 %) in 
behavioral data when an individual is rested (see Chapter 3 and Doran et al., 2001); the 
distribution of the rc term in PFC (Eq. 4.29 and Figure 4-8) was scaled based on this 
percentage of occurrence under rested conditions. The model predicts that anticipation 
responses occur at longer ISis. Model cell traces for the PVT under rested conditions for 
a 1000 ms fixation interval and a 9000 ms fixation interval are shown in Figure 4-12 and 
4-13, respectively. 
The mean RT for these data across all lSI was ~230 ms (excluding anticipations). 
To analyze performance on the PVT under sleep-deprived conditions (a> 0), twice this 
baseline mean was used as the cutoff to categorize lapses. Therefore, for all remaining 
simulations of the PVT, RTs > 460 ms are counted as lapses and are not included in 
reports ofRT distributions. 
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Figure 4-11: Model predictions of performance on the PVTunder rested and sleep-deprived 
conditions. Panels A and B represent model predictions under rested conditions when a= 0 and panels 
C and D represent model predictions under sleep-deprived conditions when a= 0.45. The top panels 
plot the mean (filled square), 25th, 50th and 75th percentiles (box) and standard deviation (error bars) at 
each ISI for normal RTs. The bottom panels plot the percentage of the total number of trials simulated 
at each ISI for which the RT was categorized as either a lapse in attention (solid columns) or 
anticipation (open columns). 
4.3.3 Model simulations ofPVT under sleep deprivation 
To simulate performance on the PVT under sleep-deprived conditions, adenosine levels a 
> 0 were assumed while baseline levels of dopamine ( 5 = 0) were maintained. Figure 4-
llC reports the distribution of RTs plotted as a function of the length of the fixation 
interval (inter-stimulus interval, ISI) for 75 PVT trials for a= 0.45. The model predicts 
that the RT-ISI relationship is maintained under sleep deprivation, with a shift across all 
ISI towards longer RTs. Figure 4-llD reports the number of lapses and number of 
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anticipations observed at each lSI bin as a percentage of the total number of trials. The 
model predicts that more lapses occur at short lSI and more anticipations occur at long 
lSI. Model cell traces for the PVT under sleep deprivation are compared to rested 
conditions for a 1000 ms fixation interval and a 9000 ms fixation interval in Figures 4-12 
and 4-13, respectively. 
Cortical regions Thalamic BG loop Collicular BG loop Preparatory regions 
Figure 4-12: Cell traces of all model cell types during the PVT for cue onset at I 000 ms. The PVT was 
simulated for a cue onset of 1000 ms (vertical dashed line) under rested (dashed lines) and sleep-
deprived (solid lines) conditions. For rested a= 0 and for sleep deprived a= 0.45 was used in 
simulations. The activity for each model cell type is plotted. Gray lines indicate model cell types driven 
by the fixation stimulus and black lines indicate model cell activity driven by the target stimulus. The 
value of parameter rc was fixed at 0.004. The model predicted an RT = 272 for the rested condition 
and an RT = 510, representing a lapse in attention, for the sleep-deprived condition. 
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Figure 4-13: Cell traces of all model cell types during the PVTfor cue onset at 9000 ms. The PVT was 
simulated for a cue onset of 1000 ms under rested (dashed lines) and sleep-deprived (solid lines) 
conditions. For rested a= 0 and for sleep deprived a= 0.45 was used in simulations. The activity for 
each model cell type is plotted. Gray lines indicate model cell types driven by the fixation stimulus and 
black lines indicate model cell activity driven by the target stimulus. The value of parameter rc was 
fixed at 0.0107. The model predicted an RT = 175 for the rested condition and an RT = - 452, 
representing an anticipation, for the sleep-deprived condition. 
In Chapter 3 it was reported that under sleep deprivation the ratio of lapses to 
anticipations remains constant while the total number of lapses and anticipations varies 
with length of time awake and circadian phase. Figure 4-14 shows the ratio oflapses to 
anticipations as a function of a. The model predicts that for a::::; 0.10, the number of 
anticipations exceeds the number of lapses. In Chapter 3 it was shown experimentally 
that the number of anticipations exceeded the number of lapses for < 16 hours of 
wakefulness. The model predicts that for a> 0.10, the number of lapses exceeds the 
number of anticipations. At a= 0.45, the model predicts a ratio of lapses to anticipations 
of 7.44:1; a ratio of ~7:1 lapses to anticipations was found experimentally in Chapter 3 
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for >24 hours awake. The present implementation of the model does not include the 
influence of circadian phase. 
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Figure 4-14: Increases in lapses in attention and anticipations across sleep deprivation. Increasing 
values of a > 0 represents progression towards a sleep-deprived state. For each value of a, the 
percentage oflapses (filled squares) was computed as the total number oflapses in attention recorded 
across all lSI divided by the total number of trials performed for N = 675 trials. The percentage of 
anticipations (open squares) was similarly computed for each value of a. At a = 0.45, the ratio of 
lapses to anticipations reached~ 7:1, matching what was observed experimentally in Chapter 3. 
4. 3. 4 Model simulations of the effect of caffeine on PVT under sleep deprivation 
The adenosine antagonist, caffeine (Fredholm et al., 1999; Xie et al., 2007) reduces the 
sleep-loss-induced increase in response times on the PVT (Wyatt et al., 2004 and Chapter 
3). The effect of caffeine, x, was tested in the model by multiplying the adenosine factor, 
1 
a, by another term, X, to reflect a divisive effect of caffeine: X=--. To test whether 
1+ X 
effects of caffeine are mediated primarily through A1Rs or A2ARs, model simulations 
were generated for the case where caffeine acted at both receptor types and compared to 
simulations where 
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Figure 4-15: Model predictions of the effects of caffeine on PVT performance during sleep 
deprivation. Data are plotted as the difference in RTs (top panels) and difference in percentage of 
lapses and anticipations (bottom panels) from predictions of the sleep deprived condition without 
caffeine (simulations in Figure 4-llC,D). Panels A and B report model predictions for caffeine acting 
on both A 1Rs and A2ARs. Panels C and D report model predictions for caffeine acting on A 1Rs only. 
Panels E and F report model predictions for caffeine acting on A 2ARs only. 
caffeine acted at only A 1Rs or only A2ARs, fora= 0.45 and X= 1. Figure 4-lSA,B shows 
the predicted distribution of RTs and the total number of lapses and anticipations for the 
case in which caffeine acted at both receptor types. Data are plotted as the difference in 
mean RTs and difference in total number of lapses and anticipations, from the sleep-
deprived condition a= 0.45 (from Figure 4-llC,D). The model predicts that caffeine 
acting via both A 1Rs and A2ARs reduces RTs, lapses and anticipations, as has been 
observed experimentally (Chapter 3). Figure 4-lSC,D shows the same predictions for the 
case in which caffeine acts only at A 1Rs and Figure 4-lSE,F shows the case in which 
caffeine acts only at A 2ARs. The model predicts that the effects of caffeine to reduce RT 
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and reduce the number of lapses and anticipations are mediated through both receptor 
subtypes, although the model predicts that the effect is slightly stronger via A1Rs. The 
model also predicts that caffeine acting via A2ARs increases the number of anticipations. 
4.3.5 Model simulations of the effect of dopamine on PVT under sleep deprivation 
As reported in Chapter 3, the wake-promoting agent, modafinil, decreased RTs, lapses in 
attention and anticipations under sleep deprivation. Modafinil has been shown to increase 
extracellular dopamine (Wisor et al., 2001) and may also exert wake-promoting effects 
via dopamine-dependent adrenergic receptors (Wisor and Eriksson, 2005). In all previous 
simulations, baseline levels of 8 = 0 were assumed during rested and sleep-deprived 
conditions. The effect of modafinil via dopamine was tested in the model by increasing 
the dopamine factor to 5 = 0.20 (both D1Rs and D2Rs) during the sleep-deprived 
condition in which a= 0.45. To test whether effects ofmodafinil are mediated primarily 
through D1Rs or D2Rs, model simulations for the case where modafinil acted at both 
receptor types were compared to simulations in which modafinil acted at only D1Rs or 
only D2Rs, for a= 0.45 and 5= 0.20. Figure 4-16A,B shows the predicted distribution of 
RTs and the total number of lapses and anticipations for the case in which modafinil 
acted at both receptor types. Data are plotted as the difference in mean RTs and 
difference in total number of lapses and anticipations, from the sleep-deprived condition 
a= 0.45 (from Figure 4-llC,D). The model predicts that modafinil acting via both D1Rs 
and D2Rs reduces RTs and lapses but increases anticipations. Figure 4-16C,D shows the 
same predictions for the case in which modafinil acts only at D1Rs and Figure 4-16E,F 
shows the case in which modafinil acts only at D2Rs. The model predicts that the effects 
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of modafinil to reduce RT and reduce the number of lapses are mediated through both 
receptor subtypes, although the model predicts that the effect is slightly stronger via 
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Figure 4-16: Model predictions of the effects of modafinil on PVT performance during sleep 
deprivation. Data are plotted as the difference in RTs (top panels) and difference in percentage of 
lapses and anticipations (bottom panels) from predictions of the sleep deprived condition without 
modafmil (simulations in Figure 4-llC,D). Panels A and B report model predictions for modafinil 
acting on both D1Rs and D2Rs. Panels C and D report model predictions for caffeine acting on D1Rs 
only. Panels E and F report model predictions for caffeine acting on D2Rs only. 
4. 3. 6 Model simulations of the stop-signal RT task 
In the stop-signal reaction time task, the target stimulus requiring a GO response is 
followed, on a subset of trials, by a stop stimulus. The stop stimulus is presented with a 
variable stop signal delay (SSD) to determine the threshold at which· a pre-potent 
response can be inhibited. Model simulations were run to generate predictions of the 
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stop-signal reaction time task under rested (a = 0) and sleep-deprived conditions (a > 0). 
For each trial, a fixation stimulus was presented for 1000 ms at (x,y) = (1,1). At the end 
of the fixation interval, a target stimulus was presented at (x,y) = (2,1). To test the ability 
to inhibit response, the stop stimulus was presented at (x,y) = (0, 1) after a variable SSD 
from the onset of the GO signal and remained on until either a response was recorded or 
the end of the trial, which was set to 2000 ms after the onset of the target stimulus. If the 
end of the trial was reached without a response, this was considered a successful 
inhibition of the pre-potent response. 
Under experimental conditions, the stop-signal reaction time (SSRT) is calculated 
as the difference between the median RT during non-stop trials and the value of the SSD 
for which ~50% of STOP signals result in successful inhibition of the pre-potent 
response. To estimate the SSRT from model simulations, for each condition (a= 0 and a 
> 0), a trial was first run to determine the RT when the stop stimulus is not presented. 
The ramping constant, rc, in the PFC equation was held constant at rc = 0. 0005. The 
model was then simulated at each condition to determine the maximum SSD at which the 
pre-potent response was successfully inhibited. The SSRT was computed for each 
condition as the difference between the average RT and this SSD. Figure 4-17 reports 
the SSRT for the rested condition where a= 0 and for increasing levels of a> 0. The 
model predicts that the SSRT decreases with sleep deprivation, with a decrease of ~30 ms 
in the SSRT from a= 0 to a= 0.45. Although perceptual processing of the stop-signal is 
slowed, the GO-signal's ability to initiate action is slowed even more by sleep 
deprivation. Because of the way it is calculated, this differential slowing appears as a 
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reduced S SR T. 
It has been proposed that the hyperdirect path way through the STN mediates 
response inhibition on the SSRT; however, there is disagreement over whether the STN is 
more active during fast SSRTs or slow SSRTs (Aron and Poldrack, 2006; Li et al., 2008). 
Response inhibition may also be mediated through the indirect pathway (Li et al., 2008). 
In the model, the stop-signal activates both pathways. To test the relative contribution of 
each pathway to the SSRT, model simulations were generated in which either the STN 
activation or indirect pathway activation by the stop stimulus was omitted. Results are 
plotted in Figure 4-17. The model predicts no difference in SSRT when the indirect 
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Figure 4-17: Model predictions of the stop signal reaction time (SSRT) under rested and sleep 
deprived conditions. The stop-signal task, as described in the main text, was simulated under rested (a 
= 0) and sleep-deprived (a > 0) conditions. Predictions of the full model (filled squares), which 
includes direct effects of the stop stimulus in both the striatal indirect pathway MSPNs and in the 
hyperdirect pathway STN, are compared to predictions in which an effect of the stop stimulus is 
included only in the indirect pathway MSPNs (open triangles) or only in the STN (open circles). 
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pathway only is active compared to when the hyperdirect pathway only is active for a < 
0.30, and in each case the predicted SSRT is higher than the SSRT predicted when both 
model pathways are active. For a 2: 0.30, the model predicts a shorter SSRT when the 
indirect pathway only is active, compared to when the hyperdirect pathway only is active. 
The model predicts decreases in the SSRT with sleep deprivation in both pathways, 
although the decrease is greater when the indirect pathway only is active. 
4.4 Discussion 
This chapter describes how adenosinergic, dopaminergic and cholinergic effects on 
multiple interacting cortical and subcortical areas, including parietal and prefrontal 
cortices, the frontal eye fields, multiple basal ganglia loops, the thalamus and superior 
colliculus, influence RTs on oculomotor and psychomotor tasks during rested and sleep-
deprived conditions. The model reproduces both behavioral and electrophysiological data 
and therefore produces testable predictions about the neural systems involved in the 
effect of sleep deprivation on the planning and execution of planned and reactive 
responses. The following paragraphs review key model competencies, exploring ways in 
which they might suggest future directions of study. 
4.4.1 Habituation in the striatal indirect pathway and anticipatory preparation in the 
striatal direct pathway generate the inter-stimulus interval effect 
One of the main features of the present model is that it can reproduce the relationship 
between inter-stimulus interval and normal RTs, anticipations and lapses that have been 
observed on the PVT under rested conditions. The model predicts that this ISI-RT 
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relationship is maintained under sleep deprivation conditions, as has been observed 
experimentally (e.g. Chapter 3 and Tucker et al., 2009). We previously proposed a simple 
network model that successfully generated the ISI-RT relationship by combining an 
inhibitory component, which declined linearly across the fixation interval, with an 
excitatory component, which increased linearly across the fixation interval (Chapter 3). 
The model proposed here is based on the same principles as the simple network model: 
the striatal indirect pathway MSPN activity declines across the fixation interval via 
habituation of the fixation-related FEF plan cell projection, and striatal direct pathway 
MSPN activity accumulates across the fixation interval via a preparatory signal arising 
from pre-frontal cortex. Thus, for a short lSI, a long RT is generated because of three 
separate effects: 1) strong activity in the striatal indirect pathway MSPN prior to 
habituation that keeps the gate closed; 2) little accumulated preparatory activity in PFC to 
drive activity in striatal direct pathway MSPNs; and 3) strong inhibitory activity in 
striatal direct pathway MSPNs arising from intra-striatal collaterals of the indirect 
pathway projection. The latter two effects keep activity in striatal direct pathway MSPNs 
close to zero, and thus when target-related FEF plan layer cells are activated, more time 
is needed for striatal direct pathway MSPNs to accumulate enough strength to inhibit GPi 
sufficiently to open the thalamic gate. In contrast, when the lSI is long, habituation in the 
striatal indirect pathway MSPNs weakens the indirect pathway output, which releases 
both GPe and direct pathway MSPNs from inhibition. Concomitantly, during the long 
lSI, significant accumulation of preparatory activity in PFC drives striatal direct pathway 
MSPN activity significantly above zero such that when the target stimulus is received, 
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direct pathway MSPNs are primed to readily inhibit GPi which opens the gate quickly. 
Despite changes to adenosinergic, dopaminergic and cholinergic inputs to manipulate the 
interactions between indirect and direct to generate lapses and anticipations, as described 
below, this ISI-RT relationship remains intact. However, it would not remain intact if the 
model's PFC ramping activity were removed, consistent with several empirical reports 
(Stuss et al., 2005; Vallesi et al., 2007). 
4.4.2 Preparatory activity in pre-frontal cortex arises from hippocampal monitoring of 
visual inputs 
In the model, activity in the striatal direct pathway MSPNs is primed during the fixation 
interval by preparatory activity arising from PFC. The preparatory activity in PFC itself 
arises from input from a hippocampal region which performs a match-mismatch 
computation between the current visual input of the fixation stimulus and its working 
memory expectation for the upcoming target stimulus. During the fixation interval, 
projections from LIP to hippocampus indicate the presence of the fixation stimulus; this 
violation of the hippocampus expectation for the target stimulus triggers a transient boost 
in hippocampal activity, which is then integrated by the PFC as a ramping signal that 
increases monotonically with each hippocampal activity boost. This model assumption 
was based on studies from trace conditioning experirllents reporting an increase in 
hippocampal activity during the trace interval (Clark et al., 2001, 2002; Knight et al., 
2004), studies of the hippocampus as a match-mismatch detector showing sustained or 
increased hippocampal activity when expectations are violated (Sakai et al., 2002; 
Kumaran and Maguire, 2007; Duncan et al., 2009) and studies reporting an increase in 
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hippocampal activity across delay intervals prior to target acquisition (Olsen et al., 2009). 
Our implementation represents just one process by which ramping activity could 
be generated in pre-frontal cortex cells to prime striatal direct pathway MSPN activity 
during the fixation interval. Such preparatory activity has been observed in many cell 
types for many different tasks. Tinsley and Everling (2002), for example, report a 
population of cells which increase in activity across the gap interval during the gap task; 
these cells were presumed to be from PFC, as they were recorded from areas 8 and 46 of 
rhesus monkeys, areas which also overlap with FEF regions of cortex. Hikosaka et al. 
(1989) identified a population of caudate neurons that increased in activity during an 
interval in which a target was expected to appear. Additionally, Tinsley and Everling 
report a population of cells that decreased in activity across the gap interval in the same 
region. These electrophysiological studies complements the clinical studies (Stuss et al., 
2005; Vallesi et al., 2007) to help identify potential neural correlates for the model-
hypothesized decreases and increases in activity in striatal indirect and direct pathway 
MSPNs, respectively, that drive the RT-ISI relationship. 
4.4. 3 Adenosinergic and dopaminergic competition in the basal ganglia gives rise to 
lapses in attention during sleep deprivation 
The behavioral changes on the PVT observed under sleep deprivation include increases in 
both lapses in attention, defined as very long RTs, and anticipations, defmed here as RTs 
under 100 ms and negative RTs that occur before the onset of the target stimulus. A 
major goal of the current modeling effort was to generate both lapses and anticipation 
RTs in the presence of increased levels of adenosine. Adenosine has been proposed as 
159 
both a sleep homeostasis marker and a sleep-promoting agent due to observations that 
extracellular levels of adenosine increase in the basal forebrain during extended 
wakefulness (Porkka-Heiskanen et al. 2002, Basheer et al. 2004) and that perfusion of 
adenosine into basal forebrain leads to reduced wakefulness and increased sleep (Portas 
et al. 1997; Basheer et al. 2004). The basal forebrain sits just ventral to the basal ganglia, 
and in some treatments, ventral pallidal regions of basal forebrain are included as basal 
ganglia structures (see Chapter 2 for discussion). A major assumption of our model, 
therefore, was that increases in extracellular adenosine have a significant influence on the 
adenosine receptors located on striatal and pallidal neurons in basal ganglia, leading to 
the behavioral changes on the PVT observed during sleep deprivation. 
As adenosine accumulates, the distribution of inhibitory A1Rs on direct pathway 
striatal MSPNs and excitatory A2A.Rs on indirect pathway striatal MSPNs and GPe 
generates an imbalance between the direct and indirect pathway that favors the closed 
thalamic gate. Thus, one consequence of increased adenosine is stronger excitation of 
indirect pathway MSPNs during the fixation interval to inhibit both GPe and striatal 
direct MSPN, preventing their inhibition of GPi. This strong indirect pathway activity 
delays inhibition of GPi even once the fixation signal has been extinguished and direct 
pathway MSPNs have received a target-related plan from FEF. Furthermore, the 
inhibitory action of adenosine on striatal direct MSPNs reduces their overall activation 
level, further delaying activation of direct pathway MSPNs to the levels necessary for 
inhibition of GPi in order to release the thalamic gate. These effects accumulate to 
generate a lapse in attention, particularly at short lSI. 
160 
At longer lSI~ strong inhibition of direct pathway MSPN activity during the 
fixation interval is compensated by increased preparatory activity arising from PFC, 
which itself is influenced by the action of adenosine, as is further discussed below. 
Although the overall activation level of direct pathway MSPNs is limited by the amount 
of adenosine acting via inhibitory A1Rs, this preparatory activity counteracts the strong 
inhibitory signal arising from striatal indirect pathway MSPNs, such that when a target 
stimulus is received, striatal direct pathway MSPNs can still reach activity levels 
necessary to inhibit GPi. Thus at longer lSI, we hypothesize that fewer lapses in attention 
are observed (see Chapter 3) due to compensatory PFC activity preparing the striatal 
direct pathway MSPNs for activation by target-related FEF planning. In fact, at the 
longest lSI, preparatory activity arising from the PFC can overcompensate for the 
inhibition from striatal indirect pathway MSPNs, resulting in the production of 
anticipations. 
The adenosine-dopamine opponency in the striatum which we model here is 
complemented by a dopamine-acetylcholine opponency, which we do not explicitly 
model. The sole known source of ACh in the striatum is a class of giant aspiny 
intemeurons that are intrinsic to striatum and strongly innervated by dopaminergic 
afferents from the midbrain (Kubota et al., 1987; Chang, 1988). These cholinergic 
intemeurons are often called TANs because they are tonically active neurons (Koos and 
Tepper, 2002; Goldberg and Reynolds, 2011) which release ACh onto both classes of 
MSPNs (Calabresi et al., 2000) with opposite effects: ACh is inhibitory to D1-MSPNs 
and excitatory to D2-MSPNs. DA acts via postsynaptic D2Rs to inhibit the striatal TANs, 
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which synergizes with the direct effects of DA on MSPNs to shift the balance of striatal 
processing in favor of D1-MSPNs, relative to D2-MSPNs. Tozzi et al. (2011) have 
reported co-expression of A2ARs with D2Rs in striatal TANs, which mimics the co-
expression seen on D2-MSPNs. Thus during prolonged wake as well as during sleep, 
adenosine accumulation would be expected to act via A2ARs on TANs to facilitate intra-
striatal release of ACh, which would also help shift the balance in favor of the indirect 
pathway. Thus, although not explicitly modeled, this is consistent with our model 
hypothesis that an increase in adenosine during sleep deprivation results in lapses in 
attention due to delayed activation of direct pathway. 
4.4.4 Top-down attention is mediated by cholinergic signaling originating from the basal 
forebrain 
Lapses in attention also arise in the model due to top-down modulation of sensory 
information in PPC and FEF from cholinergic basal forebrain. Under presumed rested 
conditions when the level of extracellular adenosine in the basal forebrain is effectively 
zero, strong tonic cholinergic inputs to parietal area 7a and LIP enable strong internal 
representation of the external visual stimulus. Furthermore, strong tonic cholinergic input 
to FEF plan layer facilitates sensory-motor cooperation between FEF and LIP. Rising 
levels of adenosine in basal forebrain suppress this cholinergic activity, which reduces 
the strength of the sensory information in PPC and FEF, resulting in lower activity in 
both regions and leading to reduced activation at downstream sites. This effect of 
adenosine on cholinergic inputs to reduce activity is in addition to the direct effects of 
adenosine in basal ganglia. Thus, while interactions within the basal ganglia maintain the 
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RT-ISI relationship via compensatory mechanisms, an overall slowing in RTs across all 
lSI as has been observed experimentally (see Chapter 3) is mediated through top-down 
cholinergic attention. 
It might be expected that in a :rpotor planning system in which adenosine 
effectively lowers activation everywhere, except on indirect pathway striatal MSPNs, that 
such a system would be unable to generate anticipation responses. Yet, both lapses and 
anticipations are observed to increase on the PVT under sleep deprivation (Chapter 3). 
Importantly, lapses and anticipations increase proportionally and vary with circadian 
phase, strongly suggesting that the same underlying mechanism mediates both response 
types. The present model proposes two synergistic effects of adenosine that result in an 
increase in preparatory activity in PFC during sleep deprivation. In the model we propose 
that cholinergic input suppresses preparatory activity, despite excitatory effects of 
acetylcholine elsewhere in the model, such as PPC and FEF. The hippocampus receives 
cholinergic projections from the medial septum (Gaykema et al., 1990; Linke et al., 
1994), whereas projections to PPC originate from other basal forebrain regions such as 
the nucleus basalis of Meynert (Pearson et al., 1983; Selden et al., 1998). In a study 
testing the effect of systemic administration of an acetylcholinesterase inhibitor (Furey et 
al., 2000), visual cortical regions showed an increase in activation in response to higher 
acetylcholine levels, while left hippocampus and PFC regions showed reduced activation; 
such activation patterns were associated with reduced RT and improved performance on a 
working memory task. These facts exemplify the principle that segregated sources of 
acetylcholine (e.g., within striatum, the NBM, or the medial septum) can be decoupled 
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from each other and may have quite distinct (e.g., arousing or de-arousing) effects within 
the segregated territories to which they project. Thus, in the model, baseline cholinergic 
levels suppress hippocampal activity such that only low boosts in activity during the 
fixation interval are transmitted to the PFC, resulting in low ramping activity. 
Suppression of cholinergic inputs by adenosine under sleep deprivation releases the 
hippocampus from this cholinergic inhibition, allowing larger boosts in activity to be 
integrated by PFC as the hippocampus monitors the violation of expectancy across the 
fixation interval, leading to higher ramping activity in the PFC. 
Additionally, the PFC is directly influenced by adenosine to boost ramping 
activity. In the model it is assumed that the amount of recurrent excitation in PFC 
depends on the level of adenosine, with higher levels of adenosine eliciting higher 
recurrent excitation. Although the model assumes a direct excitatory effect of adenosine, 
sparse evidence suggests that the action may be mediated indirectly through A1Rs on 
inhibitory intemeurons in PFC. Gao et al. (2001) report that dopamine acting via D1Rs 
reduces excitation. As DrRs and A1Rs are known to have opponent effects elsewhere in 
the brain (e.g. striatal direct pathway MSPNs) and there exists some evidence that A1R-
D1R heteromers are found in the PFC (Fux:e et al., 2007), one possible mechanism of 
action is that adenosine acting via ArRs within these heteromer may inhibit the action of 
inhibitory PFC intemeurons, thereby disinhibiting recurrent excitation. Although the 
exact mechanism needs to be further explored, the model suggests that adenosine-
mediated increase in preparatory activity in PFC is sufficient to predict the increase in 
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anticipations observed experimentally under sleep deprivation, despite decreases m 
activity witbin the rest of the network. 
Although most of the effects of cholinergic input in the model are based on tonic 
acetylcholine levels, phasic cholinergic signaling may also influence behavior and is 
likely to be affected by sleep deprivation. Phasic cholinergic signaling has been 
correlated with the behavioral shift evoked by the target stimulus (Parikh et al., 2007; 
Parikh and Sarter, 2008). In the model, we have incorporated this observation by 
initiating a burst response in cholinergic basal forebrain in response to strong FEF output 
activity. FEF output activity was chosen as a representation of the behavioral shift from 
planning to execution in response to the target stimulus. Although this phasic cholinergic 
signal does not have functionality in the current implementation of the model, it may 
have broader implications for other tasks that involve learning and reward acquisition. 
4.4.5 Comparison to existing models of reaction time tasks under sleep deprivation 
Other models have been proposed to describe the effects of sleep deprivation on PVT 
reaction time; none approach the detailed level of neural specification described here. In 
a recent paper (Ratcliff and Van Dongen, 2011 ), the diffusion decision model (for review, 
see Ratcliff and McKoon, 2008) was fit toRT distributions from PVT data collected from 
participants who underwent a 36-hr sleep deprivation. The diffusion decision RT model 
assumes a noisy, non-monotonic ("diffusion") process by which evidence accumulates 
over time from a starting point to one or more decision criterion boundaries. The effect of 
sleep deprivation was modeled by a simultaneous decrease in the mean value of a 
parameter representing the rate at which evidence accumulates and increase in its 
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variance, which resulted in a significant decrease of the ratio between the two (the "drift" 
ratio, analogous to a signal-to-noise ratio). The decrease in evidence accumulation was 
necessary to predict the proportion of lapses in attention observed under sleep 
deprivation, using both a 500 ms and 1500 ms cut-off. The increase in variance was 
necessary to predict the overall increase in RT variability observed under sleep 
deprivation. The authors did not, however, test whether the model was able to generate 
anticipations. An increase in the rate of evidence accumulation would likely generate 
anticipations; similarly in our model an increase in preparatory activity in .PFC was 
necessary to drive activity in the striatal direct pathway MSPNs during the fixation 
interval. For anticipations to be generated in the diffusion model, however, evidence 
accumulation would need to begin prior to the onset of the target stimulus; this is not how 
the diffusion process is currently implemented. 
The PVT has also been implemented within the framework of the ACT-R 
cognitive architecture, which utilizes condition-action rules (called "productions") and 
auxiliary memory modules as a basis for modeling a variety of cognitive tasks (Anderson 
et al., 2004; Gunzelmann et al. 2009). Lapses in attention were generated in this model by 
reducing the parameter representing arousal or motivation. This change alone, however, 
would produce a series of lapses in attention despite evidence that fast RTs are still 
possible with sleep deprivation (e.g. Drummond et al., 2005); thus, the parameter 
representing the threshold at which a response is executed was also decreased as a 
compensation for the decrease in arousal threshold. As in the drift diffusion model, 
anticipations could not arise naturally in the ACT-R implementation of the PVT, because 
. - .·' ~ ··. - . . "·-'/_ ...... 
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the target stimulus was required to initiate response production. A mechanism was added 
to produce anticipations; essentially this mechanism generated a random key press, 
regardless of whether the stimulus was present, which could boost the respond parameter 
beyond threshold, especially when the threshold was reduced during sleep depri.vation. 
This implementation does not, therefore, propose a specific neural mechanism for the 
generation of anticipations. 
In both of the models just described, the length of the fixation interval is 
essentially ignored and thus it is expected that neither model would be able to generate 
the observed RT-ISI relationship. We previously proposed a simple network model in 
which a single population of cells was driven by a combination of an excitatory time-
dependent cue-onset expectancy signal and an inhibitory time-dependent waning of 
attention to the fixation signal (Chapter 3). This model was able to predict the correct RT-
ISI relationship under rested conditions. Increasing the rate of increase of the cue-onset 
expectancy signal and decreasing the salience of the fixation signal at the onset of 
fixation was sufficient to generate an increase in lapses and anticipations under sleep 
deprivation while maintaining an appropriate RT-ISI relationship. 
The model that we propose here implements the basic features of this simple 
network model within a neurophysiological framework that allows us to hypothesize the 
neurotransmitter systems involved to generate testable predictions of pharmacological 
treatments to reduce the effects of sleep deprivation. For example, this model predicted 
that caffeine, acting via A1Rs and A2ARs reduced RTs under sleep deprivation and 
reduced both the number of lapses and number of anticipations, in agreement with the 
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data analysis presented in Chapter 3. There is some disagreement within the literature 
over whether the arousal effects of caffeine are mediated primarily through A1Rs or 
A2ARs. Huang et al. (2005) studied, wild-type, ArR and A2AR knockout mice and found 
that caffeine increased wakefulness only in the wild-type and A1R knockout mice, 
suggesting that the arousal effect is mediated through A2ARs. A follow-up study 
determined that this A2AR -mediated arousal effect of caffeine was specific to A2ARs in 
the shell of the nucleus accumbens, with no effects seen from A2ARs located in the core 
of the nucleus accumbens or elsewhere in the basal ganglia (Lazarus et al., 2011). Van 
Dart et al. (2009), however, reports that the arousal effect of caffeine in the pre-frontal 
cortex is mediated by A1Rs, as both caffeine and an ArR antagonist, but not an A2AR 
antagonist, perfused into the pre-frontal cortex of mice elicited reductions in delta power 
EEG. Maximino et al. (2011) further reports that in zebrafish the caffeine effect on 
arousal is mediated through ArRs. The model predicted that the effect of caffeine was 
greatest when caffeine acted at both ArRs and A2ARs. Caffeine acting through A1Rs only 
was slightly more effective at reducing RTs and lapses than caffeine acting via A2ARs 
only. The model also predicted that caffeine acting via A2ARs only increased the number 
of anticipations, although this was not observed experimentally in Chapter 3. 
Simulations of the model also predicted the direct effect of increasing dopamine 
levels, e.g. through a wake-promoting agent such as modafinil. The model predicted that 
increases in dopamine acting on both DrRs and D2Rs decreased RTs and reduced the 
number of lapses, but also increased the number of anticipations. Although non-
significant effects of modafinil on anticipations were reported in Chapter 3, data plotted 
168 
in Figure 3-3 suggest that there may be a slight increase in the number of anticipations 
for the group receiving modafinil. The effect of increasing dopamine was slightly higher 
via D1Rs compared to D2Rs, suggesting a dominant role of the striatal direct MSPNs. 
The model that we propose here also readily adapts to predict the effects of sleep 
deprivation on a number of basic oculomotor tasks. The model predicts that the SSRT on 
the stop-signal task decreases as sleep deprivation increases, suggesting that under sleep 
deprivation it becomes easier to inhibit a pre-potent response even when the stop stimulus 
is presented at a long delay relative to the onset of the target stimulus. This is likely due 
to a relatively greater slowing of GO signal processing, and RT, than of stop signal 
processing. Whether a response is inhibited depends on a "race": the signal that reaches 
the thalamic gate first "wins" the race and determines the response type. The results of 
the model suggest that, under sleep deprivation, the stop signal's ability to affect the 
thalamic gate is slowed less than the GO signal's ability. Notably, slower build-up of 
direct pathway activity provides more opportunity for it to be undermined by indirect 
pathway activity or vetoed by hyperdirect pathway activity. Simulations of the model 
assessed the relative contribution to response inhibition of the hyperdirect pathway 
through the STN and the indirect pathway through the striatal MSPNs. Activation of the 
indirect pathway only predicted shorter SSRTs than activation of the hyperdirect pathway 
for higher levels of sleep deprivation. These predictions seem to agree with the findings 
of Li et al. (2008), in which it was reported that the STN was more active in individuals 
with long SSRTs and the caudate head more active in individuals with short SSRTs. The 
stop-signal task has not been administered within a sleep deprivation protocol; thus, 
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experiments are necessary to determine both the effect of sleep deprivation on SSRT and 
which pathways are involved across sleep deprivation. 
4.5 Conclusions 
Here we have introduce an updated implementation of the TELOS model that, in addition 
to accurately predicting results of classic oculomotor tasks, incorporates adenosinergic, 
dopaminergic and cholinergic effects in basal ganglia and frontal and parietal cortices to 
simulate performance on a psychomotor vigilance task under sleep deprivation. The 
model highlights several key regions of the brain which undergo modulation during 
prolonged wakefulness that leads to impaired ability to successfully plan and execute 
motor responses. Our addition of adenosinergic, dopaminergic and cholinergic 
modulation of distinct brain regions enables the model to test pharmacologic agents that 
target these neurotransmitter systems and study their effects within the brain and on 
behavioral outcomes. Our model has generated testable hypotheses for oculomotor tasks 
that have not been previously studied under a sleep deprivation paradigm. Additionally, 
our model proposes the involvement of the hippocampus, a region more associated with 
timed-reaction (e.g., trace conditioning) tasks than with reaction time tasks, and a 
potentially important brain region for a wide range of cognitive tasks that are susceptible 
to cholinergic, and therefore sleep deprivation, effects. 
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4.6 Mathematical model 
4. 6.1 Implementation and membrane equations 
The model was implemented as a system of ordinary differential equations and simulated 
in MatLab v7.3.0 (The MathWorks, Natick, MA) using a fourth order Runge-Kutta 
numerical integration method. Figures 4-3, 4-4, 4-5, 4-7 and 4-9 show all of the model 
cell types accompanied by the variables which represent their membrane potentials as 
described by nonlinear shunting equations of the general form 
dxi ( ) E I 
-=-Ax.+ B-x. I. -Cx.J. dt I I I I I (4.1) 
where xi represents the activity of the cell, the parameter A represents the rate of passive 
decay controlling how fast the cell returns to baseline activation levels in the absence of 
input, the parameter B is the excitatory saturation constant representing the maximum 
activity level of xi, the parameter C controls the level of inhibition, and I{ and 
I/ express excitatory and inhibitory inputs, respectively. 
4. 6. 2 Visual inputs 
At each time step, the visual field is divided into a two-dimensional 3 x 3 grid centered 
over the input space indexed by coordinate space ( x, y) . If an external visual stimulus is 
present at any position ( x, y), then the visual input I: = 1 ; otherwise, I: = 0 . All visual 
inputs to the model are delayed by 50 ms to simulate the approximate visual response 
latency ofPPC (Bisley et al., 2004). 
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Model inputs 1: are convolved with a Gaussian kernel to approximate visual 
cortical receptive field properties, in order to generate the pre-processed internal signal 
_ . (-(p-x)2 -(q-y)2J 
Jxy - L Ipq exp 2 
(p,q)e'¥ ( 0.5) 
(4.2) 
where 'Pis the set of eight nearest neighbors in the Cartesian input space. 
4.6.3 Parietal area 7a 
Inputs Ixy first excite cells in parietal area 7a. Visual inputs are received by PPC input 
layer P:. A transient onset response is elicited at PPC output layer P; resulting from 
interactions between excitatory P: and inhibitory interneuron P~, the activity of which is 
itself modulated by excitatory P: . The PPC input layer P: is defined by: 
1 dP: x ( x) 
---=-P + 1-P I 10 dt xy xy xy (4.3) 
In Eq. 4.3, Ixy serves as the excitatory signal toP:, and a passive decay term -P: causes 
activity to decrease towards zero in the absence of input. 
Activities P: excite inhibitory interneuron activities P~ defined by: 
1 dPI -~ = (1- pi )J, (Px)-BvP (PI) 1 0 dt xy 1 xy xy (4.4) 
In Eq. 4.4, the shunted excitatory input signal J;_ ( P:) with a faster-than-linear signal 
function is: 
.t;_ ( x) = {x2 for x ;::: 0.1 
0 for x < 0.1 
(4.5) 
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Low activity P:, cannot excite interneuron activity P~ due to the 0.10 threshold, but 
strongly excites P~ for rising values above threshold due to the faster-than-linear signal. 
When a stimulus is presented to the PPC, therefore, interneuron activity P~ is not 
initially active, but becomes strongly active after a delay. The strength of this activity, 
however, is balanced by inhibition activated by the cholinergic projection, BvP, arising 
from basal forebrain (see Eq. 4.31, which ensures that BVP > 0). 
Both populations of cells described in Eq. 4.3 and 4.4 project to PPC output cells 
P; with activity defined by: 
1 dPY -~= -Py +(1-Py)J, (Px)f (BVP)-lOOPY (P1 ) 2 1 0 dt xy xy 1 xy 2 xy xy (4.6) 
The weak passive decay term, -P;, in Eq. 4.6 allows P; to be quickly activated by 
shunting excitatory inputs to elicit a transient onset response from both P:,, with a faster-
than-linear signal in Eq. 4.5 for inputs above the 0.1 threshold, and a cholinergic 
projection, B;, with the linear signal function: 
J; (x) = 10+10x (4.7) 
This linear signal function defines a basal level of excitation that is modulated by the 
strength of the cholinergic input. Cholinergic inputs to inhibitory interneurons P~ and PPC 
output layer P; act synergistically to enable strong responses to visual stimuli when 
acetylcholine levels are high. 
The transient onset response IS truncated by delayed input from inhibitory 
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intemeurons, ( P~ r . Following the transient onset response cells, P~ continue to fire at a 
lower activity level for the duration of the visual stimulus. 
4. 6. 4 Lateral intraparietal cortex 
The model PPC also includes lateral intraparietal (LIP) neurons with activities P~ 
defined by: 
p~E = ( 3.5 + 0.5BVP)h ( P~ )+2F~ + h ( P~) 
p~I =1+ 2.: (10a([P~rr +0.3F~) 
pq*xy 
1 dPL 
_ _____![_ = _ 1 QpL + (1- pL) pLE _ pL pU 1 0 dt xy xy xy xy xy 
(4.8) 
The excitatory input, p~E , consists of three terms. The first term, ( 3.5 + 0.5BvP) h ( P~), 
carries visual information from parietal area 7a cell activities P~, the effect of which is 
shaped by the sigmoid signal function: 
(4.9) 
This sigmoid function ensures that the lower activity levels P~ following the transient 
onset response are able to excite LIP cells to maintain LIP representations for the 
duration of the visual stimulus. Visual information carried from P~ to LIP cells is 
modulated by cholinergic inputs arising from basal forebrain. 
The second excitatory term from FEF output layer cells, F~, excite LIP cells 
associated with the same retinotopic locus, zy, to promote a consensus in plan 
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representation between FEF and PPC in order to select and execute a saccade of the 
correct direction and amplitude. The third term, h ( P~) represents a recurrent on-center 
excitation shaped by sigmoid signal function: 
(4.10) 
which supports P~ activation while inhibiting neighboring cells via the recurrent off-
surround term 100 ( [ P~ J) 4 • This inhibitory signal, along with the signal from off-
surround FEF output cells, 0.3 F~ in Eq. 4.8, embodies competition among plans both 
within LIP, and between LIP and FEF, respectively. The symbol [argt indicates 
rectification: its value is the arg if arg ~ 0, and 0 otherwise. 
4. 6. 5 Frontal eye fields 
The model FEF plan layer cells are defmed by: 
(4.11) 
The excitatory input consists of three terms. The first term, BVP P~, carries plan 
representation from the LIP P; , modulated by cholinergic inputs from basal forebrain. 
The coefficient k!Pr on the second excitatory term, k!Prfs ( .1\f) scales the recurrent 
excitation generated from active fixation-related FEF plan layer cells shaped by the 
sigmoid function: 
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(4.12) 
Recurrent excitation from fixation-related FEF plan layer cells primes target-related FEF 
plan layer cells prior to the onset of the cue stimulus when the signal for fixation is 
strong. The parameter k!Pr = 0.00018 for target-related cells and k!Pr = 0 for fixation-
related cells. Without this term, activity of target-related FEF plan layer cells would be 
zero during the fixation interval. Non-zero activity from target-related FEF plan layer 
cells projecting to striatal direct pathway MSPNs, B8D, is necessary in order for activity 
in B8D to ramp over the fixation interval. 
The third excitatory term, k.vp [sxy -OAT, is fro?l superior colliculus (s~e Eq. 
4.37). The rectified signal grows linearly with Sxy above the signal threshold 0.4 but is 
zero for all Sxy below threshold. The parameter ks!P = 8 for target-related cells and 
ksfP = 0 for fixation-related cells. 
FEF plan layer cells are affected by passive decay, - F~, and are actively 
inhibited by FEF intemeurons, defined by: 
1 dF~ I ( I)[ ~ ( p) L] 
---= -0.5Fxy + 1- Fxy LJ fs Fpq + 0.8Pxy 
10 dt (p,q)-#(x,y) 
(4.13) 
The FEF interneuron mediates off-surround inhibitory projections from both FEF plan 
layer cells and LIP cells, which work together to ensure that the FEF plan layer holds 
only a single plan at one time. 
FEF plan layer cells are also inhibited by FEF postsaccadic cells, defmed by: 
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1 dF: x ( x) ( ) 
--=-0.5F + 1-F 100}; S 10 dt xy xy 6 xy (4.14) 
where lr, (x) is a Heaviside signal function, which transforms suprathreshold SC activity, 
S xy, above 0.20 to a constant signal with value 1: 
( ) _ {1 for x > 0.20 fr,x- 0 for x :::;; 0.20 (4.15) 
These post-saccadic cells fire upon partial completion of a successful motor 
response as indicated by strong SC activation (Eq. 4.37). Activity F:, silences FEF 
target-related planning activity. 
Once a plan has been excited in FEF, plan layer cell activities try to excite deeper 
FEF output layer cell activities (Figure 4-5) to execute the motor plan. FEF output cells 
will not fire, however, until a BG gate has been opened as a result of plan consensus 
between FEF plan layer cells, F~ , and LIP cells, P~. FEF output layer cells, F~, are 
defined by: 
(4.16) 
The excitatory input to FEF output layer cells, F~, from FEF plan layer cells, F~ , is 
gated by pallidal receiving regions of the thalamus, Txy. The thalamus is activated by the 
opening of a BG gate, and therefore FEF output cell activity is quiet until thalamic 
activity, Txy, exceeds a threshold of 0.20. FEF output layer cells are inhibited by FEF 
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postsaccadic cells once a motor response has been executed. The parameter k pfo = 1 0 for 
target-related cells and kpfo = 0 for fixation-related cells. 
4. 6. 6 Thalamus-projecting basal ganglia 
The model contains two basal ganglia loops, the first of which controls the timing of 
thalamic activation that allows FEF output cells to fire (Figure 4-5). The thalamus-
projecting basal ganglia loop includes five populations of cells that represent the striatal 
medium spiny projection neurons (MSPNs) of the direct and indirect pathway, the 
external segment of the globus pallidus, the subthalamic nucleus, and the internal 
segment of the globus pallidus. 
The striatal indirect B81 (Eq. 4.17) and direct B 8D (Eq. 4.19) pathways work in 
opposition to each other: activation of the indirect pathway keeps the BG gate closed to 
prevent a motor response, e.g. during fixation prior to the onset of the cue stimulus, and 
activation of the direct pathway opens the BG gate in response to excitation from plan 
representations in LIP, P~, and FEF plan layer cells, F~ . In this implementation of the 
model, however, it was also necessary to be able to generate an anticipatory motor 
response prior to the onset of the cue stimulus while the fixation stimulus was still 
present, that is, when LIP and FEF plan layer cell representations did not agree. The 
equations implemented below describe how this type of motor response is possible. 
The striatal indirect pathway is defmed by: 
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Bff ~(l-5,+a,X)35ff(?;:w~F; J 
Bf1 =(1+o2 -azx)(1+92:[F:qT +s:L[Fp~TJ 
pq pq 
(4.17) 
dES! = (1- BSI) BSI - BSI BSI 
dt E I 
The primary excitatory input to the striatal indirect pathway is the FEF plan layer 
cellF: where W}; represents the following map: 
WF = {1 if ( x, y) = ( 1, 1) 
xy 0 otherwise 
( 4.18) 
which filters out all activity except at the fixation location ( x, y) = (1, 1) 
Activity representing the fixation plan excites the indirect pathway to keep the BG 
gate closed. The strength of the fixation plan arising from the fixation-related FEF plan 
layer cell is modulated by a time-dependent habituation term, BH, which declines as the 
length of the fixation interval is extended (see Eq. 4.25). 
Striatal indirect pathway cells are inhibited by feedforward inhibitory 
intemeurons from FEF plan cells, represented by 9 L [ F:q r, and via feedback from FEF 
pq 
output layer cells, sL::[ F! J, once the BG gate has been opened. The projection to 
pq 
striatum of collaterals from deep pyramids, exemplified here by FEF output cells, is well 
established (Reiner et al., 2010), and it preferentially affects indirect pathway MSPNs, 
both through direct excitation and inhibition mediated by striatal intemeurons. Here it is 
assumed that the latter effect is dominant 
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In Eq. 4.17, dopamine and adenosine neurotransmitter levels are represented by 
the constants 5 and a, respectively (Figure 4-4). On the striatal indirect pathway, both 
dopaminergic D2 and adenosinergic A2A receptors are expressed post-synaptically on 
MSPNs, where they competitively modulate neuronal excitability (Xie et al., 2007). 
A2ARs and D2Rs are hypothesized to form heteromers on striatal indirect pathway 
MSPNs (Fuxe et al., 2007; Xie et al., 2007). Adenosine acting via A2ARs both promotes 
GABA release at the striatopallidal terminals (Shindou et al., 2001; 2008) and reduces 
D2R signaling, whereas dopamine acting via D2Rs opposes adenosinergic promotion of 
GABA release at the striatopallidal terminals (Fuxe et al., 2007). In the model, GABA 
released from striatopallidal terminals affects GPe activity, B0 Pe (see Eq. 4.21). Given 
such evidence that adenosine and dopamine have interacting rather than independent 
effects on the striatal indirect pathway MSPNs, we therefore model the A2AR-D2R 
heteromer as (1-52 +a2 ) rather than assuming independent post-synaptic effects, which 
would be modeled as ( 1- 52 ) ( 1 + a 2 ) • The term ( 1- 52 + a 2 ) is constrained such that 
(1-52 +aJ > 0. 
The adenosine antagonist, caffeine (Fredholm et al., 1999; Xie et al., 2007) 
reduces the sleep-loss-induced increase in response times on the PVT (Wyatt et al., 2004 
and Chapter 3). A divisive effect of caffeine was included on each adenosine factor in 
. X 1 Eq. 4.17 and subsequent equatiOns as = --. 
1+ X 
The striatal direct pathway is defined by: 
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pq 
BfD ~(!+a1X-01{9~[F:,t +300(!+a,x)BSJ J (4.19) 
dBSD = (1- BSD lnSD _ BSD BSD 
dt )DE I 
Direct pathway MSPNs receive excitation from both LIP cells, P~, and FEF plan layer 
cells, F~. F~ activity is filtered by W~, which represents the following map: 
we ={Oif(x,y)=(1,1) 
xy 1 otherwise 
(4.20) 
W~ therefore filters out activity occurring at the fixation location ( x,y) = (1,1). FEF and 
LIP are connected by reciprocal on-center off-surround pathways such that activity in 
analogous target-related cells cooperate whereas activity in discrepant target-related cells 
compete. Strong excitation is thus elicited with direct pathway MSPNs when plan 
representations in LIP and FEF are consistent. Inputs from FEF plan layer cells are 
modulated by an expectancy term, ( 1 + 200C0 ) , arising from prefrontal cortex output cells 
(see Eq. 4.29), to prime the direct pathway MSPNs during fixation prior to the onset of 
the cue stimulus. Strong excitation of the direct pathway opens the BG thalamic gate, T, 
to allow excitation of FEF output layer cells, F:; . 
Direct pathway MSPNs receive several inhibitory projections, including 
feedforward inhibitory intemeurons within striatum that are excited by FEF plan cells, 
represented here simply by 9 L [ F;q J and inhibition from local recurrent axon 
pq 
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collaterals arising from the striatal indirect pathway, B81 (Taverna et al., 2008). Release 
of GABA from these axon collaterals is modulated by pre-synaptic A2ARs (Mori and 
Shindou, 2003; Rosin et al., 2003). 
AIRs and DIRs are hypothesized to form heteromers on striatal direct pathway 
MSPNs and modulate neuronal excitability post-synaptically at corticostriatal terminals 
(Fuxe et al., 2007). Dopamine acting via DIRs promotes MSPN activity leading to an 
increased release of GABA at the striatonigral terminal to reduce activity in B0 P1 (see Eq. 
23). Adenosine acting via AIRs reduces GABA release at the striatonigral terminals and 
also inhibits DIR signaling (Fuxe et al., 2007). The action of the AIR-DIR heteromer was 
therefore modeled in a similar manner to the A2AR-D2R heteromer as(1+51 -a1). The 
term ( 1 + 51 - a1) is constrained such that ( 1 + 51 - a1) > 0. 
Inputs from direct pathway MSPNs, B8D, and activity ansmg from indirect 
pathway GPe, BGPe, converge on the GPi, B 0 P1, which is ultimately responsible for 
gating thalamic activity. The GPe is defined by: 
(4.21) 
GPe cells are tonically active, but receive additional excitation from the subthalamic 
nucleus, BsrN (Eq. 4.22). The primary inhibitory input to BGPe comes from the indirect 
pathway MSPNs, B 81 , such that when the indirect pathway MSPNs are active, GPe 
activity is suppressed. GABA release at the striatopallidal terminal is facilitated by pre-
synaptic A2ARs (Shindou et al., 2008). 
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STN activity, B8TN, is defined by: 
-
1 dBsm =(1-BSTN)(o.o16+o.o5 L [F~-oArJ-o.1BSTNBGP• 
25 dt (p,q);<(x,y) 
(4.22) 
Like GPe, STN cells are also tonically active, but receive additional inputs from target-
related FEF output layer cells. Although STN excites GPe, reciprocal projections from 
GPe inhibit STN, and therefore STN activity is self-limited by the GPe-STN inhibition 
(Wichmann and DeLong, 1996). GPe synergistically reduces GPi activity via a direct 
projection and indirectly by inhibiting STN, the activity of which promotes GPi 
activation. The GPi is defined by: 
(4.23) 
GPi are tonically active to keep the thalamic gate (Eq. 4.24) closed. Additional excitation 
from STN, which is activated by FEF output layer cells after the gate has been open, can 
re-close the gate. GPi activity is inhibited when converging inputs from the striatal direct 
MSPNs and the GPe on the indirect pathway are strong. These converging inputs can 
open the gate by reducing GPi activity below the threshold level of 0.30 needed to 
prevent thalamic activation, defmed by: 
dT =-1.5T +150(1-T )[0.3-BGPir 
dt 
(4.24) 
When the thalamic gate is opened by reduced inhibition from GPi, FEF plan layer 
cells are able to excite FEF output layer cells (Eq. 4.16). The fast integration rate in Eq. 
4.24 ensures that the gate opens rapidly. Activity T returns to 0 through the passive 
decay term -l.ST . 
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The model assumes an activity-dependent reduction in synaptic efficacy on the 
fixation-related FEF plan cell projection to indirect pathway striatal MSPNs. As the 
fixation interval is extended (Grossberg, 1968; 1972; Lovinger and Choi, 1996), 
excitation from the corticostriatal projection is reduced via a habituation term defined by: 
dBH ( H) ( ) H [ P ]+ 
--=0.11-B -0.25 1+a1X B F; 1 -0.1 dt 
(4.25) 
where BH habituates via term (1+a1X)Bn[~~ -0.1Jif activity in the fixation-related 
FEF plan layer cell ~~ > 0.1, but accumulates to a baseline level of 1 otherwise. The 
strength of habituation is modulated by the level of adenosine via the term(l + a 1X) 
following results by Lovinger and Choi (1995) reporting that adenosine acting via A1Rs 
on corticostriatal projections initiates short-term synaptic depression. 
4. 6. 7 Hippocampus and prefrontal cortex 
Hippocampal output cells, H 0 , are d~fmed by: 
(4.26) 
Hippocampal output cells monitor visual input via LIP, P~, for a mismatch between the 
expectation of the target stimulus and the current visual input (Kumaran and Maguire, 
2008; Olsen et al., 2009; Duncan et al., 2009). Starting 400 .ms after the onset of the 
fixation stimulus, the hippocampus receives a boost every 1 00 ms via r ( r = 5 ) for 15 
ms while the fixation stimulus remains on; otherwise, r = 1 . Hippocampal output cells 
are excited by fixation-related LIP input and inhibited by target-related LIP input. LIP 
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input is filtered through the signal function 
(4.27) 
Hippocampal intemeurons provide feedforward inhibition: 
1 dHI I VP ( I) ( L ) lOdt = -0 .1H + B 1- H l(x,y)~Cl,l) (4.28) 
This feedforward inhibition is suppressed by strong cholinergic input from basal 
forebrain and a passive decay term. 
Hippocampal output cell activity, H 0 , projects to prefrontal cortex, which 
generates a preparatory signal that primes the direct pathway for a motor response during 
the fixation interval. The preparatory activity, C0 , from PFC is defmed by: 
The excitatory term includes an effect of the hippocampal output projection, H 0 , and 
recurrent excitation if C0 exceeds a threshold value of 0.10. Both these effects are scaled 
by the factor rc , drawn randomly from the distribution in Figure 4-8 at the start of each 
trial. The strength ofthe recurrent excitation (Gao et al., 2001; McCormick et al., 2003) is 
proposed to grow with increasing levels of adenosine, represented by a 1 • Gao et al. 
(2001) reports that dopamine reduces recurrent excitation in PFC via D1Rs. There is 
evidence supporting the existence of ArR-D1R heteromers in PFC (Fuxe et al., 2007). 
Thus our hypothesis for an adenosine-mediated recurrent excitation in PFC proposes that 
adenosine acts via this heteromer with an opponent effect to that observed for dopamine. 
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Although our model implements this effect as direct excitation by adenosine, it may be 
the case that the heteromer exists on inhibitory intemeurons in PFC, and thus adenosine 
may act to boost recurrent excitation in the PFC by disinhibition. 
PFC activity is suppressed by feedforward inhibition, C1 : 
(4.30) 
PFC activity is strongly suppressed by activation of post-saccadic FEF cells once a 
response has been executed in SC. 
4. 6. 8 Cholinergic ventral pallidum/basal forebrain 
Cholinergic inputs to cerebral cortex project diffusely therein, and arise from the nucleus 
basalis of Meynert, which, like the ventral pallidum, is a part of the basal forebrain that 
receives a very strong projection from the striatum, especially from the nucleus 
accumbens, and so should be regarded as part of an extended BGS (Chapter 2). In the 
model, cholinergic neurons project to areas ofPPC to modulate the strength of the visual 
inputs and to FEF to modulate sensory-motor interactions (Figure 4-7). Cholinergic 
activity in the basal forebrain is defined by: 
Cholinergic cells are tonically active, and the term (1- a 1 X) represents suppression of 
ACh release by adenosine acting via A1Rs (Strecker et al., 2000; Stenberg et al., 2003; 
Thakkar et al., 2003). Phasic increases in acetylcholine are driven by activation of FEF 
output layer cells, based on experiments (Parikh et al. 2007, Parikh and Sarter 2008) 
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showing that the phasic increase in acetylcholine was locked to the onset of the cue-
evoked shift in behavior. Cholinergic basal forebrain neurons also receive inhibitory 
projections from the striatal indirect pathway MSPNs (Henderson 1997), with presumed 
A2ARs acting pre-synaptically at their terminals to facilitate GABA release (Rosin et al., 
2003; Shindou et al., 2001; 2008). There are two components of this indirect pathway 
control in the term (7 + F1). The F1 represents input from the model's indirect pathway, 
whereas the constant, 7, represents broader indirect pathway input from parts of the 
striatum not otherwise modeled, such as the shell of the nucleus accumbens, which has 
been strongly implicated as a site of caffeine effects (Salinas et al., 2002; Lazarus et al., 
2011). Adenosine amplifies the effects of these terms, but this amplification is 
counteracted by caffeine's divisive effect on the term X 
4. 6.9 Collicular-projecting basal ganglia 
The second basal ganglia loop is controlled by converging inputs of LIP and FEF output 
layer cells to excite SC cell activities to execute a motor response (Figure 4-5). The 
collicular loop, like the thalamic loop, contains two populations of striatal MSPNs. The 
collicular-projecting striatal direct pathway is defined by: 
G:E =(1+o1 -a1x)(sow~[P~T +1oots([F~T)) 
G'j/' ~(1-01 +a1X{10+20( :~p~J + h([F~J))] 
dGSD 
__ xy_ = (1- GSD) GSDE - GSD GSDI dt xy xy xy xy 
(4.32) 
Excitatory inputs from LIP and FEF output layer cells provide a second level of 
assurance that the plan to be executed is consistent. Inputs from LIP are rectified, and 
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input from FEF output layer cells are rectified and passed through the sigmoid signal 
function: 
(4.33) 
which requires FEF output layer cells to be strongly activated before they can activate 
MSPNs on the collicular BGS loop. The inhibitory inputs include the sum of rectified 
LIP inputs, the sum of all FEF output layer cells passed through the sigmoid signal 
function in Eq. 4.33 and the projection from the collicular loop's striatal indirect MSPN 
(Eq. 4.34). 
The collicular-projecting striatal indirect pathway receives projections only from 
the thresholded and rectified LIP cells and is defined by: 
(4.34) 
with map w; defined in Eq. 4.18 to filter out activity in non-fixation-related LIP cells. 
The collicular striatal indirect pathway holds the gate closed only when fixation-related 
LIP cells are active. 
Both collicular striatal direct and indirect pathway MSPNs include modulation by 
dopamine and adenosine, as described for the thalamic striatal indirect and direct 
pathways (Eqs. 4.17 and 4.19, respectively). 
The collicular striatal indirect pathway holds the gate closed during fixation by 
inhibiting GPe, which is defined by: 
(4.35) 
188 
GPe cells are normally active due to the balance of excitation and inhibition, but are 
strongly inhibited when striatal indirect pathway is activated. When inhibited, the 
decrease in GPe activity releases SNr from inhibition, which allows the gate for motor 
response to remain closed. 
The SNr controls the normally-closed gate to execute motor responses and is 
defined by: 
(4.36) 
As in the thalamic-projecting GPi, the collicular-projecting SNr is inhibited by strong 
converging inputs from striatal direct pathway and GPe. SC cannot be activated until SNr 
is inhibited below threshold. 
4. 6.10 Superior colliculus and motor response production 
The model SC consists of a population of cells, S xy, that are excited by consistent inputs 
from LIP and FEF output layer cells to execute a motor response: 
(4.37) 
LIP and FEF output layer inputs to SCare passed through the sigmoid signal function: 
(4.38) 
so that low levels of activity in either or both cell populations do not excite SC. High 
levels of activity in LIP and FEF output layer cells cannot alone activate a motor 
response; activity in SNr must also be reduced below a threshold of 0.30 in order to 
releaseS xy from strong inhibition, once SNr itself is inhibited. 
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In the original implementation (Brown et al. 2004), the model was designed 
specifically to generate saccade production; however, here we generalize the population 
of SC cells to serve as the trigger for execution of any motor response (e.g. button press). 
A motor response is generated when the level of any S xy exceeds a threshold of 0.20. 
4. 6.11 Updated indirect and hyper direct pathways to model the stop-signal task 
In order to model the effect of the stop stimulus in the stop-signal task, additional 
projections were added to the striatal indirect pathway MSPNs (Eq. 4.17) and to the STN 
(Eq. 4.22). The striatal indirect pathway MSPN for the stop-signal task includes the 
additional excitatory term(1+80.F(~,y)=(O,IJ), where (x,y) = (0,1) represents the stop 
stimulus: 
B: ~ (1-O, +a,) 3 .5B8 ( ~ W ,';F,:;) ( 1 + 80F(;,,,.,,,,1) 
Bf1 =(1+62 -a2)(1+92:[F:qr +52:[F~r) 
pq pq 
dES! = (1- BSI) BSI - BSI BSI 
dt E I 
(4.39) 
The STN for the stop-signal task includes the additional excitatory term, 
( 1 + 15.F(;,q)=(O,I)), such that 
1 dBSTN ( sm)( ~ [ o J+)( p ) STN GPe 
---= 1-B 0.016+0.05 L.. Fpq-0.4 1+15.F(p,qJ=co.1J -O.lB B 25 dt (p,q);<(x,y) 
(4.40) 
These additional projections were equal to 0 during the PVT and the other basic 
oculomotor tasks that were simulated and therefore does not change predictions of those 
tasks. 
CHAPTERS 
CONCLUSION 
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5.1 Empirical and computational approaches to understanding the role of adenosine 
in variations in reaction time across multiple time scales 
This dissertation presents new· empirical analyses and computational modeling to 
understand the mechanisms underlying variations in reaction time (RT) on simple RT 
tasks at multiple time scales. Using results from the psychomotor vigilance task (PVT), 
variations in RT were shown to depend on the duration of the preceding inter-stimulus 
interval (order of seconds), the time-on-task duration (order of minutes), and sleep 
deprivation duration (order of hours to days). Sleep deprivation was marked by dramatic 
impairment in performance on the PVT, including increases in lapses in attention and 
anticipation responses. A simple neural network model described these results as a 
change in the relative influence between excitatory and inhibitory processes during 
response preparation and a more detailed neural network model ascribed these changes to 
the effects of adenosine in the basal ganglia and cortex. This dissertation, therefore, 
advances the understanding of the role of adenosine in sleep and wake regulation in basal 
ganglia and cortex, and provides a detailed computational model that can be utilized to 
test the effects of sleep deprivation under the influence of wake-promoting 
pharmacological agents acting in opposition to adenosine's effects. 
The first part of the dissertation presented a conceptual model ofhow connectivity 
within the basal ganglia system (BGS) can give rise to the effects of sleep and wake 
observed in rodent lesion studies (Qiu et al., 2010; Vetrivelan et al., 2010). In these 
.. ·, ·;. ·~.· .. ~ .· 
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studies, lesions to striatal regions decreased wakefulness while lesions to the globus 
pallid us (GPe) produced strong increases in wakefulness across a 24-hr period. It was 
reported in Chapter 2 that these lesions were well described by the known interactions of 
the BGS with thalamus and cortex if cholinergic pallidal and striatal-recipient 
corticopetal zones (SRCP), including SI and NBM regions of basal forebrain, were 
included within the definition of the pallidal regions lesioned in Qiu et al. (20 1 0). There 
we noted that our model predicts that a GPe lesion in primates should not produce the 
same effect, because the corticopetal cholinergic and GABAergic cells that are common 
in rodent GPe although present in primate SRCP zones, are apparently absent from 
primate GPe, as such. Although there are species differences, Chapter 2 presented 
extensive evidence that cholinergic and non-cholinergic regions of basal forebrain are 
part of a larger region that is pallidal by virtue of receiving projections from striatal 
MSPNs, particularly the D2-ENK-MSPNs of the BGS indirect pathway. Furthermore, it 
was shown in Chapter 2 that lesions to such regions would produced the observed 
increase in wakefulness only if lesions differentially targeted GABAergic pallidal 
neurons while leaving cholinergic neurons intact; increased wakefulness could then be 
explained by a compensatory increase in cholinergic activity to cortex. 
Chapter 2 also outlined a role of adenosine and dopamine m sleep-wake 
regulation in the BGS. Dopamine acts synergistically on the striatal direct and indirect 
MSPNs to promote cortical activity, Adenosine acts synergistically on the striatal direct 
~. 
and indirect MSPNs to suppress cortical activity. Adenosine and dopamine interact 
within the striatum via A1R-D1R heteromers on striatal direct pathway MSPNs and A2AR-
~---
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D2R heteromers on striatal indirect pathway MSPNs. In the conceptual model presented 
in Chapter 2, it was proposed that rising levels of adenosine during sleep deprivation 
suppress cortical activity 'Via direct promotion of the striatal indirect MSPNs and 
indirectly by reducing the action of dopamine in the striatal direct MSPNs. Thus, 
increased indirect pathway and decreased direct pathway activation leads to a transition 
from a high cortical arousal state to a reduced cortical arousal (drowsy) state, which in 
turn produces impairments in cognitive performance. 
The second part of the dissertation presented an empirical analysis of 
experimental data to explore variations in RT across three time scales and under the 
influence of wake-promoting agents acting on the adenosinergic and dopaminergic 
systems. It was shown in Chapter 3 that RTs on the PVT depend on the length of the 
preceding inter-stimulus interval (lSI), with slow RTs occurring in higher frequency 
following short ISis and fast RTs occurring in higher frequency following long ISis. The 
simple neural network proposed in Chapter 3 attributed the RT-ISI relationship to the 
interactions between two processes: a time-dependent excitatory process that increased 
over the lSI as the expectancy for the target stimulus increased and a time-dependent 
inhibitory process that decreased over the lSI. Further exploration with the simple neural 
network model revealed that the time-dependent excitatory process alone was sufficient 
to reproduce the RT-ISI relationship. 
In Chapter 3 it was also shown that sleep deprivation resulted in impaired 
performance on the PVT, leading to an increase in lapses in attention and anticipations. 
Both lapses in attention and anticipations depended on the preceding lSI. Lapses in 
- l. 
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attention occurred more frequently following short lSI and anticipations occurred more 
frequently following long lSI. Sleep deprivation did not alter the RT-ISI relationship for 
non-anticipation, non-lapse RTs. Variations in RT, lapses in attention and anticipations 
also depended on the length of time into the task, with longer RTs, more lapses in 
attention, and more anticipations occurring in the fmal 2 minutes of the 1 0-minute PVT 
compared to the first 2 minutes. This time on task effect itself was subject to the effects 
of sleep deprivation, with greater time on task effects observed as the length of sleep 
deprivation increased. 
The simple neural network model presented in Chapter 3 was able to predict the 
observed increases of lapses in attention and anticipations under sleep deprivation with 
two parameter changes. An increase in the parameter representing the rate of increase of 
the time-dependent excitatory process generated an increase in anticipation responses at 
long lSI. A decrease in the parameter representing the salience of the target stimulus 
generated an increase in lapses in attention. Different combinations in these two 
parameters also reproduced the observation that lapses and anticipations co-vary at a 
relatively constant ratio of~ 7:1 for sleep deprivation durations longer than 24 hours, with 
variations in the total number of lapses in attention and anticipations due to circadian 
phase. These observations suggested that the underlying mechanisms generating the 
increased production of lapses in attention and anticipations were influenced by the same 
changes during sleep deprivation, which we proposed in Chapter 4 to be driven by 
adenosine. 
It was also shown in Chapter 3 that the wake-promoting agents caffeine and 
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modafrnil reduced RTs, lapses in attention, and anticipations without altering the RT-ISI 
relationship. Greater neurobiological detail was necessary to describe these effects than 
could be provided by the simple neural network model. Thus, in Chapter 4, the 
conceptual model proposed in Chapter 2 was merged with the TELOS model (Brown et 
al., 2004; Silver et al., 2012), which describes how the frontal cortex interacts with 
parietal cortex, BGS, thalamus and superior colliculus to generate planned and reactive 
saccadic eye movements. This updated TELOS model was implemented to describe the 
behavioral changes in RT reported in Chapter 3. 
The updated TELOS model included a detailed representation of the direct and 
indirect pathways of the BGS to control voluntary movement. Based on the conceptual 
model proposed in Chapter 2, the influences of adenosine and dopamine were 
incorporated within these pathways to describe how increasing levels of adenosine reduce 
thalamic and cortical activation, due to direct inhibition of striatal direct MSPNs activity 
via ArRs and indirectly through enhanced activation of the indirect pathway via A2ARs. 
These synergistic actions of adenosine within the BG predicted slower RTs and increases 
in the frequency of lapses in attention. 
In the model presented in Chapter 4, adenosine also reduced the activity of 
cholinergic projections arising from pallidal and SRCP zones of the basal forebrain, 
which were incorporated to modulate activity within the posterior parietal cortex (PPC). 
In the model, PPC generated an internal representation of the external visual stimulus that 
is processed by frontal cortical regions to activate a motor response plan. It was reported 
both in Chapter 2 and Chapter 4 that the activity of these cholinergic projections is 
. ' 
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reduced by adenosine acting on A1Rs under sleep deprivation. In the model, reduced 
cholinergic activity resulted in reductions in PPC representations of the visual stimulus, 
which was analogous to the reduction in the parameter representing the salience of the 
excitatory stimulus in the simple neural network model necessary for generating lapses in 
attention. In the detailed model, reductions in activity in the PPC propagated throughout 
the model to the BGS, impairing the ability of the direct pathway to activate the thalamic 
gate, thus leading to slower RTs and lapses in attention. 
One major hypothesis of the updated TELOS model was the necessity of a 
preparatory signal to prime the BGS direct pathway during the fixation interval to 
generate both non-anticipation fast RTs and anticipations, particularly at long lSI. This 
preparatory signal, which was functionally equivalent to the time-dependent excitatory 
process proposed in the simple neural network model in Chapter 3, was hypothesized to 
originate from activity arising from interactions between the pre-frontal cortex (PFC) and 
hippocampus (HPC). In the model it was proposed that the HPC functioned as a match-
mismatch detector which maintained in working memory an expectancy for the target 
stimulus and monitored the current visual stimulus, via a projection from lateral 
intraparietal cortex (LIP), for violations of this expectancy when the fixation stimulus 
was present. A transient boost in HPC activity was elicited for each time interval in 
which the fixation stimulus was detected and this information was integrated by the PFC; 
activity in PFC thus increased monotonically across the fixation interval. The model 
predicted that for longer fixation intervals, activity accumulation within PFC was 
sufficiently high to prime activation within striatal direct MSPNs enough to override 
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inhibition of the thalamic gate even prior to the onset of the target stimulus, thus eliciting 
an anticipation response. 
Although preparatory activity has been demonstrated in several cell types, the 
choice to model preparatory activity as arising from this HPC-PFC interaction was 
motivated by evidence from a study in which activity in HPC and PFC was shown to 
decrease in response to increased levels of acetylcholine and, further, that this decreased 
activity was correlated with a reduction in RT on a working memory task (Furey et al., 
2000). Our hypothesis was based on an assumption extending from these results, that 
decreased cholinergic input to HPC and PFC due to increased adenosine would increase 
their activity, leading to a higher preparatory signal from PFC to striatal direct MSPNs 
that would increase the number of anticipations observed at longer fixation intervals. 
Prior clinical reports have also implicated PFC as necessary for the normal RT-ISI 
relationship. The model also hypothesized that an additional action of adenosine was to 
reduce inhibition of recurrent excitation in PFC, which further contributed to an increase 
in preparatory activity, which elicited a greater number of anticipations in a dose-
dependent manner with increasing levels of adenosine. 
The updated TELOS model presented in Chapter 4 thus provided a hypothesis for 
how both increases in lapses in attention and increases in anticipations could arise from 
increases in adenosine levels under sleep deprivation. Increases of both response types 
depended on both direct and indirect effects of adenosine. Direct effects of adenosine 
within BGS increased the number of lapses and direct effects of adenosine within PFC 
increased the number of anticipations. Adenosine reduced cholinergic activity, which led 
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to an increase in the number of lapses via reduction of PPC activity and led to an increase 
in the number of anticipations via enhancement ofHPC-PFC. 
In Chapter 3, the simple neural network model included a time-dependent 
inhibitory process that decreased across the fixation interval. The minimal neural network 
model to produce the experimentally observed RT-ISI relationship and increases in lapses 
in attention and anticipations under sleep deprivation needed to include only the time-
dependent excitatory process and inhibition by the fixation stimulus without a time-
dependent decay. In the detailed model presented in Chapter 4, it was hypothesized that 
activity in the striatal indirect MSPNs decreased across the fixation interval due to short-
term synaptic depression incorporated via a habituation term. An action of adenosine via 
AIRs was also incorporated to modulate the strength of this short-term synaptic 
depression such that activity in the striatal indirect MSPNs declined more rapidly under 
sleep deprivation. In contrast to results from the simple neural network model, in the 
detailed model this time-dependent decay of input to the inhibitory indirect pathway was 
necessary to generate all the observed experimental results, particularly the increase in 
anticipations observed under sleep deprivation. 
The model in Chapter 4 was used to test contrasting experimental findings about 
whether caffeine mediates arousal primarily through AIRs or A2ARs. Although the results 
of some studies have suggested that arousal is mediated by caffeine acting via A2ARs 
only, model predictions suggested that some arousal effects of caffeine are mediated 
through AIRs, which supported results from Van Dort et al. (2009) and Maximino et al. 
(2011). Model simulations were also used to generate a testable hypothesis about the 
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effect of sleep deprivation on the stop-signal task. The model predicted that the stop 
signal reaction time (SSRT) would decrease under high levels of sleep deprivation, 
suggesting that it is easier to inhibit a pre-potent response under sleep deprivation, likely 
due to a decrease in the ability to perform the pre-potent response quickly. As the stop-
signal task has not been administered during a sleep deprivation study, it remains to be 
tested how model predictions compare to experimental findings. 
5.2 Future Directions 
The goal of the current set of data analyses and proposed updates to the TELOS 
model was to present and assess evidence to further elaborate and refme a hypothesis 
regarding how the effects of adenosine in the BGS and cortex may mediate changes in 
RT observed on multiple time scales and particularly under sleep deprivation. It is 
currently unknown whether increases in extracellular adenosine are solely responsible for 
impairments in cognitive performance observed under sleep deprivation. It is likely that 
changes in several neurotransmitter systems within BGS and cortex play an interactive 
role in such cognitive deficits. The review in Chapter 2 revealed several interactions 
between the BGS and the ascending arousal system which have not been included in the 
present model. For example, in Chapter 2 it was reported that the neurotransmitter 
histamine (HST) originates from the TMN of the ascending arousal system and acts via 
H3Rs on MSPNs to antagonize the effects of dopamine acting at both D1Rs and D2Rs. 
The recent study by Ellender et al. (20 11) supports the hypothesis that HST promotes 
switching from a sleep mode, which favors D2-MSPNs and indirect pathway activity, to a 
.. t' 
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wake mode, which favors D1-MSPNs and direct pathway activity. Whether changes in 
tonic levels of HST work synergistically with adenosine during sleep deprivation to 
promote indirect pathway activity and reduce thalamic and cortical activation by BGS 
remains to be determined. The actions of adenosine described in the detailed model in 
Chapter 4 appear to be sufficient to describe cognitive impairments observed on simple 
RT tasks; the inclusion of HST may be necessary to describe impairments observed on 
other cognitive tasks that involve BGS activation. 
Relatively little is known about the time course of adenosine across extended 
acute sleep deprivation episodes, as most of the literature regarding adenosine has been 
derived from mouse studies in which wakefulness was extended only up to 6 hours. For 
example, several published reports, including the data presented in Chapter 3, have 
revealed that cognitive performance under sleep deprivation is subject to circadian 
modulation. The assumption is that adenosine represents a homeostatic drive for sleep 
that increases under sleep deprivation. However, it is possible that adenosine levels are 
subject to circadian modulation, which would explain the circadian modulation observed 
in cognitive performance impairments. An alternate hypothesis is that the circadian 
system produces a compensatory drive that opposes the actions of adenosine within the 
BGS and cortex. Thus, one potential extension of the existing TELOS model would be to 
incorporate a circadian drive originating from the suprachiasmatic nucleus to test how 
circadian variations in predictions of performance are generated. Several models of the 
circadian system's inputs and outputs have already been proposed, including St. Hilaire et 
al. (2007). 
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A major assumption of the detailed model is the hypothesis that the HPC monitors 
the current visual input and signals the preparatory activity in PFC that primes the striatal 
direct pathway MSPNs in preparation for the upcoming target stimulus. Furthermore, it is 
unclear what role adenosine plays within this circuit. Several brain regions exhibit 
preparatory activity (e.g. Tinsley and Everling, 2000; Hikosaka et al., 1989). The HPC 
and PFC were hypothesized to generate this signal during the fixation interval on the 
PVT due to past reports identifying activity within HPC during the trace interval of trace 
conditioning studies which require timed reactions. Clinical studies have further 
implicated the PFC (e.g. V allesi et al., 2007). Further neuroimaging studies might 
implicate additional brain regions as contributors to preparatory activity during the 
fixation interval on the PVT. 
Neither the simple neural network model in Chapter 2 nor the detailed TELOS 
model in Chapter 3 attempted to describe the effects of time on task (TOT) on RTs, 
lapses in attention, and anticipations. Decreases in cortical and subcortical activation, as 
measured by regional cerebral blood flow (rCBF) by PET and fMRI, have been observed 
to be correlated with changes in performance across TOT, including in areas of thalamus, 
SI and cortical regions associated with the right frontoparietal attention network (Paus et 
al., 1997; Coull et al., 1998; Lim et al., 2010). The neural substrate underlying the TOT 
effect is unknown; the finding of decreases in rCBF in SI suggests that changes in 
cholinergic activation may be responsible for the decline in performance across the task. 
Parikh and Sarter (2008) report session-related elevations in cholinergic activity relative 
to pre-task baseline that peaked in pre-frontal cortex by 8 minutes, with lower, sustained 
201 
elevations in ACh release for the remainder of a 40-minute task. Recall that in results by 
Furey at al. (2000) and in our model, higher levels of ACh were associated with lower 
activity in HPC and PFC, resulting in slower RTs. Such session-related increases in ACh 
release within PFC may, therefore, explain TOT effects observed in PVT. Further 
experimental and simulation studies are necessary to determine such effects. 
The inclusion of dopamine and adenosine receptor subtypes in the detailed model 
enables predictions of the actions of pharmacological agents targeted towards either 
direct or indirect pathway function. For example, A2AR antagonists have emerged as a 
potential treatment for the primary motor symptoms of Parkinson's disease (Jenner et al., 
2009). Most studies of A2AR antagonists as a PD treatment have tested its administration 
in conjunction with dopaminergic therapy. Both A2AR antagonists and DA independently 
act to reduce the effect of adenosine. Few experimental studies to date have explored the 
use of A2AR antagonists as a monotherapy, or its effect on non-motor symptoms of PD, 
including sleep disturbances and cognitive dysfunction. One potential application of the 
model, therefore, would be to use model simulations to explore the interactions between 
sleep loss and cognitive dysfunction in PD to determine the best treatment options to 
ameliorate both motor and non-motor symptoms of PD. 
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Narrative Report 
My research as a computational research associate in the Division of Sleep Medicine at 
Brigham & Women's Hospital has included both computational and experimental 
approaches towards understanding the effects of light on the human circadian pacemaker 
and the effects of sleep deprivation on human cognitive performance and alertness. My 
early work focused on updating an existing mathematical model of the human circadian 
pacemaker (developed by Richard Kronauer) to include (1) effects of non-photic stimuli 
(2) melatonin phase resetting and suppression by light and (3) light wavelength 
sensitivity. In January 2011, I supervised an MIT student during a month-long extemship 
to incorporate a direct alerting effect of light on cognitive performance and alertness in 
this model. 
In addition to the mathematical modeling work, I have also explored new analysis 
methods for data collected in the DSM. I implemented a physiologically-based melatonin 
model (developed by Emery Brown) to estimate melatonin phase from plasma melatonin 
profiles (Master's Thesis). I supervised an undergraduate student on a research project 
comparing the estimates of this model to several other existing analysis methods for 
estimating phase; a publication of this work is currently under review with PLoS One. I 
have applied pattern recognition algorithms to predict current and future performance 
impairment from performance and alertness data collected both in the lab and in the field; 
a publication of this work is currently under review with Accident Analysis and 
Prevention. I am currently working on a project to estimate parameters of a model of 
sleep slow wave activity (developed by Peter Achermann) using a non-linear least 
266 
squares optimization procedure to compare differences in sleep slow wave activity 
between younger and older individuals before and after sleep deprivation. 
I have conducted two human inpatient research studies at Brigham & Women1s 
Hospital as project leader. One study explored the effect of monochromatic light 
exposure at different wavelengths on the pupillary light reflex. The other study explored 
the effect of very short duration light pulses on the phase resetting response of the human 
circadian pacemaker. This latter study has revealed that the human circadian system is 
more responsive to shorter duration light pulses than would be expected from existing 
studies and model predictions, and the former study uncovers potential mechanisms of 
circadian photoreception driving these unexpected responses to brief light stimuli. 
Publications for both of these studies are currently in preparation, and the results are 
being incorporated into the circadian light mathematical model. 
I am also completing my doctoral dissertation research at Boston University in the 
Department of Cognitive and Neural Systems. This work involves incorporating the 
effects of sleep deprivation within an existing computational model of the cortical, basal 
ganglia and thalamic circuits that interact to produce volitional movements. This model 
simulates a motor response to visual stimuli and captures many characteristic effects of 
sleep deprivation on motor planning and action, including longer reaction times, 
increases in attentional lapses and increases in anticipatory responses. The model 
incorporates the interaction between the adenosinergic and dopaminergic systems in the 
basal ganglia and can reproduce the effects of pharmaceutical agents (e.g. caffeine, 
modafrnil) on reaction times. Several publications based on this work are currently in 
preparation. 
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